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ABSTRACT 
The biological role of the trace metal chromium has 
been a much studied topic since it was identified as a major 
component of the glucose tolerance factor. This factor, 
isolated from yeast, has been. shown by numerous investigators 
to have a significant effect on the improvement of impaired 
glucose tolerance in certain animal and human subjects. It 
has also been shown to have a potentiating effect on insulin 
with regard to glucose oxidation by epididymal adipose tissue. 
Although the exact identity of the glucose tolerance factor 
is unknown at present, it is known with certainty that one 
of its components namely trivalent chromium, possesses simi-
lar activities. Such observations have led many investigators 
to label trivalent chromium as a cofactor of carbohydrate 
metabolism and a factor necessary for insulin action. In this 
dissertation the techniques of circular dichroism spectroscopy 
and frontal gel chromatography were utilized to provide evi-
dence for an interaction between insulin and trivalent chromium 
in an attempt to further clarify the role of this trace metal. 
A solution of porcine zinc-free insulin (1.71 X l0- 5M) 
. +3 +2 
was prepared in 0.067M phosphate buffer, pH 7.42. Cr and Zn 
were added to final concentrations of 1.71 X 10-4 and 0.85 X 
l0- 5M, respectively. Circular dichroism spectra were recorded 
over the range of 250 to 310nm. For porcine zinc-free insulin, 
a broad negative extremum was observed at 274nm with an 
·vi 
ellipticity of -143 deg cm2 per decimole. For porcine zinc 
insulin the negative extremum was observed at 276nm with an 
ellipticity of -165 deg cm2 per decimole. Addition of tri-
valent chromium to the porcine zinc insulin resulted in a 
significant diminution of the negative band to -144 deg cm2 
per decimole; the same ellipticity observed for porcine.zinc-
free insulin. These results are consistent with a dissociative 
effect for cr+3. 
Under similar conditions, the circular dichroism spectra 
of porcine zinc-free insulin at concentrations of O.lmg/ml, 
0.2mg/ml and 0.5mg/ml were recorded in lOcm, 5cm and 2cm cells, 
respectively, in an attempt to focus attention on the insulin 
aggregation process. For the O.lmg/ml solution in the lOcm 
cell, the negative extremum was observed at 274nm with an ellip-
ticity of -179 deg cm2 per decimole. For the remainding 
solutions, ellipticities of -191 and -197 deg cm2 per decimole 
were obtained. This clearly indicates a concentration dependent 
aggregation with progression to the more concentrated solutions. 
The addition of zn+ 2 to zinc-free insulin resulted in a signi-
ficant increase in the negative extremum in all three cases. 
Situations with both cr+3 and zn+2 present resulted in ellip-
ticities nearer to that of zinc-free insulin again highly 
suggestive of a dissociative effect for cr+3. 
Finally, the technique of frontal_ gel chromatography 
was utilized as an aid in the clarification of the previously 
discussed circular dichroism changes. Insulin concentrations 
over the range of 0.005 to 4mg/ml were studied and molecular 
vii 
weights from 4,503 to 26,077, respectively, were determined. 
The technique was then utilized to study the effect of Cr+3 
and Zn+ 2 on the aggregation of porcine zinc-free insulin in 
0.067M phosphate buffer, pH 7.42. Solutions identical to 
those used in the circular dichroism studies were chroma-
tographed. Molecular weights of 8,565, 10,079, and 12,502 
were obtained for zinc-free insulin at concentrations of 
O.lmg/ml, 0.2mg/ml and 0.5mg/ml, respectively. Pre-incubation 
of the insulin solutions with zn+ 2 resulted in molecular 
weights of 8,387, 11,022 and 16,866. Pre-incubation with 
+2 +3 . both Zn and Cr resulted in molecular weights of 8,521, 
10,187 and 13,105 for the same concentration sequence, further 
supporting a dissociative effect for Cr+ 3 . 
viii 
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CHAPTER 1 
INTRODUCTION 
Elements which are necessary for biological function 
are known as essential, that is, without them, life does not 
exist. This definition was broadened by Schroeder (1), to 
include those elements necessary for special purposes which 
1 
provide pe~fect health but without which life can still exist 
at an unhealthy level. Both of these categories remain un-
filled at the present time. However, with the help of 
sophisticated techniques, scientists are gradually unraveling 
the mysteries of the nature and mechanism of action of more 
recently characterized essential elements. By the most rigid 
definition, no trace element essential for life in other mam-
mals has been proven to be essential for human beings. In 
other words, according to Schroeder, no one has deprived a 
group of people of an element to the point that deficiency has 
resulted in death and as a result the minimal human require-
ments of many essential trace elements are not known. 
The Essential Trace Elements 
At present, two groups of elements (essential bulk 
elements and essential trace elements) have been defined (1). 
Under the heading of "essential bulk elements" are included 
calcium, sodium, silicon, potassium, magnesium, sulfur, phos-· 
phorus and chlorine. Included as "essential trace elements" 
1 
2 
are iron, manganese, fluorine, chromium, zinc, copper, cobalt, 
molybdenum, iodine, selenium, vanadium, nickel, and arsenic. 
In another study, tin and silicon have been designated as 
essential trace elements (2). Human requirements for most of 
the bulk elements are known since, according to Schroeder, 
disorders have resulted from depletion and have been cured by 
restoration. 
Let us now briefly review the principal functions of 
the essential trace elements. 
The role of iron in the body is almost exclusively 
confined to the processes of cellular respiration. Iron is 
a component of hemoglobin, myoglobin and cytochrome, as well 
as the enzymes catalase and peroxidase. In all of these 
compounds, the iron is a component of porphyrin. Collagen 
is synthesized by a series of sequential steps involving 
assembly of a praline and lysine rich polypeptide precursor 
called "protocollagen" (3). Hydroxylation of appropriate 
praline and lysine residues in protocollagen, which occurs 
before the collagen extrudes into the extracellular matrix, 
requires iron as Fe (II). No other metal ion will replace iron. 
Although animal experiments have indicated that man-
ganese is an essential element, its functions are poorly 
understood. In vitro, manganese activates several enzymes, 
among them blood and bone phosphatases, yeast, intestine and 
liver phosphatases, arginase, carboxylase and cholinesterase. 
A role for manganese as a coenzyme for certain intracellular 
respiratory enzyme systems has also been suggested. Deficiency 
F 3 
in animals and birds affects bone, reproduction, and brain 
growth, resulting in abnormalities of bony growth, stillbirths, 
early death and sterility of the mother and convulsions. 
It has been shown that fluorine is essential for growth 
and general development (2). Fluorine concentration in blood 
plasma is homeostatically controlled with bone and teeth 
serving as the main storage organs and containing normally 
between 100 to 7,000 ppm. The fetus contains fluorine and the 
placenta plays an active role in fluoride transfer. Rather 
constant concentrations are maintained in soft tissues such 
as liver, heart and brain. The element occurs in practically 
all foods and feeds; food being the main source for animals 
and man aside from drinking water. Fluoride is a poison for 
some enzyme systems. Specifically, it inhibits the conversion 
of glyceric acid to pyruvic acid by enolase in anerobic 
glycolysis. The importance of organically bound fluorine must 
be mentioned since it has been determined that the fluorine-
containing compound in human serum is a weak lipid soluble 
organic acid. Despite an increasing interest in this el~ment, 
certain basic questions such as the chemical nature of fluorine 
in food, discrepancies in the utilization of fluorine compounds, 
its biochemistry in soft tissues, and its mode of action remain 
to be clarified. 
Chromium has been classified as a necessary cofactor 
in carbohydrate metabolism. Studies have further suggested 
that trivalent chromium may act together with insulin in pro-
moting utilization of glucose. Chromium (III) is the element 
4 
of major interest in this dissertation and will be presented 
in greater detail later. 
Zinc is a structural and functional component of the 
enzyme carboxypeptidase A and participates directly in the 
catalytic action of the enzyme (4). Carboxypeptidase A 
catalyzes hydrolysis of that peptide bond which is adjacent 
to th~ terminal free carboxyl group. Zinc is also associated 
with several other enzymes, including carbonic anhydrase 
which is involved in acid-base balance and alcohol dehydro-
genase whiph begins the oxidation of alcohol. In all these 
enzymes, zinc is present in amounts stoichiometric to the 
number of catalytic sites. It has also been demonstrated 
that a zinc deficient diet impaired the cell mediated immune 
system whereas it did not adversely effect the humoral system. 
Copper is an excellent catalyst for oxidation-reduction 
systems, showing great versatility for an impressive variety 
of reactions, including an association with cytochrome oxidase 
of the electron transport scheme. Copper is also associated 
with catalase, tyrosinase, monoamine oxidase, ascorbic acid 
oxidase an<l uricase. In a recent study (5), copper chelates 
of certain drugs have been shown to improve anti-inflammatory 
activity dramatically. In the case of aspirin the copper 
aspirinate was found to be 20 times more active than aspirin 
in animal tests simulating arthritis. Compounds that normally 
don't show any anti-inflammatory activity, namely anthranilic 
acid and nicotinic acid, became active in animal tests when 
chelated with copper. In this study copper complexes were 
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also shown to have antiulcer activity. Since copper 
deficiency has been shown to lead to aneurisms and softening of 
bones in experimental animals, a role for copper in promoting 
the tensile strength of the f iberous proteins collagen and 
elastin has been suspected (3). 
Cobalt's principal function is as a necessary con-
stituent of vitamin B12 1 which is manufactured by bacteria 
and required by mammals for the production of red blood cells. 
Molybdenum is a constituent of the enzyme xanthine 
oxidase which is involved in the metabolism of purines to uric 
acid. Liver aldehyde oxidase, a f lavoprotein which catalyzes 
the oxidation of aldehydes, also contains molybdenum. This 
element is also a constituent of the nitrogenase enzyme 
complex involved in the process of nitrogen fixation by bacteria 
and blue-green algae. 
Iodine has only one well-established role in the body, 
namely, to complete the formation of thyroxin, the thyroid 
hormone, which contains four atoms of iodine per molecule. 
Very little is known about the specific role or roles 
of selenium and, to date, there are only three enzyme-catalyzed 
reactions that have been shown to require the participation of 
a selenium containing protein (6). These are the reactions 
catalyzed by (i) formate dehydrogenase of bacteria, (ii) 
glycine reductase of clostridia and (iii) glutathione reductase 
of erythrocytes. 
Nutritional studies from four laboratories have shown 
that vanadium is an essential trace element for the chick and 
r 6 
rat (7). Those physiological functions that became impaired 
when either the rat, or the chick, or both, consumed a diet 
low in vanadium were reduced body and feather growth, impaired 
reproduction and survival of the young, altered blood cell 
levels and iron metabolism, impairment of hard tissue meta-
bolism and altered blood lipid levels. In this study, current 
techn~ques of refinement and purification of diet constituents 
were implicated as the cause of the low levels of this element 
as well as others in man's diet. More specifically, high 
levels of ranadium have been reported to lower serum lipids, 
the effect resulting from the ability of this element to 
inhibit the synthesis of cholesterol. 
Nickel deficiency in chicks results in suboptimal liver 
function as evidenced by ultrastructural degeneration, in-
creased lipid and a decreased phospholipid fraction, Rats 
deprived of nickel also show a reduced oxidative ability of 
liver homogenates and abnormalities in the liver polysome 
profile. These findings (8) are consistent with nickel being 
an essential nutrient for chicks and rats. 
Arsenic may be an essential nutrient, at least in rats 
(9). Pregnant rats raised on a diet containing just 30 ppb 
arsenic developed rough hair, slow growth rates, and enlarged 
and darkened spleens that contained 50% more iron than those 
of control animals receiving 5 ppm of arsenic, Blood cells 
of off spring of the arsenic deprived rats broke down more 
easily in saline solution than those of control rats. 
Tin is necessary for growth in rats at a level of 
1-2 ppm in the diet (2). It occurs normally in foods, feeds 
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and tissues. Tin salts as well as organotin compounds are 
effective. Its biological chemistry is unexplored. 
Silicon is necessary for growth in rats, meta-silicate 
producing optimal effects at 50mg/100g in the diet (2). Bone 
deformations develop in silicon deficiency. Silicic acid in 
bound form is a building block of connective tissue, serving 
as a cross-linking agent. High levels of bound silicon wer~ 
detected in acid mucopolysaccharides and in connective tissue 
proteins, notably collagen. The silicon atom, having the 
same steroechemistry as carbon is structurally rigid and thus 
contributes to the architecture of connective tissue and 
membranes. 
Concerning the association of ions in biological 
systems, cytochrome c oxidase may be regarded as the ultimate 
in the integration of the functions of iron and copper. Here 
in a single molecule are combined the talents of the heme 
group and copper ions to bind oxygen, reduce it with electrons 
from other cytochromes in the electron transport chain and 
finally convert the reduced oxygen to water. Other cupro-
ferro (heme) proteins include a chemically similar enzyme, 
tryptophan-2,3-dioxygenase, that catalyzes the insertion of 
molecular oxygen into the pyrrole ring of tryptophan, yielding 
N-formylkynurine. It has been found to have two atoms of 
Cu(I) and two molecules of heme. Recent work on the biosynthesis 
of connective tissue components has revealed a direct role for 
iron and copper enzymes and a probable role for manganous and 
zinc ions as well. Finally, a recently discovered enzyme, 
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cysteamine oxygenase, has been reported to contain one atom 
each of copper, iron and zinc in a molecule weighing 100,000 
daltons (10). 
The discovery of the essentiality of these trace 
elements has opened up new possibilities in the areas of 
biochemistry and medicine. It is the purpose of this dis-
sertation to concentrate on one important essential trace 
element, namely chromium, in an attempt to further elucidate 
its mode of action in the development of impaired glucose 
tolerance.:-
Chemistry of Chromium 
The most important ore of chromium is chromite, Fecr2o 4 • 
The element was not known to the ancients, but was discovered 
in 1798 in lead chromate, PbCro4 , which occurs in nature as 
the mineral crocoite. 
Chromium is a member of group VIA of the periodic table. 
It has oxidation states ranging from Cr- 2 to Cr+ 6 , but it most 
1 Cro, +2 c +3 d c +6 common y occurs as Cr , r , an r , Divalent 
chromium, however, is relatively unstable, being rapidly 
oxidized to the trivalent form; thus only two forms, trivalent 
and hexavalent, are found in nature. The oxidation potential 
of hexavalent to trivalent chromium is strong, and therefore 
it is highly unlikely that oxidation of the trivalent form 
could occur !.!!.. vivo (11). The hexavalent form of chromium, 
almost always linked to oxygen, is a strong oxidizing .agent. 
By far the most stable and important oxidation state of 
chromium is chromium (III). It is the most stable of the 
9 
trivalent transition metal cations in water. The trivalent 
ion has a 3d3 configuration, which leaves 6 orbitals, 4sl, 
3d2, and. 4p 3 , to accept electron pairs from ligands. The three 
electrons of the Cr+ 3 ion are unpaired and are in low energy 
orbitals. 
Trivalent chromium forms octahedral complexes of co-
ordination number 6, and a large number of complexes are known 
including water, ammonia, urea, ethylenediamine, halide, 
sulfate and organic acids. Ligand displacement reactions of 
cr+ 3 complexes are about 10 times faster than those of Co+ 3 , 
with half-times in the range of several hours. It is largely 
because of this kinetic inertness that the compounds persist 
for relatively long periods in solution, even under conditions 
in which they are thermodynamically very unstable. Chromic 
ion does not exist in solution. It forms complexes with water 
and other anions in acid solution. In alkaline solution, it 
olates by forming polynuclear compounds that precipitate with 
time. Olation is enhanced by alkali and by heating to 
120°C (12). 
The hexaquo ion, [Cr(H2o) 6 J+3, which is regular octa-
hedral, occurs in aqueous solution and in numerous salts such 
as the violet hydrate, [Cr(H2o) 6 JC13, and in an extensive 
series of alums MCr(so4 ) 2 .12H2o in which Mis any common 
univalent, monatomic cation except for L:i+r which is too small 
to be accommodated without loss of stability of the structure. 
The aquo ion is acidic (pK=4), and the resulting hydroxo ion 
condenses, in a process referred to as elation, to give a 
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dimeric hydroxo bridged species: 
[Cr (H20) 61 
-H+ +3 __ __.. +2~ +4 [Cr (H20) 5oH] ~ [ (H 20) 5cl?""'OH- Cr (H O) ] 'ow·' 2 s 
on addition of further base, soluble polymeric species of high 
molecular weight and eventually dark green gels are formed. 
Direct evidence on hydration (aquation) is not easy to 
acquire. However, according to Benson (13), oxygen-18-
experiments have clearly established the existence of the 
species [Cr(H20)6]+ 3 . On mixing a solution of chromium and 
H2
18o, a ~~ow isotopic exchange takes place: 
[Cr(H2o)nl+ 3 + nH218o ;::=rcr(H218o)nl+ 3 + nH 2o 
which can be followed by sampling the oxygen-18 content of the 
solvent at various times by vacuum distillation. The isotopic 
exchange has a half life of about 40 hours at 25°C. For a 
given solution of chromium, the number of "unbound" water 
molecules can be calculated from the isotopic dilution which 
1 f h . . ' d . h h 180 . ' resu ts a ter a s ort mixing perio wit t e -containing 
solvent. The number of "bound" water molecules is the dif-
ference between this value and the total number present. The 
ratio of chromium ions to molecules of bound water was found 
to be 1 to 6 as a result of experiments similar to the above. 
The number of water molecules comprising the primary coordination 
shell of a metal ion has rarely been so exactly defined as 
for the case of Cr(III). 
The replacement of water in an aquo complex by an 
anionic group (the reversal of aquation) is called anation, 
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For example, consider a chromium complex in which A is a 
ligand: 
(CrA5H2o)+3 + Y----4 (CrA5Y)+
2 + H20 
The following scheme occurs: 
+3 (CrA5 ) + y +3 (CrA5 ) (Y ) 
+2 +3 -
rate= d(CrA5Y )/dt = k 3 (CrA5 ) (Y) 
In a study concerned with the behavior of chromium 
... 
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compounds in the physiological pH range (14), the absorption 
spectrum of chromic acetate in phosphate buffer exhibited 
two maxima near 420 and 570 nm. Both maxima underwent gradual 
bathochromic shifts to 430 and 600 nm respectively as the 
elation process began. Decreased absorbance (hypochromism) 
was also observed at both maxima. According to the article, 
a previous study resulted in a marked hyperchromism as the num-
ber of carboxyl groups coordinated to the central chromium atom 
increased. It was concluded that the bathochromic shifts with 
hypochrornism were evidence of the entrance of hydroxy groups 
into the coordination sphere of chromium. 
Chromium Occurrence in Biological Material 
One of the earlier experiments indicating that chromium 
ions might have biological activity was that of Curran (15) 
who showed that the synthesis of cholesterol and fatty acids 
from acetate by rat liver was enhanced in their presence. 
Since then many attempts have been made to establish tissue 
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levels of this element and to identify it with certain bio-
chemical reactions. Plasma chromium concentrations have been 
reported by many investigators (16,17). Most of the values 
fall between 10 and 50 ppb. Low plasma chromium levels may 
be suggestive of low dietary chromium intake, but they do not 
necessarily mean chromium deficiency. Plasma chromium is not 
in eq~ilibrium with the body stores and consequently may re-
flect only the most recent dietary intake. Feldman (18) 
reported an average plasma chromium concentration of 29 ppb 
with a range from 11 to 64 ppb. It has also been suggested 
(19) that plasma concentrations of chromium may only represent 
1/100 of the chromium concentrations in most organs. Reports 
on urinary chromium cover an even wider range, from nondetec-
table amounts to a maximum of 350µg/liter (20). In two care-
fully controlled studies, averages of 5 and 4µg/liter were 
found (21,22), with ranges from 3.5 to 6.Sµg/liter and 1.8 to 
llµg/liter respectively. 
The question of the valence state of chromium found in 
biological material has not been completely answered. Divalent 
chromium probably does not exist in biological material, since 
it is easily oxidized by air. It is possible to distinguish 
between the trivalent and hexavalent forms of chromium with 
methods that require oxidation to the highest oxidation state 
for solvent extraction or for formation of a colored complex 
(23). Omission of the oxidation step would result in the de-
termination of hexavalent chromium only. Another assay with 
the oxidation step included would yield the total chromium 
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content of the sample. The difference between the two would 
give a measure of the trivalent form. One group of investi-
gators, using atomic absorption spectroscopy and solvent 
extraction with and without prior oxidation, were unable to 
detect any hexavalent chromium in human serum (18). Also, 
after intravenous injection of chromate into rats no hexa-
valent chromium was detectable. Hexavalent chromium added to 
tissue in vitro was reduced within a few minutes, indicating 
that this valence state is very unstable when in contact with 
organic matter (24). As a result it has been concluded that 
chromium is probably present in biological matter in the tri-
valent state. 
In the absence of stabilizing ligands, the elation 
process of trivalent chromium discussed previously, would lead 
to the formation of large hydroxo bridged species of colloidal 
nature which would eventually precipitate out of solution. 
Reaction of cr+3 with ligands that successfully compete with 
OH- for coordination protects against precipitation at neutral 
pH by minimizing or preventing elation and resulting in soluble 
chromium-ligand complexes (25). It is this coordination with 
ligands present in the intestines that keeps chromium soluble 
and makes it available for absorption. 
Chromium-Protein Interactions 
As far as chromium-protein interactions are concerned, 
probably the best understood reaction of chromium with a protein 
is the chrome tanning of hide. The tanning process transforms 
collagen into leather through cross~linking of the protof ibrils 
...... 
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of collagen by chromium. · It has been suggested that chromium 
reacts with the free carboxyl groups of the acidic amino 
acids of the protein forming stable interchain and intrachain 
complexes. As confirmatory evidence, methylation of the free 
carboxyl groups prevents the tanning process (26). The tan-
ning reaction is initiated by raising the pH of the solution, 
resul~ing in the formation of elated complexes. These act by 
accepting carboxyl groups of the collagen strands into their 
.., 
coordination sphere, at the expense of previously bound water 
molecules.: 
By means of ultracentrifugation techniques, three metals 
namely Al+3, Fe+3, and cr+3, were shown to cross-link the pro-
tein conarachin II (27). Al+ 3 and Fe+ 3 reacted rapidly, but 
the metal-protein complexes were unstable and easily dissociated 
by dialysis against phosphate buffer suggesting an ionic bond. 
The reaction of chromium proceeded much slower with the re-
sulting complex resistant to dialysis against phosphate buffer. 
These findings indicate the formation of coordinate covalent 
links through which chromium binds to protein. 
The ability of trivalent chromium to stabilize the 
conformation of a protein was studied by Pchelin and co-workers 
(28). They studied the thermal dependent conversion of gelatin 
from a spiral form to a random conformation utilizing optical 
rotation techniques. They concluded that salts of trivalent 
chromium fix the random coil as well as the spiral conformation 
so that the transition does not occur. 
At pH 7.35, ovalbumin and human plasma proteins were 
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found to strongly bind Cr+ 3 as the acetate complex, but not 
+3 
er , as potassium chromate. (29). More detailed measurements 
~ vitro and in vivo subsequently demonstrated that of all 
serum proteins, siderophilin bound almost all the chromium 
administered in physiological doses (30). Stimulation of oxy-
gen consumption in a succinic-cytochrome c dehydrogenase system 
+3 by Cr· has been reported (31). Chromium had the greatest ef-
feet of all the metals tested, producing approximately twice 
the stimulation of the next effective element, aluminum, on a 
~ 
mole-to-mole basis. The enzyme phosphoglucomutase, which has 
a very important function in the early steps of glucose meta-
bolism, also has a requirement for chromium (32). There is 
evidence that the digestive enzyme trypsin contains one atom 
of chromium per enzyme molecule. Chromium can be removed by 
dialysis, indicating that it is not firmly bound. The residual 
activity of trypsin after dialysis is only 5% of the original, 
and it is restored to normal by addition of chromium (33). 
Chromium was also reported to stimulate the activity of another 
protein-splitting enzyme, rennin, as measured by an increased 
rate of milk coagulation (34). 
Chromium Requirement for Microorganisms 
The studies on the effect of chromium in bacteria re-
ported in the literature are few and do not allow a conclusion 
as to the function of the element in these organisms. Aerobacter 
aerogenes responded to a reduction of the metal content of the 
medium with a deranged pattern of fermentation products (35) .. 
Addition of chromium or manganese restored the pattern to normal. 
16 
chromium, like other metals, can inhibit various functions 
when higher concentrations are applied. Corynebacterium 
diphtheriae responded to 10-5M Cr+ 2 with reduced toxin pro-
auction and with depressed growth (36). Chromium, iron and 
aluminum in the trivalent state caused irreversible inactivation 
of E. coli (37). 
The relation between chromium and brewers' yeast is 
being investigated again, after it had been shown that brewers' 
y~st, but not Torula yeast, is an excellent source of glucose 
tolerance ~actor (GTF). This factor is a chromium-containing 
organic complex required for the maintenance of a normal glu-
cose tolerance in rats (38). It has also been shown (39) that 
the addition of glucose to the medium of brewers' yeast greatly 
enhances the uptake of chromium by this organism. The mechanism 
governing this stimulation is unknown. Also, a 16-hr preincu-
bation of the yeast with chromium, but not the direct addition 
of the element of the reaction flasks, resulted in a 40-50% 
stimulation of co2 production over that of controls. The re-
sults strongly suggest that the chromic ion does not act as the 
simple complex that is added to the medium (hexaquo chloride), 
but that it is built into an organic complex or chelate after 
it penetrated into the yeast. In another experiment, chromium 
containing fractions were extracted from yeast grown in a 
chromium-enriched medium. Addition of these fractions to yeast 
in the Warburg apparatus produced an immediate stimulation of 
co2 production, whereas chromic chloride was without effect in 
this system (39,40). This provided further support for the 
existence of an activated chromium complex. 
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Glucose Tolerance 
Male Sprague-Dawley rats fed a 30% Torula yeast ration 
for a few weeks after weaning developed a progressive impair-
ment of intravenous glucose tolerance (41). Glucose tolerance 
remained normal in rats fed the basal Torula diet to which 
was added a small percent of brewers' yeast (38). These ob-
servations suggested a deficiency in the Torula yeast ration 
of a yet unidentified nutritional factor. This unknown 
principle was designated glucose tolerance factor (GTF) to 
point out ~ts only then known function (42). Purified fractions 
were obtained that not only prevented the development of im-
paired glucose tolerance but also cured the impairment overnight 
with a single oral dose of lOOµg/lOOg of body weight. Careful 
ashing of an active preparation failed to destroy most of the 
initial activity. These observations indicated the presence 
of an inorganic material responsible for the biological effects. 
Subsequent testing of 47 different elements in GTF-deficient 
rats detected GTF activity only in trivalent chromium complexes 
(43). Similar effects have been observed when chromium com-
plexes were incorporated in the diet (44) or when they were 
intravenously injected (45), however the latter route required 
a lower dose, 
The influence of chromium on glucose tolerance is 
closely tied to the action of insulin (46). When rats raised 
on a low chromium diet were subcutaneously injected with 100 mu 
of insulin/lOOg of body weight after 18 hr of fasting, their 
hypoglycemic response was significantly less than that of 
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chromium-supplemented controls. Similarly, incorporation of 
glucose carbon into tissue glycogen 1 hr after injection of 
1 mu of insulin/lOOg of body weight was much greater in 
chromium-supplemented rats than in their chromium-deficient 
controls. Chromium-supplemented rats also maintained a higher 
glycogen concentration in their tissues after 18 hr of fasting 
than ~id low chromium controls. The results suggest that the 
impaired glucose tolerance in chromium deficiency may be due 
to a decreased response of the deficient animal to its endo-
genous insµlin. 
A more severe impairment of glucose tolerance than is 
observed in rats in an ordinary environment develops when 
the animals are maintained in a laboratory from which traces 
of metals are excluded as much as possible. The average glucose 
removal rate for 6 rats raised under these conditions was 
1.12 ~ 0.2 (47), as compared with 2.6 ~ 0.1 % /min' for a group 
in an ordinary environment (38). Chromium supplementation 
improved the impaired rate to an average of 3.5%/min, a value 
normal for rats of the age group utilized. 
Mode and Site of Chromium Action (Effect of Synthetic Chromium 
Complexes) 
Epididymal adipose tissue removed from rats raised 
on a low chromium diet exhibited a decreased glucose uptake 
in the presence of insulin as compared to the chromium supple-
mented rats (Table 1). Also, the addition of optimal doses of 
chromium to the medium resulted in a potentiation of the insulin 
effect, as reflected in a steeper slope of the dose-response 
... 
.. 
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TABLE I. ~Effect of dietary chromium supplementation on 
intravenous glucose tolerance and on glucose uptake by 
epididymal fat tissue [From Mertz, et.al. (44)]. 
. ·~'· 
.• 
•• 
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Glucose uptake 
Supplement N"o. of \\'eight Glucose removal rats rate l\Vith lmilli-Without unit insulin 
per Jlask 
-- ---
µg Cr/100 g diet" g 3 excess glucose/ µg/ 100 mg//,,b minb 
None g 244 3.7 ± 0.5 20 ± 3 
I 
33 ± 5 
1000 10 236 5.7 ± 0.5 22 ± 4 55 ± 5 
a Added as hexaurca chromium(III) trichloride. 
b l\Iean and standard error . 
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curve to insulin in the presence of chromium (Figure 1) , 
Chromium also increased the effect of insulin on the 
utilization of glucose for fat synthesis (44) as well as for 
oxidation to C02 (45), In these systems the magnitude of the 
effect of optimal chromium concentrations was similar to that 
observed when glucose uptake was measured. The fact that 
glucose uptake and the utilization of glucose for two dif-
ferent pathways are affected by chromium and that the element 
is ineffective in the absence of insulin suggests that the 
site of action of chromium is near the site of action of insulin. 
Mitochondria have been found suitable for polarographic 
measurements (48). Mitochondrial preparations exhibit a 
polarographic wave under appropriate conditions, that appears 
to originate from sulfhydryl groups located in the mitrochondrial 
membrane. This wave was shifted to a more positive potential 
when insulin was added, indicating a reaction of membrane 
sulfhydryl groups with insulin. Chromium was also shown to 
react with membrane sulfhydryl groups and to form a complex 
with three insulin molecules, Finally, when chromium was added 
to a mixture of mitochondria and insulin, the shift of the 
resulting polarographic wave to a more positive potential was 
threefold greater than the sum of the shifts caused by chromium 
or insulin individually (49). These results have been inter-
preted to mean that chromium facilitates the formation of 
disulfide links between the intrachain disulfide of insulin 
and the membrane sulfhydryls by participating in a ternary 
complex. It has been suggested that in such a complex the 
.·· 
.. 
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FIGURE l • .' Potentiation of low levels of insulin by 
chromium in vitro. Epididymal adipose tissue of low-
chromium rats incubated for 2 hr in Krebs-Ringer phos-
phate medium. Solid circles, without; open circles, 
with O.lµg cr+3/flask. [From Mertz, et.al. (44)). 
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chromium probably coordinates to the four sulfur atoms in-
valved in the formation of the disulfide bridges. It remains 
to be proven, however, that the chromium-sulfur bonds are of 
major importance when one considers the possible interaction 
of this metal with other residues. 
Metabolism of Chromium 
Chromium is excreted in urine and feces. Urinary ex-
cretion is the major route, accounting for at least 80% of 
injected chromium, but elimination via the intestine also plays 
a role although the mechanism remains unclear. The plasma 
chromium level in the fasting state is not a meaningful indi-
cator of the tissue chromium stores and may be related to the 
nutritional chromium state only in extreme cases. A much more 
sensitive indicator is the reaction of plasma chromium to a 
glucose challenge (50). It was found that young, healthy 
persons responded to an oral glucose load of lOOg with a dis-
tinct rise of their plasma chromium levels within 30-120 minutes. 
Increases from 30 ppb in the fasting state to 150 ppb after 
glucose have been observed. In contrast to these findings, 
rises were not always seen in diabetic patients. In four dia-
betics with impaired glucose tolerance, plasma chromium did 
not respond to glucose at all. After two of these were given 
daily chromium supplements for extended periods of time, which 
led to an improvement of glucose tolerance, both exhibited 
pronounced increases in their chromium levels during repeated 
glucose tolerance tests. Similar results were seen in 
diabetics to whom chromium was given but failed to improve 
glucose utilization. 
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The lack of plasma chromium response and its appear-
ance in certain diabetics after chromium supplementation 
suggest that the plasma increments of chromium after a glucose 
load are derived from a specific pool that may be deficient 
in some persons and that can be replenished after a period of 
chromium supplementation. The form in which chromium appears 
in the plasma is unknown, It might be the biologically active 
complex, glucose tolerance factor, secreted into the plasma 
when excessive amounts of glucose have to be metabolized. 
In ~ recent study concerning the role of chromium in 
the diabetogenic effect of pregnancy (51), the mean fasting 
Cr concentration for pregnant women near term was found to be 
considerably lower than that of nonpregnant subjects. The 
administration of an intravenous or oral glucose load did not 
result in any significant change in the low plasma chromium 
concentration of pregnant subjects, but it consistently provoked 
a rapid fall of plasma Cr in nonpregnant subjects. This fall 
in plasma Cr in normal women was not accompanied by a decrease 
in plasma concentrations of other heavy metals. Fasting levels 
of blood glucose were within the normal range for all subjects. 
The mean rate of glucose assimilation after a single glucose 
load was nearly identical for the pregnant and nonpregnant 
subjects, however, decreased tolerance to glucose was demon-
strated with repetitive glucose loading for the former group. 
Also, mean fasting plasma insulin levels were statistically 
similar, however, the pregnant group exhibited an expected 
marked increase in insulin release after a glucose load that 
was not exhibited by the normal group. The investigators 
' 
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suggested that the failure of pregnant women to respond with 
a plasma chromium fall may be related to the already depressed 
state of the plasma chromium concentration. The fall in plasma 
chromium in this study was in contrast to the observations of 
a previous study (50). The authors suggest that the exaggerated 
insulin secretion in pregnant subjects may be compensatory for 
the i~pairment of peripheral glucose utilization. They further 
suggest that Cr may be necessary for insulin to express its 
maximal hormonal action and that the poor chromium mobility 
in pregnan~y may be related to the altered carbohydrate meta-
bolism and insulin ''resistance" observed in late pregnancy by 
various investigators (52,53). The developing fetus reportedly 
accumulates chromium such that fetal tissues at term contain 
appreciably higher levels than maternal tissues (54). Mertz (55) 
suggests that pregnancy may accentuate the marginal chromium 
nutrition in the mother and result in a lowering of the body 
stores of chromium. 
In another study it was shown that the stress of acute 
infectious illness induces a decrease in serum chromium con-
centrations following a glucose load (56). Such factors as 
decreased food intake were eliminated but increased excretion 
and metal redistribution remained to be investigated. The 
authors concluded that such alterations in Cr metabolism may 
be related to the diabetogenic characteristics of pregnancy 
and that decreases in plasma Cr may serve as a sensitive 
indicator of peripheral carbohydrate metabolism. It was also 
pointed out that stress-induced chromium deficiencies may an-
tagonize insulin action which may in 9art explain the prediabetic 
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or glucose intolerant states observed during infection and 
pregnancy. 
ToxicitV of Chromium 
According to a recent report (25) published by the 
committee on Biologic Effects of Atmospheric Pollutants, a 
division of the National Academy of Sciences, chromium as a 
metal was labeled as biologically inert and unable to produce 
toxic or other harmful effects in man. Also, compounds of 
chromium in the trivalent state were stated as having no es-
tablished' toxicity. According to the report, the chief health 
problems associated with chromium are related to hexavalent 
chromium compounds, which are irritant and corrosive and may 
be absorbed by ingestion, through the skin and by inhalation. 
Acute systemic poisoning was stated as a rare occurrence and 
usually accidental. Chromium in the hexavalent form was clearly 
implicated as a cause of ,ulceration of the skin and of ulcera-
tion and perforation of the nasal septum. The report pointed 
out that the only important long-term effect of hexavalent 
chromium was an increased incidence of lung cancer in workers 
exposed to high levels of airborne chromate and that the in-
cidence of cancer at other sites in the body is not increased; 
nor does the risk appear in the user industries. Skin effects 
of hexavalent chromium were classified as "Primary Irritant 
Dermatoses" and "Allergic Eczematous Contact Dermatitis". 
Glucose Tolerance Factor (Actions) 
The effect of trivalent chromium complexes on the im-. 
provement of impaired glucose tolerance has been discussed 
~ : above (50). 26 The glucose tolerance factor (GTF), extracted 
from brewers' yeast also has the ability to improve impaired 
glucose tolerance. The extraction procedures differ among 
investigators, from a simple alcohol extraction followed by 
fractionation by gel filtration (57) to a 50% ethanol extraction, 
adjustment to pH 3.5, treatment with activated charcoal, elution 
with .NH40H-ethanol-ether followed by Dowex-50 cation exchange 
and Sephadex column chromatography (58). As discussed pre-
viously, GTF has chromium as its active ingredient. At present 
the chemi~al nature of this factor has not been determined with 
certainty, however, some of the biological properties have been 
characterized. In the rat epididymal adipose assay, GTF frac-
tions produced a significant increase in co2 production from 
glucose-1-14c in the presence of insulin as compared to controls 
of insulin alone (57). In another study (59) a single intra-
peritoneal injection of GTF significantly lowered the non-fasting 
plasma glucose levels in genetically diabetic mice from 830 to 
537 mg/lOOml (29%), 4 hrs post-injection. Furthermore, in 
support of the suggestion that insulin and GTF act synergis-
tically, a combination treatment of GTF and insulin was found 
to be more effective than either treatment alone. GTF lowered 
the non-fasting plasma glucose level by 180 mg/100 ml (16%) 
12 hrs post-injection, insulin lowered the glucose level by 
128 mg/100 ml (11%), while the combination of GTF and insulin 
lowered the level by 406 mg/100 ml (37%). 
Recently a group of investigators observed that diabetic 
patients excrete less GTF-chromium in their urine than do 
non-diabetics (60). This low incidence of GTF-chromium in 
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diabetic urine was presumed to arise through a blockage or 
impairment in the in vivo conversion of chromium to its bio-
logically active form. In this study several insulin re-
quiring diabetics were given 10 grams of brewers' yeast (the 
richest source of GTF) daily. According to the investigators, 
the subjects experienced an average decrease of 25 units in 
their daily insulin requirement, resulting in a decrease of 
one-fourth to one-third of the insulin need. 
As far as chromium-insulin interactions are concerned, 
it has be.en discussed above that trivalent chromium forms 
complexes with insulin and mitochondria and that both com-
plexes may involve chromium-sulfur linkages (48). It has 
also recently been shown that partially purified GTF binds 
to insulin, the resulting product having a significantly 
greater effect on glucose uptake by epididymal adipose tissue 
that that of native insulin (61). According to the authors, 
acetylation of the a and £ amino groups of insulin inhibited 
the binding of GTF to insulin thus implicating these moieties 
in GTF binding. The acetylation of insulin also inhibited 
the potentiating effect of GTF with respect to glucose uptake 
by epididymal adipose tissue. 
Identification of The·Glucose Tolerance Factor 
According to one group of investigators (19), two cate-
gories of chromium exist in nature. The first consists of 
simple compounds such as chrom alum and chromic chloride 
which have been shown to possess insulin potentiating activity 
in vitro. The second category consists of compounds related 
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to GTF which have outstanding insulin potentiating activi-
ties in vitro. Since the discovery of the glucose tolerance 
factor or as it is sometimes called "compounds exhibiting 
GTF activity", many attempts have been made to elucidate its 
structure. Recently nicotinic acid was identified by mass 
spectroscopy as the compound associated with chromium in the 
complex (58). According to the author, analysis of highly 
purified GTF preparations from yeast also indicated the pre-
sence of glycine, glutamic acid and a sulfur containing amino 
acid. With this in mind an attempt was made to synthesize 
synthetic compounds which hopefully would exhibit GTF activity. 
Synthetic complexes were prepared which potentiated the action 
of insulin on glucose oxidation by chromium deficient rat 
epididymal adipose tissue and improved the impaired glucose 
tolerance of chromium deficient rats when injected intra-
venously (62). Another study was performed to eliminate 
nicotinic acid as the causative agent (63). It was found 
that the product of incubating nicotinic acid with insulin 
at a molar ratio of 1 was no more effective on glucose oxi-
dation than insulin alone whereas that of nicotinic acid-
chromium complexes and insulin was significantly more potent. 
The results of another study (64) concerned with the 
comparison of certain physical and chemical properties of 
synthetic nicotinic acid-chromium complexes and purified 
concentrates from brewers' yeast yielded striking similar-
ities. In both cases absorption spectra were almost identical 
with a maximum at 262 nm. Biological activity was found in 
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similar eluates of Dowex-50 cation columns eluted with NH4 0H 
and Sephadex G-15 columns eluted with acid. Also, similar 
Rf values were found through paper chromatography utilizing 
biological activity as a means of identification. According 
to the author, the findings suggest, but do not prove, that 
GTF activity of yeast is related to nicotinic acid-chromium 
complexes. 
At present the exact structure of the synthetic nico-
tinic acid-chromium complexes is not known with certainty. 
Recently, in analogy to the well known nicotinic acid complexes 
of other transition metals, it has been suggested (65) that 
the complex could be described as the tetra-aquo-dinicotinato 
form (Figure 2) . A complex such as this can still undergo 
olation and eventually precipitate out of solution with time. 
Stabilization of the complex can be achieved however by re-
placing the coordinated water molecules with ligands not 
undergoing elation. Since glycine, glutamic acid and a sulfur 
containing amino acid were also found to be associated with 
the glucose tolerance factor, an attempt was made to react 
these amino acids with the preformed chromium-nicotinic acid 
complex in the following manner (58). Chromic acetate and 
nicotinic acid were dissolved at a molar ratio of 1:2 in 80% 
ethanol and boiled under reflux for 2 hours until the color 
of the preparation had turned to blue. Subsequently 
L-glutamic, L-glycine and L-cysteine were added at molar 
ratios to chromium of 1:1 and the solution boiled under re-
flux for an additional 6 hours. At the end of the reaction 
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FIGURE 2~ Tetra-Aquo-Di-Nicotinato Chromium Complex 
[From Mertz (65)]. 
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the ethanol was distilled off in vacuo and the clear purple 
solution was filtered from an insoluble precipitate. The 
resulting compound (soluble fraction) showed great stability 
against alkali and heat and also exhibited biological acti-
vity equal to or greater than that of the tetra-aquo-dinico-
tinato chromium complex. An appropriate structure was 
sugg~sted (Figure 3). 
A possible mode of interaction between GTF, insulin and 
the receptor site has been proposed utilizing the synthetic 
models di~cussed above (58). The two nicotinic acid ligands 
supposedly are attracted to basic groups on the insulin mole-
cule and tissue receptor, thus bringing the insulin close 
to its site of action (Figure 4). According to the authors, 
the amino acids coordinated to the four coplanar sites are 
important for stability during transport of the complex and 
would have to dissociate and be replaced by water molecules 
before the ternary complex can be formed. The four coordinated 
water molecules could then exchange with the four sulfur 
atoms involved in the disulfide exchange reaction. Again, 
I would like to point out that the exact chemical structure 
of the naturally occuring glucose tolerance factor has not 
been identified arid that these structures and modes of inter-
action are only hypothetical. 
Levels of Chromium in Human Tissues 
It has been shown that the chromium content of human 
tissue declines with advancing age (66). According to 
Mertz (67), a decrease of tissue levels of several elements 
... 
.. 
FIGURE 3.: Possible structure of dinicotinato-amino acid 
Cr-complex [From Mertz, et.al. (58)). 
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FIGURE 4 .. Hypothetical ternary complex of chromium at 
site of action [From Mertz, et.al. (58)]. 
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has been observed during the early days of life, however 
chromium is outstanding in that its concentrations continue 
to decline until old age. He proposes that the overall 
decline can be discussed from two aspects. It may be a re-
flection of a normal process, eliminating from the organism 
I 
excessive amounts that are no longer required as age increases. 
The .alternative explanation is nutritional. It assumes that 
a suboptimal dietary chromium intake is the cause for the de-
clining tissue levels in the U.S. population. According to 
the authqr, it is probably safe to accept an average chromium 
concentration of Sµg/liter of urine in the U.S. population, 
corresponding to an average daily urinary excretion of 7-8µg. 
Accepting the highest observed figure for absorption of chromic 
chloride, 3% of an oral dose, the daily dietary intake would 
have to be at least 270µg of the element in order to compensate 
for the losses. This is considerably less than the estimated 
50-BOµg of chromium in the average U.S. diet. At present, 
the average dietary chromium requirement of man is a much de-
bated issue, however, if the above figures are valid, it is 
evident that a suboptimal chromium intake could easily lead 
to a depletion of body chromium stores. 
According to Schroeder (1), the causes of the losses 
from body stores in adolescence and later are probably ex-
plained as follows: When pure sugar (glucose) is fed in a 
large amount to a fasting person, three changes take place: 
a) blood sugar is elevated; b) insulin in blood increases; 
c) chromium in blood increases, being mobilized from tissue 
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stores. In a diabetic, variable amounts of sugar are ex-
creted in the u~ine whereas in normal people little or none 
may appear. The chromium in the blood, elevated in response 
to the sugar and perhaps accompanying the insulin, reaches 
the kidneys where some is excreted, perhaps 20% of that in 
the blood according to Schroeder. At this point the author 
impl.icates the refining of foods and points out that if the 
sugar is unrefined and contains chromium as all unrefined 
sugars do, presumably enough is absorbed to compensate for 
the urinary loss and as a result no net loss develops. Fur-
' 
ther information is provided concerning the chromium content 
of refined and unrefined sugar. 150 grams of glucose was 
reported to have 3-4µg of chromium whereas a similar equiva-
lent of raw sugar contained approximately 36µg of the metal. 
These facts together with the obligatory urinary loss of 
12-25µg of chromium per day as reported by Schroeder could 
lead to a severe depletion of chromium. The report also 
stated that the major source of carbohydrate calories in the 
American diet other than sugar is refined white flour. Re-
portedly whole wheat contains 175µg of chromium per 100 grams 
whereas refined white flour contains 23µg. Also white bread 
has 14 while whole wheat has 49µg of chromium. 
As stated previously, chromium deficiency may be a 
contributing factor to the impaired glucose tolerance asso-
ciated with late pregnancy (51). It has also been demon-
strated that the mean chromium level in the hair of parous 
women was less than one-third of the average concentration 
in nulliparous women (68). In another study it was re-
ported that hair chromium levels were significantly lower 
for diabetic children as compared to nondiabetics (69). 
Also, a recent study concerned with the determination of 
hepatic chromium content in post-mortem tissue from diabetic 
and control subjects demonstrated a significantly lower mean 
hepatic chromium content for the diabetic group thus support-
ing ~he relationship between impaired glucose tolerance and 
chromium deficiency (70) . 
Effect of Chromium Supplementation 
' 
It has been reported that oral supplementation with 150 
to lOOOµg of chromium (III) per day for 15 to 120 days was 
associated with an improved glucose tolerance in 3 out of 6 
diabetics (71). In the same study short term administration 
of the element was ineffective. Also, the glucose tolerance 
of normals was not influenced. One interesting aspect of 
this study was ~he utilization of the following tests in an 
attempt to detect untoward reactions to chromium (III). The 
following determinations were performed during control tests 
and post test periods: erythrocyte sedimentation rate, hema-
tocrit, total and differential leukocyte counts, erythrocyte 
morphology on sme~r, blood urea nitrogen, creatinine clearance, 
urine concentrating ability, renal excretion of phenosul-
fonphthalein, plasma clearance of bromsulfalein and serum 
levels of alkaline phosphatase and glutamate-oxaloacetic 
transaminase. With the above criteria, no detectable toxicity 
was found. 
i 
l 
According to the authors, the improvement of glucose 
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tolerance observed could be due to a mechanism by which 
chromium facilitates the insulin-tissue interaction resulting 
in a more effective insulin action. The authors also point 
out that impaired glucose tolerance is not the only symptom 
of a low chromium state in animals. A more severe deficiency 
results in depressed growth and life span as compared with 
chromium supplemented controls. Also the incidence of athero-
mata in the aorta as well as the concentration of aortic lipids 
increase significantly. An excellent treatment concerning 
chromium,'deficiency and atherosclerosis has recently been 
presented (1). Finally, the authors we.re quick to point out 
the fact that their data, as well as that of others (25), 
was consistent with the hypothesis that not all cases of 
diabetes are complicated by chromium deficiency. 
In another study (72), chromium (III) supplements of 
lSOµg daily were given to 10 apparently healthy residents 
of an old-age home. Each elderly subject exhibited an ab-
normal oral glucose tolerance test. Chromium administration 
was associated with disappearance of all abnormal features 
of the mean glucose tolerance test in 4 of the 10 elderly in-
dividuals so treated, and with no change in the test of the 
remaining 6 subjects. It was suggested that some of the 
non-responders may have been severely deficient of chromium 
and may have shown improvement in the glucose tolerance test 
if chromium supplementation had been continued over a longer 
period of time. 
It has been suggested that chromium (III) deficiency 
may be the cause of the impaired glucose tolerance seen in 
J8 
certain malnourished infants. As a result the effect of 
chromium (III) administration was investigated (73). Twelve 
malnourished infants with impaired glucose tolerances were 
treated with 250µg of Cr(III) as CrC13 .6tt2o. All twelve im-
proved rapidly whereas only 2 out of the 5 cases not given 
cr(III) improved. In another study, the effect of chromium 
(III) on the fasting blood sugar levels and glucose removal 
rates in cases of protein-calorie malnutrition of the marasmic 
type was investigated (74). According to the authors, 9 of 
the 14 ca~es of infant Marasmus included in the investigation 
showed a significant improvement of glucose removal after 
administration of chromium. No change was observed in five 
of the cases. Also, the administration of chromium caused 
no significant changes in the fasting blood sugar values. 
Insulin Biosynthesis and Release 
Despite the fact that accounts of diabetes mellitus 
appear in man's earliest medical literature, the etiology 
of the condition remains unknown. According to a recent 
article (75), diabetes is a rapidly increasing health problem. 
The number of diabetics in the United States has grown from 
1.2 million in 1950 to an estimated 5 million now, an in-
crease of more than 300 percent while the population has 
grown only about 50 percent. Treatment with insulin has 
markedly increased the life expectancy of diabetics. But 
in spite of treatment with insulin, strict diets, and oral 
antidiabetic agents, diabetes is still the fifth leading 
cause of death by disease in this country and the second 
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leading cause of blindness. 
There is increasing evidence to suggest that diabetes 
mellitus may represent a heterogenous group of disorders 
characterized by glucose intolerance. Epidemiologists have 
produced much evidence that there is a link between viral 
infection and the onset of diabetes (75,76). Defects in the 
number or integrity of insulin receptors or in their coupling 
to messengers which effect the biological activity of insulin 
in tissues sensitive to this hormone have also been impli-
cated (777. An unusual diabetic syndrome with severe insulin 
resistance due to antibodies that impair insulin-receptor 
binding to monocytes has been reported (78). Endocrinolo-
gists have shown that a second hormone, glucagon, is involved 
in the pathology of diabetes, suggesting that much better 
control of diabetic symptoms can be accomplished by regulation 
of the concentration of both insulin and glucagon (79). 
In view of the fact that most of the current literature 
suggests that the defect exists at the level of the pancreatic 
islet, I feel that it is most appropriate to briefly discuss 
some of the current concepts of insulin biosynthesis and re-
lease together with current thoughts about insulin-receptor 
interactions and the phenomenon of insulin self association 
which I feel may be important sites for the action of 
chromium (III). 
A recent review (GO), concerned with the intracellular 
aspects of protein synthesis recognizes the process as 
occurring in the following six steps. (1) synthesis, 
•· 
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(2) segregation, (3) intracellular transport, (4) concen-
tration, (5) intracellular storage, and (6) discharge. The 
article was written with respect to the pancreatic exocrine 
cell, however, the same concepts apply to the endocrine cell. 
In the latter, the contents are released directly into the 
blood stream. Also, endocrine cells apparently discharge 
their secretory product along the entire plasmalemma instead 
of discharging within restricted plasmalemmal regions as exo-
crine cells do. According to the author, proteins for export 
are synth~sized on polysomes attached to the membrane of the 
rough endoplasmic reticulum. The new peptide chains elongate 
directly into the cisternal space of the endoplasmic reticulum 
through pores beneath the point of ribosomal attachment and 
are thus separated from the cytoplasm of the cell as they are 
synthesized. It is well recognized that proinsulin is syn-
thesized in this manner (81). Processes such as conformational 
change and disulfide bound formation were suggested as possible 
reasons why the segregation process is irreversible and that 
once inside the cisternal space, the polypeptide can no longer 
get out. Disulfide bond formation within the proinsulin 
molecule may occur spontaneously as the molecule enters the 
cisternal space of the endoplasmic reticulum, thus preventing 
its exit. From the cisternal spaces of the rough endoplasmic 
reticulum, the secretory proteins are transported to the 
Golgi complex. The geometry of the connections between the 
endoplasmic reticulum and the Golgi complex is a confusing 
matter. Some investigators have reported that the two com-
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partments are permanently connected by continuous tubules 
(82) while others have reported that the connection is inter-
mittent and continuity is established by shuttling vesicles 
which are probably buds of the reticular network (83). These 
vesicles are thought to travel into the Golgi region of the 
cell where they empty their contents into larger vesicles 
call~d condensing vacuoles or immature granules. Also, very 
little is known about the energy requirements of this trans-
port process. 
The ~ecretory proteins reach the condensing vacuoles in 
a dilute solution that is progressively concentrated at these 
sites into a level comparable to that found in mature sec-
retion granules. A large concentration factor is supposedly 
achieved (84). The energy requirement of this concentrating 
process is the subject of much debate. It has been suggested 
that large, stable aggregate formation under the influence 
of a sulfated polyanion {85), or through protein-protein 
interactions could be partly responsible. Such a hypothesis 
could explain concentration and intracellular transport 
against a chemical gradient. This is highly possible in 
the case of proinsulin since it exhibits a self-associative 
behavior similar to insulin (86). Proinsulin differs from 
insulin in that it has a connecting polypeptide portion (C-
peptide) which links the carboxy terminus of the insulin B 
chain to the amino terminus of the insulin A chain. It has 
been suggested that the conformation of the insulin moiety 
in proinsulin is nearly identical to that of insulin 
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itself (87). The connecting peptide does not appear to obs-
cure those monomer surf aces of insulin which are involved in 
the association of insulin to dimers and to hexamers (88). 
The current structure of the proinsulin hexamer has the C-
peptide portion oriented externally which, according to many 
investigators (89), may facilitate conversion of proinsulin 
to insulin. This intracellular proteolytic conversion of 
proinsulin to insulin in the beta cell is a distinctive feature 
of insulin and distinguishes it from the classical zymogen 
activation (90). The Golgi complex appears to be the site 
of this partial proteolysis (91), however, other observations 
indicate that it probably continues within the secretory 
granules as they collect and mature within the cytosol (90, 
92,93). Two types of proteolytic activity have been proposed 
to exist for the conversion of proinsulin to insulin (94). 
One is a trypsin-like protease and the other similar to car-
boxypeptidase B, which is necessary to remove the C-terminal 
basic residues remaining after trypsin action. Only limited 
success has been achieved in actually isolating these acti-
vities from beta cell granule preparations (95,96). Evidence 
has been provided (97) that the proteolytic activities may 
he localized in the membrane containing fraction of the 
granule. Finally, at th~ level of the Golgi complex the 
secretory product is transformed from a high permeability 
membrane (endoplasmic reticulum) to a membrane whose lipid 
composition approaches that of the plasma membrane, in pre-
paration for discharge (98,99). At this point the term 
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secretion granule or beta granule is pref erred to condensing 
vacuole since the original body, now present in the cytosol, 
has been modified anatomically and has reached the end of the 
concentration step. The protein of interest (insulin in this 
case) is stored within the beta cell in these secretion gra-
nules until discharge. Many changes take place in these 
graqules as they remain in the cytosol, one being the final 
conversion of proinsulin to insulin as was discussed previously. 
Within the secretory granule, insulin exists as an ag-
gregate ~ssociated with zinc leading eventually to a crystal-
line zinc inclusion. Current research seems to indicate that 
the functional role of this aggregation process is to insure 
efficient storage of insulin in the granules. The mechanism 
whereby zinc accumulates is not known. However, it has been 
demonstrated that proinsulin binds more than 5 g-atom zn+ 2;mol 
of protein and polymerizes to form soluble aggregates under 
conditions where insulin binds only 1 g-atom/mol and is almost 
completely precipitated from solution (100). It has also been 
suggested that the binding of zinc to proinsulin may influence 
the conversion of proinsulin to insulin (101) • The C-peptide 
resulting from the proteolysis of proinsulin is also present 
in the granule and is released along with zinc when discharge 
is accomplished. The chemical process whereby the zinc-insulin 
hexamer or the highly associated insulin species present in 
the granule is converted to a soluble, dissociated species 
which is released to the blood stream is poorly understood. 
One possible explanation could be the existence of a factor 
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capable of causing dissociation of aggregated insulin species. 
Finally, I would like to briefly discuss insulin dis-
charge from the beta cell. According to Palade (80), discharge 
is accomplished by a process originally called "membrane 
fusion" and later termed "exocytosis''. He further states that 
in preparation for discharge, the membrane of the secretion 
granule fuses with the plasmalemma and that subsequent re- ' 
organization leads to fission of the fused membranes within 
the area of fusion (Figure 5). The final result, according 
to Palade; is continuity between the granule compartment and 
the extracellular medium along with continuity of the granule 
membrane and the plasmalemma of the beta cell. The author 
also points out that under normal steady-state conditions, 
excess membrane must be removed from the receiving compartment 
and added to the donor compartment, otherwise the plasma mem-
brane would continuously increase. Just exactly how this 
redistribution process is achieved remains a mystery, however, 
recent evidence (102) seems to indicate that the beta cell 
may be capable of digesting its own membrane. 
A major problem which has not yet been clearly resol-
ved for any secretory cell type concerns the factors involved 
in the translocation of granules to the cell membrane during 
exocytosis. It has been postulated that microtubules and 
microfilaments play a role in effecting secretory discharge, 
as well as in directing or moving secretory granules to their 
sites of discharge (103). There seems to be agreement how-
ever, that the manner in which these elements are involved 
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FIGURE 5.: Diagram of membrane interactions during sec-
retory discharge [From Palade (80)}. 
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in granule movement is speculative at present. Another theory, 
focusing attention on actinomyosin-like contractile proteins 
as possible elements in the secretory process has been pro-
posed (80,103). An active role for the granule and its mem-
brane in the release mechanism has also been put forward (104). 
According to the authors, the secretion granules undergo a 
morp~ological change termed ''binesis". Binesis which means 
"to couple", is a process whereby the granular membrane forms 
a lingula that protrudes from one secretory granule and in-
serts intp an adjoining secretory granule. According to the 
authors there was a threefold increase in the incidence of 
granules demonstrating binesis at a stimulatory glucose con-
centration (300 mg/ml) as compared to the granules of islets 
incuhated at a basal glucose concentration (90 mg/ml) indi-
cating active participation of the insulin secretory granule 
and its membrane in the insulin release mechanism. It was 
further suggested that this process may represent a morpho-
logical concomitant of glucose-mediated activation of the 
insulin secretory granules before exocytosis of the granule 
contents. 
Superimposed upon each or all of these processes are 
various modulating mechanisms, which influence the total re-
lease sequence at the beta cell level. The basic requirement 
of calcium ion and energy for exocytosis has been well es-
tablished (105). Lacy and co-workers (106) proposed that 
calcium may be the trigger that would initiate contraction or 
a change in the physical conformation of the microtubules or 
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microf ilaments attached to the membrane around the beta 
granule. This would 'result in a rapid displacement of the 
granules to the cell surface and liberation of these granules 
in tandem at specific loci on the plasma membrane. This view 
is further supported by an observation that microtuhules can 
be reassembled in the presence of a calcium chelating agent 
(107~. An excellent treatment concerning the control of in-
sulin secretion has recently been presented (108). The authors 
distinguished two classes of stimulating agents. The first 
group, wh~ch included those agents themselves capable of eli-
citing insulin release, were termed "initiators''. The second 
group, termed potentiators, had no effect by themselves on 
insulin secretion but increased the response to initiators. 
Examples of initiators included glucose, mannose and leucine. 
Potentiators included other amino acids, agents which increased 
cyclic Af1P concentrations and certain sugars other than glu-
case and mannose. Of ultimate importance to this scheme was 
the fact that the absence of calcium ion blocked the secretory 
response to all agents. 
Since glucose is the major effector of insulin release, 
two models for the glucoreceptor at the beta cell level have 
been proposed (108) . In the first model termed "regulator 
site" model, glucose acts as an allosteric modifier of a cell 
surface receptor. Combination of glucose with this receptor 
leads to an increase in membrane permeability with regard to 
calcium ion with eventual initiation of exocytosis. In the 
second model termed "substrate-site" model, glucose is meta-
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bolized by the beta cell which results in the presence of a 
metabolite that has the capability of initiating calcium in-
flux and exocytosis. 
Insulin-Receptor Interactions 
Many aspects of insulin-receptor interactions have been 
characterized in the past few years. Much of the work has 
been reviewed in detail {109,110). In a recent report Blecher 
and co-workers {111) found that two hormones involved in dia-
betes namely insulin and glucagon, bind in specific ways to 
surface receptors on human peripheral mononuclear leukocytes. 
Their most important observation concerns the difference in 
binding they found for both hormones between normal persons 
and those with overt late-onset diabetes or no diabetes symp-
toms but a family history of diabetes. They found that for 
all normal controls studied, there was good receptor binding 
of both glucagon and insulin. On the other hand, for overt 
late-onset diabetics, glucagon and insulin binding was about 
one-third that of controls. Similar low binding levels of 
both hormones were found in a third group with no symptoms 
but with a family history of diabetes. 
In contrast, the insulin insensitivity of adipocytes 
from obese individuals was not found to be consistent with a 
decrease in insulin binding, a decrease in the number of re-
ceptors per cell or an increase in the degradation of insulin 
(77). As a result of this study it was proposed that meta-
bolic alterations might render large fat cells less sensitive 
to some of the actions of insulin· which would in turn appear 
I 
as insulin resistance. 
In another study (112), incubation of cultured human 
lymphocytes or isolated rat fat cells at 37°C with insulin 
resulted in a time-dependent fall in the ability of the 
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thoroughly washed cells to bind I-labeled insulin. The 
effect was dependent on the concentration of insulin used in 
the preincubation period. The kinetic properties of the af-
fects, according to the authors, were more consistent with a 
catalytic, destructive process (proteolytic) than with a pro-
. 
cess of receptor occupation. Various insulin analogs were 
studied to determine whether the destructive effect of insulin 
could be correlated with the biological activity of the hor-
mone and with its proteolytic activity. These analogs of 
insulin, having greatly decreased or no biological activity 
as measured by ability to stimulate glucose oxidation and 
having no binding to insulin as measured by their inability 
to compete for the binding of iodoinsulin, are nevertheless 
effective in their ability to reduce insulin binding upon 
preincubation with fat cells. Also, all of the analogs de-
monstrated proteolytic activity, but particular mention was 
made of the insulin B-chain. Although the proteolytic effect 
was observed upon preincubation with physiological levels of 
insulin for periods greater than 16 hrs, the same effects were 
observed in shorter periods (1 to 3 hrs) with extraordinarily 
high concentrations of insulin (above Sµg/cc) . According to 
the authors, it was difficult to exclude the possibility that 
such destructive effects may under certain circumstances be 
r 
' 
' 
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manifest in vivo and the possibility exists that these effects 
may contribute to certain metabolic or pathologic derangements, 
specifically in hyperinsulinemic states such as obesity and 
adult-onset diabetes. The assumption that a higher aggregated 
species of insulin could possess proteolytic activity may ex-
plain the results that preincubation with concentrations of 
insulin greater than Sµg/cc caused decreased binding of labeled 
insulin to the cells with shorter preincubation periods. It 
would be interesting if one could synthesize a covalent dimer 
or higher:order aggregate of insulin and study possible pro-
teolytic effects. At this time, it may be important to also 
mention the possible beneficial effects of a metabolite or 
other factor that could prevent aggregation or cause disso-
ciation. 
The Three-Dimensional Structure of Insulin 
Finally, I would like to discuss the structure of the 
insulin molecule. I want to point out beforehand that the 
current three-dimensional structure that we now have of the 
insulin molecule was obtained by the X-ray analysis of in-
sulin crystals. According to Hodgkin (113), the beta granules 
show dense aggregates in the electron microscope which appear 
crystalline in nature and seem to resemble rhombohedral 
crystals of insulin. Within these crystals, particles are 
visible, the arrangement of which strongly resembles the 
packing of the hexamers in the insulin crystal structure as 
derived from X-ray analysis. As a result it has been sug-
gested that insulin probably exists as a hexamer in the beta 
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granule (114) and that further association of the hexamers 
occurs to achieve efficient sto~age of the insulin (115,116); 
the final product resembling rhombohedral insulin crystals. 
Also, there seems to be agreement among investigators that 
the conformation of insulin in solution agrees with the re-
sults of X-ray crystallography (115-117). 
Insulin is a polypeptide consisting of 51 amino acids 
and having a molecular weight of 5778. The insulin molecule 
is composed of two polypeptide chains, designated "A" and 
"B", whicri are connected by two interchain disulfide bridges 
of cystine (Figure 6). The "A" chain of insulin contains an 
intrachain disulfide bridge within which a species difference 
in amino acid composition occurs, primarily at positions B, 
9, and 10. Pork and human insulin have a similar amino acid 
composition at these positions and differ only in the carboxy 
terminal end of the "B" chain. Pork insulin, like that of 
beef, has alanine at this position; human insulin has 
threonine. 
Let us now take a closer look at the atomic arrange-
ment of the insulin monomer. I will begin with a discussion 
of the conformation of the "B" chain followed by that of the 
"A" chain. According to Blundell and co-workers (117), the 
first seven residues in the "B" chain have an extended con-
figuration (Figure 7) which is then followed by a sharp turn 
at the glycine at B8. The residues B9 to Bl9 form part of a 
well defined right handed helix. The helix separates the 
cystine disulfide bridges at B7 and Bl9 and it appears to be 
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FIGURE 7.: The "B" chain of porcine insulin [From 
Blundell, et.al. (116)]. 
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an important structural feature in the insulin molecule. The 
residues following the helix B20 to B23 constitute a "U" turn 
in the polypeptide chain so that the remaining residues B24 
to B30 can form an extended chain lying antiparallel and 
against the helix B9 to Bl9. Concerning the "A" chain 
(Figure 8), Blundell further states that residues A2 to A8 
make a short piece of distorted a-helix and the right-handed 
helical sense is retained for residues A9 to All. This ar-
rangement easily accommodates the A6-All cystine disulfide 
bridge. The residue Al2 has an extended form so that the 
following amino acids Al3 to Al9 can form a distorted right-
handed helix with its axis nearly antiparallel to that of the 
helix A2 to AB. The remaining peptides have an extended 
conformation. 
Within the hollow formed by the arms of the "B" chain, 
the "A" chain lies as a compact unit; the most obvious sta-
bilizing forces resulting from the disulfide bonds. According 
to Hodgkin (118), the covalent bonding of the two chains 
through the disulfide residues is reinforced by van der Waal's 
interactions between residues belonging to strategically placed 
nonpolar groups, B-11 leucine, B-14 alanine, B-15 leucihe, 
B-18 valine, A-13 leucine, A-16 leucine, and A-2 isoleucine, 
and these cluster around the A6-All disulfide bond. As a 
result, these nonpolar residues and the A6-All disulfide bond 
are buried within the molecule. The conformation of the in-
sulin monomer without the disulfide bonds is shown in Figure 9. 
In this configuration most of the polar groups extend over 
... 
.. 
.. 
FIGURE 8. The "A" chain of porcine insulin [From 
Blundell, et.al. {116)] . 
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FIGURE 9.: The polypeptide backbone of the whole insulin 
molecule [From Blundell, et.al. (116)]. 
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the surface of the molecule together with a few nonpolar re-
sidues which take part in further close contacts between the 
molecules in the dimer and the hexamer. As far as the inter-
chain disulfide bonds are concerned, the B7-A7 is on the 
outside of the molecule and consequently accessible to solvent 
while the Bl9-A20 is partially buried but still accessible to 
solv~nt. This is an important consideration since earlier in 
this discussion it was postulated that chromium (III) may exert 
its effect through a disulfide interaction (49,58). It must 
be rememb~red, however, that by no means is the disulfide bond 
the only site of interaction between insulin and chromium. 
Other groups, namely amino, carboxyl and hydroxy, have also 
been implicated in chromium-protein interactions (119) arid 
therefore cannot be eliminated. 
In several recent studies concerning the receptor binding 
region of insulin certain surf ace regions of the insulin mono-
mer have been implicated (116,120). Possible candidates in-
cluded Al Gly, AS Gln, Al9 Tyr, A21 Asn, B24 Phe, B25 Phe, 
B26 Tyr, Bl2 Val and Bl6 Tyr. The effects on X-ray diffraction, 
circular dichroism, receptor binding and biological potency 
of modifying the Al Gly with groups of increasing size was 
recently studied (121). The results were consistent with a 
model in which hydrophobic residues such as B24 Phe, B25 Phe, 
B26 Tyr, Bl2 Val and Bl6 Tyr are involved in receptor binding 
in a manner similar to their involvement in dimerization. 
Other studies have implicated the a-amino group of the Al 
glycine as very important for biological activity (115,116). 
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The main corttacts in the dimer are between nonpolar 
sidechains particularly in the B21 to B30 region (Figure 10). 
According to Hodgkin (118), the interaction is strong and in-
valves both hydrogen bonds forming part of a beta-pleated 
sheet type of structure between the peptide groups of B24 and 
B26 and close van der Waal\s contacts between a number of non-
polar residues (Figure 11). Dimer formation covers a number 
of hydrophobic groups on the surface of the individual molecules 
while others are concealed when contacts are made between the 
. 
dimers within the hexamer. 
In the crystalline structure and therefore probably also 
in the pancreas, aggregation occurs around 2 zinc atoms to 
form a hexamer (Figure 12). According to Blundell (117), each 
zinc is bound to an imidazole nitrogen of one of the BlO his-
tidines of each of the dimers, therefore, each zinc has bound 
to it three imidazole rings. The coordination of the zinc is 
completed by solvent molecules. Hodgkin reported (118), that 
the only hydrophobic groups remaining exposed on the surface 
of the hexamer are the AlO isoleucine and the B25 phenyla-
lanine and that these are both involved in direct intermolecular 
contacts in the crystal structure (Figure 13). The author 
also reported that there are small channels passing between 
the hexamers in the crystal structure through which small 
molecules and ions can penetrate and interact with the surface 
residues of the insulin molecules. Such channels could pro-
vide a means by which chromium (III) could gain access to 
critical insulin residues. 
... 
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FIGURE io: View of the insulin dimer [From Blundell, 
et.al. (116)] . 
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FIGURE 11; The pleated sheet structure developed 
between monomers [From Blundell, et. al. ( 116)] . 
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FIGURE 12. The development of' the dimers from monomers 
and their organization into hexamer [From Blundell, et. 
al. (116)) . 
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FIGURE 13~ The packing between the hexamers in the 
crystal [From Blundell, et.al. (116)) . 
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Insulin Conformation in Solution 
It has been reported that the zinc-insulin complex formed 
in solution consists of 6 insulin molecules associated with 
a minimum of 2 zinc ions (115). According to the authors, one 
of the most prominent changes that occurs when zinc is added 
to a solution of insulin is a marked increase in the negative 
circ.ular dichroic band at 275nm (Figure 14). A recent study 
(122), assigns changes in the near ultraviolet circular dichroic 
. spectrum (275nm) to the aromatic residues (tryosine and pheny-
lalanine)• contrary to a previous report (123) attributing the 
' 
band to a strained disulfide bridge. Evidence in favor of the 
assignment is presented. According to the authors, attenuation 
of the band at 275 is correlated with conditions that bring 
about disaggregation while a strengthening of the band is as-
sociated with conditions which enhance aggregation. A number 
of metal ions other than zinc were also studied with regard to 
their effect on the near ultraviolet circular dichroic spectrum 
of insulin. F 2+ c 2+ e I U I Pb2+, Mn 2+, Co 2+, Cd 2+ and Ni 2+ in-
creased the magnitude of the minimum at 275nm while Fe3+ and 
Mg 2+ produced no significant change. Another study (124) indi-
cated a major contribution from tyrosine moieties to the near 
ultraviolet circular dichroism spectrum. It must be remembered 
that the self association of insulin is a process that depends 
upon a number of factors, among them protein concentration, 
pH and ionic strength and that in the absence of zinc, insulin 
solutions are probably a mixture of dimers, tetramers and hex-
amers all in equilibrium with the insulin monomer. The presence 
~. 
.·· 
.. 
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FIGURE 14. Near ultraviolet CD spectrum of insulin with-
out zinc (A) and with zinc (B). Insulin concentration of 
1 mg/ml at pH 7.4. Zinc concentration in solution for 
lower curve of 1 gm-atom zinc per 2 moles of insulin. 
e reprisents mean residue ellipticity in units of deg cm2 
dmole- and A represents wavelength. [From Frank, et.al. 
(115)]. 
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of zinc displaces the equilibrium in the direction of the 
hexamer. 
At present there is much debate on the molecular size 
of the ultimate physiological unit of insulin. Unknown factors 
such as the concentration of insulin at the receptor regions 
of insulin responsive tissues add to the problem. A great 
deal of evidence seems to support the view that the monomer 
is the active form. This is supported by the fact that certain 
insulins, such as sulfated insulins and nitrated insulins, 
which only exist as monomers, are biologically active (118,125). 
Calculations based on the equilibrium constant for dimer for-
mation show that the mole ratio of monomer to dimer would be 
about 800,000 to 1 at physiological concentrations (about 
O.lng/ml of serum) (126). Finally, the retention of biological 
activity by insulin-agarose derivatives, which according to 
Cuatrecasas (127) contains bound insulin molecules that are 
exclusively monomers, provides strong evidence that the bio-
logically active species of insulin is the monomer. 
In summary, the relation between chromium deficiency 
and impaired glucose tolerance has been clearly established. 
Evidence for a potentiating affect on insulin action has also 
been presented. It remains to be shown, however, whether 
trivalent chromium, the active component of the glucose tole-
rance factor, can directly induce a conformational change in 
insulin or interact with the molecule in such a manner as to 
affect the association-dissociation process. The implications 
for this interaction are that it may significantly alter the 
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insulin-receptor interaction or the mechanism of insulin re-
lease from the beta cell both of which have been implicated 
in impaired glucose tolerance. There are several excellent 
techniques available for studying protein conformation and 
aggregation. Among them are circular dichroism spectroscopy 
and frontal gel chromatography. It is the purpose of this 
dissertation to utilize these techniques to provide evidence 
for a chromium-insulin interaction in hopes of clarifying the 
role of this important trace metal in carbohydrate metabolism. 
f 
! f. 
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CHAPTER II 
MATERIALS AND METHODS 
Materials 
Studies concerning protein-metal interactions require 
the use of a relatively pure metal-free protein preparation 
as well as strict metal-free conditions with regard to the 
preparation of solutions and cleaning of glassware. All 
glassware utilized in this study was washed in an EDTA 
(ethylenediamine tetraacetic acid)-soap solution, rinsed with 
deionized-distilled water, soaked in dilute HCl solution, 
rinsed thoroughly with deionized-distilled water and dried 
at 175°C before use. Glassware utilized in the frontal gel 
analysis experiments was treated with Siliclad, a water soluble 
concentrate produced by Clay Adams, Parsippany, NJ, followed 
by rinsing and drying at room temperature for 24 hrs. 
Two different insulin preparations were used in this 
study. One was a porcine zinc-free preparation produced by 
Eli Lilly and Co., Indianapolis, IN; the other was a bovine 
zinc insulin produced by Sigma Chemical Co., St. Louis, MO. 
The Lilly insulin (lot PJ7412) was reported as containing 
less than 0.04% zinc. This is equivalent to 0.035 g-atom of 
zinc per mole of insulin. The Sigma insulin was stated as 
having 0.5% zinc. This would be equivalent to 0.44 g-atom 
of zinc per mole of insulin. 
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The trivalent chromium complex utilized was chrom alum 
crK(S04 ) 2 ·12H2o. The buffer selected was 0.067M Sorensen's 
phosphate. It was prepared by making separate 0.067M solu-
tions of di-sodium hydrogen orthophosphate (Na 2HP0 4 , 9.47g/l) 
and potassium dihydrogen orthophosphate (KH 2Po4 , 9.08g/l). 
All three of these reagents were of the ANALAR grade and were 
obtained from BDH Chemicals Ltd., Poole, England. The final 
buffer solution was prepared by mixing 164ml of the KH 2Po4 
solution and 836ml of the Na 2HP04 solution. The pH consis-
tently remained between 7.45 and 7.47. Other physiological 
buffers, namely TES [N-tris (hydroxymethyl) methyl-2-ethane-
sulfonic acid], BICINE [N,N-bis(2-hydroxyethyl) glycine], 
HEPES [N-2-hydroxy-ethylpiperazine-N-2-ethane-sulf onic acid] 
and MES (2-(N-morpholino) ethanesulfonic acid] were obtained 
from Pierce Chemical Co., Rockford, IL, and reported as having 
less than Sppm Fe or heavy metals such as Pb. TRIS (hydroxy-
methyl) aminomethane was obtained from Calbiochem, La Jolla, 
CA, and contained less than lppm heavy metals. Ultra pure 
urea was obtained from Schwarz/Mann, Orangeburg, NJ. It was 
reported as having a heavy metal content of less than O.Olppm. 
Deuterium oxide (D20) was obtained from International Chemical 
and Nuclear Corporation, Irvine, CA, while deuterium chloride 
was obtained from Isotopes Incorporated, Westwood, NJ. All 
other chemicals used were of reagent grade and obtained from 
standard commercial sources. 
Proteins used for column calibration were ovalbumin and 
equine myoglobin (Nutritional Biochemicals Corp., Cleveland, OH), 
chymotrypsinogen A (Worthington Biochemical Corp., Freehold, 
NJ), ribonuclease A (Sigma), carbonic anhydrase (Boehringer 
Mannheim Corp., New York, NY), ACTH (Armour Pharmaceuticals, 
Kankakee, IL), and a nitrated insulin that was synthesized. 
Blue dextran for void volume determination and Sephadex G-50 
superfine resin were obtained from Pharmacia Fine Chemicals, 
Piscataway, NJ. Chelex 100, a chelating resin selective for 
heavy metals, was obtained from Bio Rad Laboratories, Richmond, 
CA. Dialysis was performed in Spectrapor tubing produced by 
Spectrum Medical Industries, Los Angeles, CA, and reported to 
have a molecular weight cutoff of 3500. 
Preparation of Zinc-Free Insulin 
In order to insure the absence of metal contamination, 
the insulin preparations were subjected to one of the two 
following procedures. The first procedure is well established 
and has previously been used to produce zinc-free insulin 
(128). The method consists of converting the insulin to the 
hydrochloride salt by dissolution in 0.25N HCl (15mg/ml). In 
this form, the zinc ions which are normally bound to the B-10 
histidines are released because of the positive charge on the 
imidazole nitrogens at the acidic pH. Eighteen volumes of 
acetone were then added and after 16 hours at 5°C, the re-
sulting precipitate was collected and washed several times 
with acetone and finally with anhydrous ether utilizing a 
Millipore suction filtration apparatus and Whatman #42 filter 
paper. The product was then dried in a vacuum at room tem-
perature for 1 hour and stored at -25°C until use. Since 
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no weight change occurred on further drying, 1 hour was se-
iected as a suitable drying period. In a recent article (122), 
it was reported that the zinc content of an insulin prepara-
tion subjected to this procedure was approximately 0.003 g-atom 
of zinc per mole of insulin as determined by atomic absorption 
spectroscopy. This represented a 190 fold decrease since the 
star~ing material contained 0.57 g-atom of zinc per mole of 
insulin. 
The second method consisted of dissolving 20mg of the 
insulin ~h 4ml of O.OSM tris-7M urea buffer, pH 8. To this 
was added O.lml of Chelex 100 chelating resin which had been 
pre-equilibrated with the same 0.05M tris-7M urea buffer until 
the pH remained at 8. After gentle overnight mixing at room 
temperature on a Roto Torque rotator (Cole Parmer, Chicago, 
IL), the resin was removed by centrifugation. The pH was moni-
tored before and after the addition of the insulin and after 
the overnight mixing procedure. In another study, the entire 
process was repeated omitting the urea from the buffer and 
in the equilibration of the chelating resin. Both prepara-
tions from this second method were utilized for the synthesis 
of nitrotyrosyl insulin. 
Isolation of "Single Peak" Insulin 
As mentioned previously, an insulin preparation free of 
other protein contaminants is necessary for these experiments. 
It has been shown that commercial preparations of crystalline 
insulin contain as much as 8% non-insulin components (129). 
As much as 6 of the 8% may be proinsulin with the remainder 
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being insulin aggregates and non-insulin material. Since 
these components may interfere with the planned experiments, 
a procedure was selected for their removal. The purification 
method selected consisted of column chromatography at 4°C 
with Sephadex G-50 {superfine) resin and lM acetic acid 
{57.5ml glacial acetic acid/liter) as the eluant. Other re-
sins~ namely Sephadex G-75, G-50 medium and G-50 fine were 
also tested. It has been suggested that insulin exists in 
the monomeric form in the presence of this eluant (130). 
A 1;5 X 90cm Pharmacia column was selected for this 
procedure. It was thoroughly cleaned and rinsed with deion-
ized-distilled water before use. Both the column and the resin 
were known beforehand to be stable toward any adverse effects 
of lM acetic acid. The correct amount of resin was then 
weighed, placed in a vacuum flask with enough lM acetic acid 
to cover it and subjected to a vacuum at 4°C for a 24 hour 
period. This process insured proper swelling of the resin and 
removal of gasses so that the column could be poured easily. 
After pouring, the column was equilibrated with a continuous 
flow of degassed lM acetic acid for a 24 hour period prior to 
protein application. The bed height was approximately 85 cm: 
The protein monitoring and collecting equipment (LKB Instru-
ments, Brorruna, Sweden) consisted of an LKB 8300 UVICORD II 
Absorptiometer, LKB 7000 UltroRac fraction collector and an 
LKB 12000 VarioPerpex peristaltic pump with 3rrun inner diameter 
silicon tubing. Percent transmittance was monitored at 280nm 
and 3ml fractions were collected. Other parameters included 
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a flow rate of 4.2 and 6ml/hr, a recorder speed of lOmm/hr 
and a sensitivity of 1:1 on the UV monitor. In all cases ex-
cellent results were obtained using the above equipment and 
column preparation techniques. The protein purification pro-
cedure consisted of dissolving 35mg of the previously prepared 
zinc-free insulins in lml of lM acetic acid followed by 
application to the column. Before application the level of 
the eluant was allowed to drop to the level of the resin 
without going below it. The sample was then applied by means 
of a Pasteur pipette and allowed to enter the resin in a similar 
manner as above. Eluant was then carefully layered on top of 
the resin, initially with a Pasteur pipette so as not to dis-, 
turb the resin and finally with the pump until it emerged from 
the auxiliary outlet at the top of the column. At this point 
the outlet was closed and the pump controlled the flow rate. 
Upon completion of the run, the fractions containing the in-
sulin were pooled, placed in filter seal flasks (Virtis Co., 
Gardiner, NY) and lyophilized. Acetic acid serves as an ex-
cellent eluant as it is removed during this process. In 
several instances the lyophilized protein was redissolved in 
a minimal amount of acetic acid and relyophilized in a smaller 
flask to insure less'loss during transfer. The insulin was 
then placed in screw cap vials, sealed with Parafilm (American 
Can Co., Greenwich, CT) and stored at -25°C in jars containing 
a drying agent. At this point the preparation was referred 
to as "single peak zinc-free insulin". Finally, a sample of 
the bovine insulin before and after purification was subjected 
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to sephadex G-50 (superfine) column chromatography in O.OSM 
tris-7M urea, pH 7.4 and polyacrylamide disc gel electropho-
resis according to the method of Williams (131), with staining 
according to the method of Chrambach (132). 
Nitration of Insulin 
An attempt was made to prepare a derivative of insulin 
that does not self-associate. This derivative could then be 
utilized for calibration of the column used in the frontal 
gel analy~is study, since a non-associating marker protein 
with a molecular weight in the range of insulin was desired. 
It has been suggested that nitrated insulin does not self-
associate (118,122). As a result, this derivative was selected 
as a candidate. Two methods were considered for the nitration 
of insulin (133,134), both of which utilized tetranitromethane 
(TNM) for the nitration of tyrosine residues. The method 
selected was a hybrid of both. The starting material was the 
zinc-free insulin prepared in the presence and absence of urea 
as discussed above. As a result, two different nitration pro-
cedures were performed; one in the presence of urea and one 
in the absence of urea. It was assumed that the dissociating 
effect of urea wo~ld allow a greater extent of nitration. 
The procedure consisted of adding 20 microliters of TNM 
(Aldrich Chemical Co., Milwaukee, WIS) to Sml screw cap vials 
containing the respective zinc-free insulin preparations. 
This amount of TNM was calculated to be a 10 fold excess with 
respect to the tyrosyl residues of insulin. Each preparation 
was then incubated at room temperature on a Roto Torque rotator 
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for a 2 hour period. After incubation the reaction was term-
inated by the addition of 1 drop of concentrated HCl. In 
both cases the pH was determined before the addition of TNM 
and after the 2 hour incubation with TNM. A similar study 
was performed without insulin to eliminate changes in pH re-
sulting from interactions between TNM and the buffer consti-
tuents. 
Before using this technique as a preparative method, 
it was decided to perform a study to determine whether 2 hours 
was a sufficient period for nitration. A pilot study was 
performed using non-urea conditions. The procedure was similar 
to that above except that 50 microliter aliquots were removed 
from the reaction vial at intervals of O, 10, 40, 80, 155, 
200 and 1127 minutes and placed directly into a Beckman quartz 
cell (Beckman Instruments, Fullerton, CA) containing 2.2ml 
of O.OlN HCl. This was considered to be sufficient acidity 
to terminate the reaction. Absorbance was recorded at 276 
and 353nm with a Heath EU707-ll spectrophotometer (GCA/ 
McPherson Instruments, Acton, MA) and 0.05M tris, pH 8, as 
the reference. Under acidic conditions, tyrosine residues 
absorb at 276nm while nitre-tyrosine residues absorb at both 
276 and 353nm. Another experiment was performed to compare 
the extent of nitration in the presence and absence of urea. 
Conditions were similar to those above except that aliquots 
were removed at O, 10, 40, 80 and 120 minutes and UV scans 
were performed over the range of 240 to 400nm with either 
0.05M tris, pH 8 or 0.05M tris-7M urea, pH 8 as the reference. 
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In a separate experiment, the buffers were treated with TNM 
in a similar manner as the previous experiment which included 
insulin. This was done in order to determine the amount of 
absorbance due to interactions between TNM and the buff er 
constituents. 
Since it is known that insulin polymerizes during ni-
trat~on with TNM (134), a series of experiments were designed 
to examine the molecular weight distribution after various 
periods of nitration. Nitrations were performed in the pre-
sence and:absence of urea as before. The reactions were 
completed at selected time intervals by the addition of 1 drop 
of concentrated HCl to the appropriate reaction vials. The 
intervals were 120 and 1127 minutes for nitration in 0.05M 
tris, pH 8 and 15, 30, 60, and 120 minutes for nitration in 
0.05M tris-7M urea, pH 8. The contents were then dialyzed in 
Spectrapor tubing at 4°C against deionized-distilled water 
(2 changes-4 liters each) and lyophilized in small Virtis 
vials. Upon completion, lml of 0.05M tris-7M urea, pH 7.4 
was added directly to the lyophilization flask and after dis-
solution, the contents were chromatographed at 4°C on a 1.5 X 
90cm Pharmacia column with Sephadex G-50 (superfine) resin 
and 0.05M tris-7M urea, pH 7.4 as the eluant. The column and 
resin were prepared as previously described. Protein moni-
toring and collecting equipment as well as conditions, were 
identical to those used during insulin purification except 
that the flow rate was maintained at 4.2ml/hr. 
Finally, the initially described procedure was utilized 
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for the nitration of insulin. After nitration, the product 
was dialyzed against deionized-distilled water, lyophilized 
and chromatographed in O.OSM tris-7M urea, pH 7.4 under the 
conditions of this section. Prior to chromatography, however, 
the column was calibrated with lml of the following markers 
at the stated concentrations: blue dextran (MW 2,000,000-lmg/ 
ml), .chymotrypsinogen A (MW 25,000-4mg/ml), myoglobin (MW 
17,800-6mg/ml), ribonuclease A (MW 13,600-9mg/ml), and single 
peak porcine zinc-free insulin (MW 5778-9mg/ml). These pro-
tein conc~ntrations resulted in excellent zones with the UV 
monitor set at a 1:2 response. The nitrated insulin fractions 
migrating in the vicinity of the native insulin marker were 
collected and pooled. Dialysis at 4°C against deionized dis-
tilled water was followed by lyophilization. The final pro-
duct, designated "nitrated insulin", was stored at -25°C until 
use. 
Solubilization of Trivalent Chromium 
This study was performed to determine the maximum amount 
of chromium (III) that could be solubilized under the condition 
of physiological pH. As a result, a suitable buffer was se-
lected in which tq perform the spectral analysis of chromium 
(III)-insulin interactions. Some of the difficulties of solu-
bilizing this trace metal under physiological conditions have 
already been investigated (14). The trivalent chromium com-
plex used in this study was chrom alum (CrK(so4 J 2 ·12H2oJ, 
formula weight 499.41. A 10-lM stock solution of this metal 
was prepared by dissolving 0.499g in lOml of dilute HCl. 
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chromium (III) is stable under this condition (pH less than 4) 
and olation is minimized (67). This process and its conse-
quences were thoroughly explained in Chapter I. The chromium 
stock solutions were kept at room temperature for at least 3 
days, during which a slight color change from violet to blue-
green occurred and remained indefinitely. Aliquots of 50, 
100 and 200 microliters were removed from the stock solution 
and added to 15ml screw cap vials containing lOml of the fol-
lowing buffers at pH 7.4: 0.067M Sorensen's phosphate, 0.13M 
phosphate, 0.05M tris, O.lM barbital, 0.05M TES, 0.05M MES, 
0.05M HEPES and 0.05M BICINE. The addition of the above ali-
quots of chromium (III) resulted in chromium concentrations 
of 5 X 10-4 , 1 X 10-3 and 2 X l0- 3M, respectively. In each 
case the pH was taken before and after the addition of chromium. 
The solutions were then agitated on a Labquake shaker (Lab-
industries, Berkeley, CA) for a period of 18 to 24 hours at 
room temperature. This was done to insure adequate time for 
the coordination of chromium and to determine whether a pre-
cipitate would form with time even though it was not observed 
initially. Finally, the solutions were checked for precipi-
tation by placing them in the light path of an inverted Bausch 
and Lomb microscope lamp. They were then labelled as either 
suitable or unsuitable. 
In another experiment, various nitrogen containing 
compounds were added to 0.067M Sorensen's phosphate, pH 7.4 
and to 0.13M phosphate buffer, pH 7.4 in an attempt to solu-
bilize more chromium (III). It was assumed that these 
compounds would act as weak cheiators of the metal. The fol~ 
lowing compounds, with their molecular weights stated, were 
added in O.lM concentrations: niacinamide (122.1), nicotinic 
acid (123.1), pyridine (79.1), urea (60.06), imidazole (68.08), 
formamide (45.04), ethylenediamine (60.1) and glycine (75.07). 
Where appropriate, the pH of the buffer was adjusted to 7.4 
with·the addition of lN HCl or l.6N NaOH. Four hundred micro-
liters of the 10-lM chromium (III) stock solution was then 
added to lOml of O.lM solutions of the above compounds in the 
respective phosphate buffers. This resulted in a chromium 
-3 
concentration of 4 X 10 M which was determined to be the most 
desirable concentration for the proposed studies. The solu-
tions were then agitated on a Labquake shaker for a period of 
18 to 24 hours. The pH in this case was determined before 
the addition of the chromium aliquots and upon completion of 
the incubation period. The solutions were checked for pre-
cipitation as before. 
Chromium-Niacinamide Interactions 
This study was designed primarily to provide evidence 
for an interaction between niacinamide and chromium (III), 
under conditions 0£ physiological pH and without harsh treat-
ment such as boiling, which has previously been utilized to 
produce a chromium (III)-nicotinic acid complex (58). Nia-
cinamide was chosen since it is structurally similar to 
nicotinic acid which has been identified as a component of 
the glucose tolerance factor. Also, dissolution of niacinam{de 
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produces a negligible pH change·when compared to nicotinic 
acid. 
An experiment was designed in which a spectrophotometer 
was utilized to record precipitation. It must be remembered 
that in the previous studies precipitation was determined by 
visual methods and that it is somewhat difficult to visually 
deter~ine different degrees of precipitation. The use of this 
instrument would undoubtedly yield more reliable data. It was 
decided to monitor the test solutions at 400nm with a Heath 
EU707-ll ~pectrophotometer. This wavelength has been used by 
microbiologists to monitor the turbidity due to bacterial 
growth (135). In the procedure, lOml of 0.067M phosphate 
buffer, pH 7.4 was placed in each of five 15ml screw cap vials. 
Likewise, lOml of a solution of O.lM niacinamide (Sigma) in 
0.067M phosphate buffer, pH 7.4 was placed in each of five 
vials. Chromium (III), in aliquots of 0, 100, 200, 300, and 
400 microliters was added to each set of five vials resulting 
in chromium (III) concentrations of 0, 1 X 10-3 , 2 X 10-3 , 
3 X 10-3 , and 4 X l0-3M, respectively. The vials were then 
agitated on a Labquake shaker at room temperature for a period 
of 18 hours. Aliquots were then withdrawn and the absorbance 
measured at 400nm in a lcm Beckman cell with 0.067M phosphate 
buffer, pH 7.4 as the reference. The recorder was adjusted 
to give a 1 to 0.1 absorbance response. After transfer, the 
spectrophotometric cell was inverted three times before the 
absorbance value was recorded. The pH was recorded before 
the addition of chromium, after the addition of chromium and 
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upon completion of the incubation period. 
Following this, a study was performed concerning the 
effect of chromium (III) on the UV absorption spectrum of 
niacinamide at physiological pH. Stock trivalent chromium 
solutions in the form of CrK(S04)2·12H2o (l0-1M) were pre-
pared in dilute HCl. Aliquots of 10 and 100 microliters were 
removed and added to 12 X 150mm screw cap culture tubes con-
taining 50ml of 2 X 10-5M niacinamide in 0.13M phosphate 
buffer, pH 7.4. The pH was monitored before and after the 
. 
addition of the acidic chromium aliquots. The final concen-
trations of chromium were 2 X 10-4 and 2 x 10-5M, resulting 
in chromium-to-niacinamide ratios of 10:1 and 1:1, respectively. 
The solutions were then agitated gently on a Labquake shaker 
for a period of 19.5 hours at room temperature. Upon comple-
tion of the incubation period, the solutions were visually 
checked for precipitation and the pH was taken. Aliquots were 
removed and placed in a lOcm Beckman cell and the UV spectra 
were recorded on a Cary 15 recording spectrophotometer (Varian 
Instruments, Concord, CA) over the range of 230 to 350nm. 
Blanks containing phosphate buffer, phosphate buffer-niacinamide 
and phosphate buffer with the appropriate chromium (III) con-
centrations were also prepared and subjected to the same 
procedure. 
Since 0.13M phosphate buffer was utilized in the previous 
experiment, it was decided to study the ability of a solution 
of 2 X 10-5M niacinamide in 0.13M phosphate buffer, pH 7.43, 
to solubilize chromium (III). Fifty milliliters of this 
solution was placed in a 15 X 'l50mm screw cap culture tube. 
Likewise, 50ml of 0.13M phosphate buffer without niacinamide 
was placed in a culture tube. A 500 microliter aliquot of a 
stock 10-lM solution of chromium (III) in dilute HCl was added 
to each of the culture tubes resulting in a final chromium 
-3 
concentration of 1 X 10 M. Both tubes were then agitated 
gently on a Labquake shaker for a period of 96 hours at room 
temperature. They were observed for precipitation and the pH 
taken periodically throughout the incubation period. This 
~ 
pilot procedure was followed by a long term spectrophotometric 
study on the solubilization of chromium (III) by 0.13M phos-
phate buffer-2 X l0-5M niacinamide solutions, pH 7.43, at 
various chromium-to-niacinamide ratios. The purpose of this 
study was to determine how long the chromium (III) would remain 
in solution. The chromium-to-niacinamide ratios selected were 
1:1, 10:1, 25:1, 40:1, 50:1, and 100:1, resulting in chromium 
-5 -4 -4 -4 
concentrations of 2 X 10 , 2 X 10 , 5 X 10 , 8 X 10 
-3 -3 1 X 10 , and 2 X 10 M, respectively. Fifty milliliters of 
the phosphate buf fer-niacinamide solution was placed in each 
of 6 screw cap culture tubes. A seventh tube contained only 
0.13M phosphate buffer, pH 7.43. Aliquots of 10, 100, 250, 
400, 500, and 1000 microliters of a stock (l0-1M) solution of 
chromium (III) in dilute HCl were added to the 6 tubes, re-
spectively. The tubes were then incubated at room temperature. 
Aliquots were withdrawn at 1, 7.5, 19, 25, 31, 43, 57, 67.5, 
80.5, 95.5, 118, 138, 150, 162 and 185 hours and placed in a 
lOcm Beckman cell. A lOcm cell was chosen to accentuate the 
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effect of precipitation. A Cary 15 recording spectrophoto-
meter was utilized to measure the absorbance at 400nm. The 
pH was recorded after 1 and 185 hours of incubation. Finally, 
as a check for bacterial presence, O.lml was removed from each 
tube and added to 9.9ml of sterile saline. After mixing, O.lml 
was removed and plated on blood agar. The plates were incu-
bated at 37°C for 48 hours after which colonies were counted 
and identified. Identification was made according to conven-
tional biochemical tests. 
Hydrogen-Deuterium Exchange of Insulin 
Hydrogen-deuterium exchange of proteins, as measured by 
infrared spectroscopy, is an extremely useful tool for the 
study of protein structure. Infrared spectra are directly in-
volved with the vibrations of atoms or groups of atoms in a 
molecule as distinguished from rotations of the whole molecule 
or from electronic motions characteristic of ultraviolet and 
visible absorption spectra. Absorption band positions are 
given in wave numbers which are expressed as cm-1. According 
to Parker (136), three bands involving the peptide bond (-CO-
NH-) are most frequently considered in the conformational 
studies of proteins. The first band, located at 3450cm-l, 
is due mainly to N-H stretching. The second, a strong ab-
sorption band at approximately 1680cm-l, is due mainly to the 
C=O stretching vibration. The third band is ascribed to a 
mixed vibration involving N-H in-plane bending and the C-N 
stretching modes. It occurs at approximately lSOOcm-1 and is 
termed a weak absorption band. The .latter two bands are re-
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ferred to as amide I and amide· II, respectively. According 
to Parker, the above frequencies refer to amide groups that 
are not hydrogen bonded. When hydrogen bonded, the N-H 
stretching vibration shifts to approximately 3300cm-1 . The 
amide I and II bands also shift when hydrogen bonds are formed. 
It has been said that the shift of the N-H stretching vibration 
-1 
to 3300cm is independent of conformation while the shifts 
-1 -1 
of the amide I and II bands to 1650cm and 1550cm , respec-
tively, are dependent upon conformation. For an interpretation, 
let us consider the a-helical and 6-pleted sheet conformation 
of polypeptides. The 6-pleated sheet is stabilized by hydro-
gen bonds between NH and CO groups in different polypeptide 
strands, whereas in the a-helix, the hydrogen bonds are be-
tween NH and CO groups in the same polypeptide chain. The N-H 
stretching vibration of both the a-helical and 6-pleated sheet 
forms occurs at approximately the same frequency, whereas the 
amide I and II frequencies differ between the two forms. As 
a result, workers have frequently used the ti-H stretching vi-
bration shifts as a sign of hydrogen bonding in the absence 
of conformational effects. Simple peptides exchange their 
labile hydrogen atoms (those bound to oxygen, nitrogen and 
sulfur) with solvent water in a few minutes. For proteins, 
the exchange may take 24 hours. According to Parker (137), the 
amide II band is very sensitive to hydrogen-deuterium exchange. 
According to Nielsen (138), the process takes place as follows: 
-CO-NH- + -CO-ND- + HDO 
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-1 AS deuteration proceeds, the amide II band at 1550cm is 
progressively replaced by the deuterated amide II band at 
-1 
1450cm , while the intensity of the amide I band remains 
constant. The extent and rate of deuteration can be deter-
mined by measuring either the disappearance of the amide II 
band or the appearance of the deuterated amide II band. Inter-
ference from HOD absorption makes the latter band less suitable 
for exchange studies. 
In this case, the exchange experiment was performed ac-
cording to previously established methods (139,140). The 
procedure consisted of placing O.Olg of a lyophilized bovine 
zinc-insulin preparation (Sigma) into a small vial containing 
lml of n2o. The time of this addition was taken as T=O. In 
order to achieve dissolution, the pD was adjusted to 2.5 by 
the addition of 10 microliters of a 25% DC1-D2o solution. Ac-
cording to Glasoe (141), the pD of a solution in o2o can be 
determined by the use of the equation 
pD = pH meter reading + 0.40 
where the "pH meter reading" is obtained with an apparatus 
standardized to read pH in H2o solutions. The solution was 
then transferred QY means of a syringe to a CaF 2 cell (Barnes 
Engineering, Stamford, CT) with a calibrated pathlength of 
0.065rnm. The reference cell, pathlength 0.065rnm, contained 
o2o adjusted to pD 2.5 with a DCl solution. The appearance 
-1 
of the deuterated amide II peak at 1450cm was measured for 
a six hour period with a Perkin-Elmer (model 337) grating in~ 
frared spectrophotometer (Perkin-Elmer, Norwalk, CT) equipped 
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with an ordinate scale expander. The instrument was equili-
brated with high purity dry nitrogen to minimize effects due 
to water. Temperature was maintained at 37.5°C with a chamber 
developed by Barnes Engineering. 
In another experiment, bovine zinc insulin was examined 
by infrared spectroscopy in the presence of 10-6 to 10-8M 
chromium (III) potassium sulfate. The pD was adjusted to 2.5 
with DCl. Temperature was maintained at 37.5°C as before. 
The same CaF2 cells were utilized. In this case the reference 
cell contained a chromium-n2o solution adjusted to pD 2.5 with 
-1 DCl. Exchange was measured at 1450cm for a 6 hour period. 
Another experiment was performed in which the reference solu-
tions, adjusted to pD 2.5 with DCl, were placed in both the 
-1 
sample and reference cells and the absorbance at 1450cm 
recorded with time under the same conditions as above. This 
would attribute spectral changes solely to insulin. It was 
then decided to test the pD of the insulin-o2o solutions with 
time. Since the solutions were not buffered, a pD change 
could account for variations in the hydrogen-deuterium exchange. 
Ten milliliters of a solution of O.Olg/ml insulin in o 2o was 
placed in a jacketed cell and the pD adjusted to 2.5 with DCl. 
The temperature was maintained at 37.5°C with an adjustable 
heating source. A micro electrode attached to a Corning re-
search pH meter (Corning Scientific Ins., Corning, NY) was 
placed in the cell and the pH versus time was recorded with a 
Sargent SLR recorder (Sargent-Welch, Skokie, IL) over a period 
of 8 hours. The solution was stirred slowly and equilibrated 
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with nitrogen throughout the experiment. 
Calibration of the CaF 2 cells was performed according to 
the Fringe method (142) . In this method the empty cell is 
placed in the spectrophotometer in the sample side. No cell 
is placed in the reference beam. The spectrophotometer is 
operated as near as possible to the 100% line on the paper to 
produce fringes of greatest amplitude. Enough of the spectrum 
is run so that 20 to 50 fringes are produced. The cell thick-
ness is calculated by the following equation. 
1 = 
where 
1 = cell thickness in microns 
w1 = starting wavelength (in microns) 
w2 = finishing wavelength (in microns) 
n = number of fringes between w1 and w2 
If the measurements are made in wavenumbers, the equation be-
comes 
n 
1 = 
where 
1 = cell thickness (in cm) 
f 1 = starting frequency 
f 2 =finishing.frequency 
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!hermal Analysis of Insulin-Chromium III Solutions 
This experiment was designed to study the spectral 
behavior of insulin-chromium (III) solutions at elevated tern-
peratures. The apparatus utilized was a Beckman T analyzer 
m 
with a Moseley X-Y recorder which permits automatic recording 
of absorbance versus temperature. The T analyzer was pro-
m 
grammed to cover the range of 28 to 98°C in 25 minutes. The 
absorbance at 238 and 276nm was measured concurrently with 
the change in temperature by means of a Cary 15 recording 
spectrophotometer attached to the T analyzer. The procedure 
. m 
consisted of adding either 10 microliters of a stock solution 
of CrK(S0 4 ) 2 ·12H2o in dilute HCl or 10 microliters of a dilute 
HCl solution to each of two lOml screw cap vials containing 
lOml of a l0- 4M solution of single peak zinc-free insulin in 
0.13M phosphate buffer, pH 7.43. Insulin concentrations were 
determined on a Cary 15 spectrophotometer at 276nm using an 
extinction coefficient of 1.04 ODU/cm (mg/ml). Similarly, 
10 microliters of the stock chromium (III) solution or 10 
microliters of the dilute HCl solution were added to lOml of 
0.13M phosphate buffer, pH 7.43. The final concentration of 
chromium was l0- 4M in both cases. The tubes were then placed 
on a Labquake shaker and incubated for 1 hour at room tern-
perature. The above aliquots were added in a sequential manner 
such that each tube was incubated for exactly 1 hour. Upon 
completion of the incubation period, a 3.5ml sample was 
removed, placed in a lcm Beckman cell and the UV spectrum 
recorded between 220 and 320nm with a Cary 15 recording 
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spectrophotometer. The sample was then subjected to the 
temperature change as discussed above by engaging the Tm 
analyzer. The pH was recorded before and after the addition 
of the acidic aliquots and upon completion of the incubation 
procedure after the solutions reached room temperature. For 
comparative purposes, 10 microliters of a stock solution of 
znso4 ·7H20 (0.5 X l0-1M) was added to lOml of 0.13M phosphate 
buffer, pH 7.43, and subjected to the above procedures. 
circular Dichroism Spectroscopy of Insulin - (Effect of 
chromium II I) 
A plane polarized beam of light can be considered as 
being composed of right and left circularly polarized components. 
The principal part of an instrument used to measure circular 
dichroic properties is a modulator crystal which resolves the 
plane polarized monochromatic ray into two circularly polarized 
components. The modulation is based on the phenomenon that 
certain uniaxial crystals, such as ammonium dihydrogen phos-
phate, when subjected to an alternating current, change their 
dichroic properties. The modulator is positioned between a 
polarizer and a sample which absorbs the left and right com-
ponents to a different degree dependent upon the wavelerigth 
and structural properties of the sample. This difference is 
detected by a sensitive photocell and recorded. Circular 
dichroism, therefore, refers to the difference in absorption 
of left and right circularly polarized light and is expressed 
in terms of molar absorption (molar extinction coefficient) 
and represented by 6E=EL-ER, where 6E = CD intensity, EL= 
rnolar absorptivity for left circ·:.ilarly polarized light and 
ER == molar absorptivity for right circularly polarized light. 
In practice, the difference in optical density for the two 
circularly polarized components is measured directly. This 
difference is then converted to a difference in extinction 
coefficient. When plane polarized light passes through an 
opti~ally active medium, the light becomes elliptically 
polarized, owing to the unequal absorption of the left and 
right circularly polarized components. According to 
Strickland (143), there are two types of CD instruments. One 
type measures the difference in absorbance of left and right 
circularly polarized light whereas the other measures the 
amount of ellipticity produced by a solution. In this case 
circular dichroism (CD) spectra were recorded using a Durrum-
Jasco ORD/UV-5 spectropolarimeter modified to a maximum 
-3 
sensitivity of 2 X 10 deg/cm (Durrum Instruments, Palo Alto, 
CA). The instrument was calibrated with camphor sulfonic acid 
to give a deflection of 15.65cm at 290nm with a scale setting 
of 0.02 deg/cm. Measurements were carried out in cells with 
optical pathlengths ranging from 2 to lOcm so that for every 
measurement optical densities remained below 2. The degrees 
of ellipticity were obtained from the following relationship: 
degrees of ellipticity = scale setting X reading 
where "scale setting" is degrees for a lcrn deflection on the 
Jasco instrument (only 2 X 10- 3 was used in this work) and 
"reading" is centimeter deflection from the baseline of the 
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CD tracing at wavelength A. Circular dichroism data are 
reported as the mean residue ellipticity represented by [8]A 
. . t f d 2 dm l -l 11' t. . . and having uni s o eg cm o e . E ip icities were 
calculated from CD spectral tracings by the following equation 
(144): 
= 
where 1 is optical pathlength in decimeters, c is protein 
concentration in g/100 ml, eA is the measured ellipticity at 
wavelength A, in degrees and ~o is the mean residue molecular 
weight, taken to be 112 in the case of insulin (122). There 
are two CD regions of interest. One deals primarily with the 
region below 250nrn and is ref erred to as the far-UV CD. Bands 
in this region usually indicate secondary structure. The 
other deals with the region from 250 to 320nm and is referred 
to as the near-UV CD. These bands may arise from tryptophanyl, 
tyrosyl, phenylalanyl and cystinyl residues (122, 123, 124) 
and usually reflect tertiary structure. 
Ten milliliters of a solution of Sigma bovine crystal-
line zinc insulin (l.71 X l0- 5M) in 0.067M phosphate buffer, 
pH 7.42, was placed in each of two screw cap vials labeled 1 
and 2. Likewise, lOml of a solution of the same preparation 
in 0.067M phosphate buffer-0.15M NaCl, pH 7.42, was placed in 
each of two vials labeled 3 and 4. One hundred microliters of 
a stock (1.71 X l0- 2M) solution of CrK(so4 ) 2 •12H2o in dilute HCl 
was added to tubes 1 and 3 resulting in a chromi~m (III) con-
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centration of approximately 1.71 x 10-4M and a chromium (III)-
to-insulin ratio of 10:1. Similarly, 100 microliters of a 
dilute HCl solution was added to tubes 2 and 4. The tubes 
were then incubated for l hour at room temperature with oc-
casional mixing. Upon completion of the incubation period, 
the contents were removed a~d placed in a lOcm Jasco cell and 
the ~ircular dichroism spectra recorded over the range of 250 
to 320nm with a Durrum-Jasco ORD/UV-5 spectropolarimeter~ 
Baselines were recorded with either 100 microliters of 
~ 
chromium {III) or 100 microliters of dilute HCl in lOml of 
0.067M phosphate buffer, pH 7.42. Solutions to be utilized 
for baseline determination were subjected to the same treat-
ment as the insulin solutions. The acidic aliquots were added 
in a sequential manner such that each tube incubated for 
exactly 1 hour. The pH was recorded before the additions and 
upon completion of the CD spectra. Similarly, 100 microliters 
of a stock (4.28 X l0-2M) solution of CrK(S04 ) 2 ·12H2o in di-
lute HCl was added to lOml of a solution of 1.71 X l0-5M Sigma 
bovine crystalline zinc insulin in 0.067M phosphate buffer, 
pH 7.42. This resulted in a chromium (III) concentration of 
4.28 X l0- 4M and a chromium (III)-to-insulin ratio of 25 to 
1. Upon completion of a 1 hour incubation period, the CD 
spectra were recorded as above. Another study was performed 
to observe the effect of a smaller concentration of chromium 
(III) and a longer incubation period. One hundred microliters 
-3 
of a stock (1 X 10 M) solution of CrK(S04 ) 2 ·12H2o in dilute. 
HCl was added to lOml of a 1.71 x 10-SM solution of Sigma 
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bovine crystalline zinc insulin in 0.067M phosphate buffer, 
pH 7.42. This resulted in a chromium (III) concentration of 
1 x l0- 5M and a chromium (III)-to-insulin ratio of 0.58 to 1. 
similarly, 100 microliters of a dilute HCl solution was added 
to lOml of the insulin solution. Upon completion of incubation 
periods of 24 and 48 hours, CD spectra were recorded over the 
rang~ of 250 to 320nm as above. Another study was designed 
to observe the time dependency of the effect of chromium (III) 
on the near-UV CD spectrum of insulin. A solution of 1.71 X 
10-5M Sig~a bovine crystalline zinc insulin was prepared in 
0.067M phosphate buffer, pH 7.42. The CD spectrum was then 
recorded as above. One hundred microliters of a stock (1.71 
X l0- 2M) chromium (III) solution in dilute HCl was then added 
at time (T)=O. After a brief mixing, the CD spectrum was re-
peatedly recorded over the range of 250 to 320nm for a 33 
minute period. The first spectrum was recorded at T=3 minutes. 
Other spectra were recorded at T=l3 and T=23 minutes. A base-
line solution was prepared and subjected to the same treat-
ment along with the insulin solution. The pH was taken before 
the addition of the acidic aliquots and upon completion of 
each incubation period. Finally, 100 microliters of a stock 
(1 X l0-2M) solution of CrK(S04 ) 2 ·12H2o in dilute HCl was 
added to lOml of a 6.66 X l0- 7M bovine crystalline zinc in-
sulin solution in 0.067M phosphate buffer, pH 7.42. This 
resulted in a chromium (III) concentration of 1 X l0-4M and 
a chromium (III)-to-insulin ratio of 6660 to 1. As before, 
100 microliters of a dilute HCl solution without chromium was 
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added to lOml of the insulin solution for comparative purposes. 
upon completion of a 24 hour incubation period, the OD spectra 
were reported. In this case, however, the range 215 to 250nm 
(far-UV CD) was examined. 
The remainder of the CD studies were performed with 
Lilly single-peak porcine zinc-free insulin. The term "zinc-
free .insulin" will be utilized below for this preparation. 
Ten milliliters of a solution of zinc-free insulin (1.71 X 
'10- 5M) in 0.067M phosphate buffer, pH 7.42, was placed in each 
of 4 sere~ cap vials labeled 1 to 4. Additions of znso4 ·7H2o 
(0.85 X l0- 3M) in dilute HCl, CrK(S04 ) 2 •12H2o (1.71 X l0- 2M) 
in dilute HCl and dilute HCl (pH 3.5) were made according to 
the following scheme: 
TABLE II. Effect of zn+2 and cr+3 on the CD spectrum of 
zinc-free insulin (addition scheme). 
Dilute 
Tube zn+2 cr+3 HCl 
# (µ 1) ( µ 1) (µ 1) 
1 100 100 
2 200 
3 100 100 
4 100 100 
This resulted in a chromium (III) concentration of 1.71 X 10- 4M 
and a zinc (II) concentration of 0.85 X l0- 5M. It also re-
sulted in chromium (III)-to-insulin, and zinc (II)-to-insulin 
ratios of 10 to 1 and 0.5 to 1, respectively. Solutions uti~ 
+2 
lized for baselines contained the above combinations of Zn , 
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cr+3 and dilute HCl in 0.067M phosphate buffer, pH 7.42. The 
tubes were then incubated at room temperature (22 to 24°C) 
for 1.5 hours. Upon completion of the incubation period, the 
solutions were placed in a Jasco lOcm cell and the CD spectra 
recorded on a Durrum-Jasco ORD/UV-5 spectropolarimeter over 
the range of 250 to 320nm. The pH was recorded before and 
afte~ the addition of the acidic aliquots and upon completion 
of the incubation period. 
Insulin Aggregation as Evidenced by CD Spectroscopy 
. 
A stock lmg/ml (1.71 X 10-4M) solution of zinc-free 
insulin was prepared in 0.067M phosphate buffer, pH 7.47. 
Aliquots of 5ml were removed and placed in lOml, 25ml and 
50ml volumetric flasks dessignated A, B and C, respectively. 
Each was then diluted to the total volume with 0.067M phos-
phate buffer, pH 7.47. The solutions were then transferred 
to screw cap culture tubes in the following manner. Solution 
A (lOrnl) was placed in a lOml screw cap tube, while solution 
B (25ml) and solution C (50rnl) were placed in 50rnl screw cap 
tubes. The insulin concentrations were approximately 0.5mg/ml 
(0.85 x lo-4M), 0.2rng/rnl (0.34 x 10-4M) and O.lrng/rnl (1.71 x 
lo-5M), respective;y. A stock (1 X 10-lM) solution of 
CrK(so4 ) 2 ·12H2o in dilute HCl was prepared. Likewise, a stock 
(0.25 X 10-lM) solution of znso4 ·7H2o in dilute HCl was prepared. 
The procedure consisted of adding 10 microliters of zn+2 or 
50 rnicroliters of cr+3 or a combination of both to the above 
solutions (A, Band C). This resulted in a zn+2 concentration 
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of o.25 X l0- 4M in solution A, 0.1 X 10-4M in solution B and 
o.05 X l0- 4M in solution C. This represented a zinc (II)-to-
insulin ratio of 0.3 to 1 in all three solutions. Similarly, 
it resulted in a cr+3 concentration of 5 x 10-4M in solution 
A, 2 X l0- 4M in solution B and l X lo- 4M in solution c. This 
represented a chromium (III)-to-insulin ratio 0£ 5.9 to l in 
all three solutions. A 3 hour incubation period on a Lab-
quake shaker at room temperature was selected and divided into 
two 1.5 hour periods. This was necessary since both zn+ 2 and 
cr+3 were:studied in certain cases. One addition was made at 
the beginning of the first period and the other at the begin-
ning of the second period. The following 9 addition pairs 
were studied, each on a separate day: 10 microliters zn+2~ 
50 microliters dilute HCl, 50 microliters dilute HCl-10 micro-
liters zn+2, 50 microliters cr+3_10 microliters dilute HCl, 
10 microliters dilute HCl-50 microliters cr+3, 10 microliters 
dilute HCl-50 microliters dilute HCl, 10 microliters zn+2_50 
microliters cr+3, 50 microliters cr+3_10 microliters zn+2 
and 10 microliters EDTA (lo-lM)-50 microliters dilute HCl. 
The scheme for one experiment is shown in Table III with the 
first addition in pair as an example. 
TABLE III. 
-
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Incubation periods for the effect of zn+ 2 on 
the CD aggregation study of zinc-free insulin. 
Period 1 Period 2 
Solution 0 to 1.5 hrs 1. 5 to 3 hrs 
A zn+2 (lOi.il) HCl (50i.il) * 
B zn+2 (lOi.il) HCl (50i.il) 
c zn+2 (lOi.il) HCl (SOi.il) 
*Refers to dilute HCl (pH 3.5) 
It must b~ remembered that baseline solutions containing the 
elements or dilute HCl were also prepared and treated in an 
identical manner as the protein solutions. Upon completion 
of the incubation period, an aliquot was withdrawn from 
solution A and placed in a 2crn Beckman cell (volume=6ml) . 
Likewise, aliquots were withdrawn from solutions B and C 
and placed in a Beckman 5cm cell (volume=l4.5ml) and a Beckman 
lOcrn cell (volume=28ml), respectively. Tl1e CD spectra of the 
solutions and their respective baselines were then recorded 
on a Durrum-Jasco ORD/UV-5 spectropolarimeter over the range 
of 250 to 320nm. UV scans between 220 and 320nm were recorded 
with a Cary 15 spectrophotometer for each solution upon com-
pletion of each CD spectrum. The pH was recorded upon 
completion of the UV spectra. Additions to the tubes were 
made in a sequential manner such that each tube incubated for 
exactly 3 hours. A typical addition scheme for the Zn+ 2 -
dilute HCl pair is shown in Table IV. 
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TABLE IV. 
+2 Stepwise addition of Zn for CD aggregation 
study. 
Time Procedure 
-
9:00 AM Add 10µ1 Zn +2 to baseline solution A 
9:30 Add 10µ1 Zn +2 to solution A 
Add 10µ1 +2 baseline solution 10:00 Zn to B 
10:30 Add 10µ1 Zn +2 to solution B 
Add 50µ1 dilute HCl to baseline solution A 
Add 10µ1 +2 to baseline solution 11:00 Zn c 
Add 50µ1 dilute HCl to solution A 
11:30 Add 10µ1 zn+ 2 to solution C 
Add 50µ1 dilute HCl to baseline solution B 
12:00 PM Add 50µ1 dilute HCl to solution B 
Record CD spectrum of baseline solution A 
12:30 Record CD spectrum of solution A 
Add 50µ1 dilute HCl to baseline solution c 
1:00 Add 50µ1 dilute HCl to solution c 
Record CD spectrum of baseline solution B 
1:30 Record CD spectrum of solution B 
2:00 Record CD spectrum of baseline solution c 
2:30 Record CD spectrum of solution c 
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Finally, an attempt was made to study the time dependency 
of the CD change at 274nm. This is the wavelength of maximum 
negative CD intensity in the near-UV CD spectrum of insulin. 
This study was performed in two parts. In part I, 10 micro-
liters of a stock (0.25 X l0-1M) solution of ZnS04·7H2o in 
dilute HCl was added to lOml of solution A in tube A. Upon 
completion of a 1.5 hour incubation period, 50 microliters of 
a stock solution (1 X l0-1M) CrK(So4 ) 2 ·12H2o in dilute HCl was 
added. The time of this addition was taken as T=O and the 
chart recorder was engaged at this point. Tube A was then in-
verted several times and it's contents were placed in a 2cm 
Beckman cell and the CD intensity at 274nm monitored for a 
period of 73 minutes with a Durrum-Jasco ORD/UV-5 spectra-
polarimeter. Solution B was then subjected to the same 
procedure. The contents of solutions A and B are defined in 
the previous paragraph. As before, the CD spectra of the base-
line solutions were recorded prior to spectra of the insulin 
solutions. The pH was recorded before the addition of the 
acidic aliquots and upon completion of the study. 
Part 2 was designed to study the time dependency of in-
sulin association in the presence of zinc. Ten microliters 
of a stock (0.5 X l0-3M) solution of znso4 ·7H2o in dilute HCl 
was added directly to 5.0ml of solution A in a 2cm Beckman 
cell. The solution was mixed and the CD intensity monitored 
at 274nm for a period of 10 minutes. 
Frontal Gel Analysis of Insulin 
It was demonstrated by Winzor and Scheraga (145) that 
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molecular sieve chromatography possesses all the qualitative 
features predicted by Gilbert (146) for ultracentrifugational 
analysis of reversibly associating protein systems. Subse-
quently, Ackers and Thompson (147) developed a theoretical 
treatment applicable to molecular sieve chromatography. More 
recently, it was demonstrated (148) that the technique is ex-
trem~ly valuable for studies involving subunit proteins. There 
are two methods by which interacting protein systems can be 
studied by means of gel chromatography. One method, called 
zonal chr¢matography, is familiar to most of us since it is 
utilized for protein purification and fractionation. It in-
volves applying small volumes of the sample to the column. 
The sample then migrates through the column and is eventu~lly 
detected by a UV monitor which records an elution profile. 
In this case the elution volume is taken as the volume to the 
peak of the profile. This method is not very valuable for 
studying proteins with interacting subunits, except under 
conditions where a slow attainment of equilibrium between 
interacting subunits takes place. Under these conditions an 
equilibrium constant may be determined because the entities 
may be separable and the areas under the peaks may be propor-
tional to the equilibrium concentrations of the various species 
present. Zonal chromatography of a rapidly associating-
dissociating protein such as insulin in a solvent (eluant) 
which promotes association-dissociation is evidenced by a 
spreading-out of the profile and loss of the sharp peak, which 
would be present if chromatography had been performed with an 
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eluant such as urea which promotes dissociation to the monomer. 
The other method for studying interacting protein systems is 
called frontal analysis. The method consists of applying large 
volumes of the sample to the column such that a sharp leading 
boundary, a plateau of constant protein concentration and a 
trailing boundary are formed. In this case, the elution volume 
is t~ken to the centroid position of the leading boundary or 
in other words, to the inflection point of the leading boundary. 
The elution volume and the form of the elution profile can be 
utilized to describe the nature of the interacting protein 
system and to determine the equilibrium constant regardless 
of the rate of attainment of equilibrium. 
In this study, the technique of frontal gel chromato-
graphy was utilized to evaluate the ability of Cr+ 3 , Zn+ 2 and 
a combination of both ions to alter the molecular weight dis-
tribution of insulin at physiological pH. The elution volumes 
(Ve) were determined by differentiating the absorbance (A) 
versus volume (V) plots of the leading boundary as recorded by 
the UV monitor. The inflection point was determined by a plot 
of dA/dV versus V. A correction for skewness was made ac-
cording to the method of Longsworth (149). The elution volumes 
were then utilized to determine the sieve coefficient (o) by 
means of the following expression (150): 
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a = 
where 
Ve = protein elution volume 
V 0 = colu..'1ln void volume 
Vt = column total volume 
The sieve coefficient is related to the molecular weight by 
the following expression (148): 
a = -A log MW + B 
A jacketed (1.3 x 25cm) column thermostated at 25°C and 
adjusted to acconunodate a bed height of 8.Scm was selected 
for this study. The column, as well as all glassware, was 
siliconized before use. Sephadex G-50 (superfine) resin was 
placed in 0.067M phosphate buffer, pH 7.47 and equilibrated 
for 24 hours under a vacuum with stirring. The column was 
then poured and equilibrated for 24 hours with degassed 0.067I1 
phosphate buffer, pH 7.17 by means of a Cheminert continuous 
flow metering pump (Laboratory Data Control, Riviera Beach, 
CA). A flow rate of 6.0ml/hour was selected. A special ap-
paratus was designed to trap bubbles produced by the pump. 
It consisted of an inverted plastic test tabe with both an 
inlet and outlet at the bottom. Any bubbles entering would 
rise to the top and therefore, would not enter the column. 
Absorbance was monitored in a lcm flow cell with either a 
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carY 15 or a Beckman DB-G spectrophotometer. A special 4-way 
sample injection valve (Laboratory Data Control) was utilized 
to insure proper application of the sample to the column. The 
valve was placed between the pump and the column. Basically, 
it consists of a main chamber and two loops (A and B) (Figure 
15). The valve is operated by a slider which can be placed 
in oDlY two positions. In one position, solvent flows from 
the pump through loop A and into the column. Meanwhile, loop 
B is open to the atmosphere and can be filled with a protein 
sample. ~t any time, the slider can be placed in the other 
position. This will automatically shift the flow of solvent 
through loop B forcing the sample ahead of it into the column. 
For this study, three different size loops were used in place 
of loop B. The first loop, used primarily for column cali-
bration, contained approximately 0.28ml. The other two con-
tained 4.8 and 8.0ml and were utilized for the frontal studies. 
The frontal gel studies were divided into 2 parts. Part 
I dealt with a study of the self-association of zinc-free in-
sulin whereas part II was concerned with the effect of Cr+ 3 , 
Zn+ 2 and a combination of both ions on the association of zinc-
free insulin. For part I, 40mg of zinc-free insulin was placed 
in a volumetric flask and diluted to lOml with 0.067M phosphate 
buffer, pH 7.47. Likewise, 25mg was placed in a volumetric 
flask and diluted to 25ml with phosphate buffer. This resulted 
in solutions of approximately 4mg/ml (A) and lmg/ml (B), 
respectively. Final insulin concentrations were determined 
on a Heath spectrophotometer at 276nm using an extinction co-
.·· 
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FIGURE is: Four-way sample injection valve schematic. 
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efficient of 1.04 ODU/cm (mg/ml). ·Dilutions of these stock 
solutions in 5, 10, 50 and lOOml volumetric flasks were then 
made with 0.067M phosphate buffer, pH 7.47. according to the 
following scheme. Kimax (type A) volumetric pipettes (Scien-
tific Products, McGaw Park, IL) were used for all transfers. 
TABLE v. Dilution of stock solutions for frontal gel analysis. 
Solution Solution Buff er Approx. 
A B Cone. 
(ml) (ml) (ml) (mg/ml) 
5.0 0 4 
2.5 2.5 2 
5.0 0 1 
4.5 0.5 0.9 
3.5 1. 5 0.7 
2.5 2.5 0.5 
1. 5 3.5 0.3 
0.5 4.5 0.1 
0.5 9.5 0.05 
0.5 49.5 0.01 
0.5 99.5 0.005 
UV scans were performed on each solution over the range of 212 
to 320nm with a Heath spectrophotometer, after which, wave-
lengths were selected at which to monitor the fronts. 
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The column was then calibrated with.the following markers at 
the concentrations stated below. For this calibration pro-
cedure the 0.28ml loop (B) was utilized. 
TABLE VI. Self-association of zinc-free insulin (markers 
for column calibration). 
Marker ~1W Concentration 
(mg/ml) 
Blue Dex tr an 2,000,000 1. 5 
Ovalbumin 45,000 6.0 
-< 
. 
Chymotrypsinogen 25,000 2.85 
Myoglobin 17,700 3.0 
Ribonuclease 12,600 4.0 
ACTH 4,500 5.0 
K2Cr04 194 0.45 
Chymotrypsinogen was prepared by dissolving 28.5mg in lml 
dilute HCl. Aliquots of O.lml were withdrawn and added to 
0.9ml of 0.067M phosphate buffer, pH 7.47, resulting in a 
final concentration of 2.85mg/ml. This was necessary because 
of the presence of small amounts of chymotrypsin in the sample 
which resulted in proteolysis if the solutions were left 
standing at neutral pH for long periods of time. Chymotrypsin 
is inactive in dilute HCl. The markers were inserted into 
loop B with a syringe and allowed to enter the column at 0.5 
hour intervals. Absorbance was monitored at 280nm with a 
Beckman DB-G spectrophotometer and profiles were recorded with 
a Beckman 10" chart recorder set at a speed of 0.2 in/min. 
Upon completion of the calibration period, sieve coefficients 
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were calculated from the elution volumes. Loop B was then 
replaced by a 4.3ml loop. This loop was filled with the 
insulin solutions stated above and a front was recorded for 
each insulin concentration ranging from 4rng/ml to 0.005mg/ml 
at its respective wavelength. Elution volumes were then 
determined and the respective sieve coefficients calculated. 
The column was then re-calibrated with the markers as before. 
In part II, a frontal gel study was performed on the 
nitrated insulins prepared previously. A O.Slmg/ml solution 
. 
of the nitrated insulin was prepared in 0.067M phosphate 
buffer, pH 7.47. It was then diluted 1:10 to obtain a 
0.05lmg/rnl solution. UV scans were performed on both solu-
tions with a Cary 15 spectrophotometer over the range of 220 
to 700nm to select the proper wavelengths for monitoring the 
fronts. A sample loop capable of holding 8.0ml was utilized 
in place of loop B for this frontal study. Absorbance was 
monitored by a Cary 15 spectrophotometer at the chosen wave-
lengths for the 0.51 and 0.05lrng/ml solutions, respectively. 
All other conditions were identical to t~e previous frontal 
gel studies except for a column bedheight of 9.0cm. Elution 
volumes were determined and sieve coefficients calculated as 
before. The column was then calibrated with the following 
markers at the concentrations stated in Table VII. For this 
calibration procedure the 0.28ml loop (B) was utilized. 
TABLE VII. 
-
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+3 . +2 Effect of Cr and Zn on the aggregation of 
zinc-free insulin (markers used for column 
calibration). 
Marker MW Concentration 
(mg/ml) 
Blue Dextran 2,000,000 1.5 
Carbonic Anhydrase 31,000 5.0 
Chymotrypsinogen 25,000 2.85 
Myoglobin 17,700 3.0 
Ribonuclease 12,600 4.0 
Nitrated Insulin 5,891 0.5 
K2Cro4 194 0.45 
The markers were inserted into the loop with a syringe ahd 
allowed to enter the column at 0.5 hour intervals. Absorbance 
was monitored at 280nm with a Cary 15 spectrophotometer and 
profiles were recorded at a chart speed of 0.2 in/min. Elution 
volumes were determined and sieve coefficients calculated as 
before. The sample loop was then replaced by an 8.0ml loop 
in preparation for the remaining frontal studies. 
To complete this study it is necessary to call your 
attention to solutions A, B and C of the previous section 
concerning insulin aggregation as evidenced by CD spectroscopy. 
In order to correlate the CD changes with changes in the mole-
cular weight distribution of insulin, it was decided to utilize 
these same solutions for frontal gel studies. The composition 
of each solution is fully described in that section. Prior 
to the addition of the acidic aliquots, however, UV scans were 
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performed with a Cary 15 spectrophotometer over the range of 
220 to 320nm in order to select the wavelength at which to 
monitor the fronts. Final insulin concentrations were de-
termined at 276nm using an extinction coefficient of 1.04 ODU/ 
cm (mg/ml). The procedure was identical except that only 4 
addition pairs were studied. They were 10 rnicroliters dilute 
HCl-50 rnicroliters dilute HCl, 10 rnicroliters Zn+ 2-5o rnicro-
liters dilute HCl, 10 microliters dilute HCl-50 microliters 
cr+ 3 and 10 rnicroliters zn+ 2-5o microliters cr+ 3 . Upon com-
pletion o~ the 3 hour incubation period, the 8.0ml loop was 
filled with each solution and the fronts were recorded. The 
elution volumes were determined and the sieve coefficient 
calculated as before. The column was then re-calibrated with 
the previously stated markers. 
CHAPTER III 
RESULTS 
preparation of Zinc-Free Insulin 
Chelex 100 chelating resin was equilibrated with 0.05~1 
tris-7M urea buffer, pH 8. The pH initially rose to 11 and 
dropped to 7.9 after 10 changes of buffer. In the preparation 
. 
of zinc-fr.ee insulin utilizing this resin, 20mg of the com-
mercial insulin preparation was dissolved in 4ml of 0.05!1 
tris-7M urea buffer, pH 8. Upon dissolution, the pH dropped 
to 7.7 and remained there throughout the procedure. This 
drop in pH upon dissolution of insulin was expected since the 
pK for insulin is approximately 5.6. After dissolution, O.lml 
of the pre-equilibrated resin was added. No change in pH was 
observed. 
Isolation of "Single Peak" Insulin 
The composition of "single peak" insulin has been 
defined (151). It is composed of arginine insulin, esterified 
insulin, monodesamido insulin and single component insulin. 
In this dissertation, commercial insulin was purified by means 
of gel chromatography in lM acetic acid. The approach con-
sisted of utilizing several different Sephadex resins, namely 
G-75, G-50 (medium) and G-50 (fine) at a flow rate of 13ml/hr. 
It can be seen (Figure 16) that Sephadex G-75 and G-50 (medium) 
were inadequate for this purpose. On the other hand, chroma-
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FIGURE l&. Utilization of various Sephadex r~sins for 
gel chror,\atography of bovine zinc-free i'.'l.sulin. ;\: 280nm; 
Eluant: IM acetic acid; Sample: lml containing 35mg insulin;'. 
Flow rate: 13ml per hour; Chart speed: 20mm per hour; ' 
Bed: 85cm; (-): G-75; (---) ~ G-50 (medium); ( · • • ·): G-50 
(fine) . 
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tography with G-50 (fine) resin resulted in some degree of 
separation. The resin selected for the purification of 
bovine zinc-free insulin was Sephadex G-50 (superfine) at a 
flow rate of 6ml/hr (Figure 17). After chromatography, the 
contents of tubes 36 to 49 were collected and designated 
"single peak bovine zinc-free insulin". Tubes 25 to 33 were 
designated "crude proinsulin" and tubes 34 and 35 were dis-
garded. The same resin was utilized for the purification of 
porcine zinc-free insulin (Figure 18). In this case, however, 
a flow rate of 4.2ml/hr was selected. Tubes 36 to 48 were 
pooled and designated "single peak porcine zinc-free insulin". 
Tubes 26 to 33 were designated "crude proinsulin" and tubes 
34 and 35 were disgarded. In a similar study (130), a com-
mercial insulin preparation was chromatographed with G-50 
resin and lM acetic acid as the eluant. A similar elution 
profile was obtained. According to the authors the first 
small peak, designated crude proinsulin fraction, was composed 
of proinsulin, nonconvertable insulin dimer and proinsulin 
intermediates. Since this peak was effectively removed in 
the purification process, it can be said that the above com-
ponents were not present in the zinc-free insulins utilized 
for the experiments of this dissertation. It has also been 
stated (130) that insulin was dissociated into monomers in 
the presence of lM acetic acid. According to Figures 17 and 
18, there seemed to be some degree of association as judged 
by the skewness of the insulin peaks. 
Concerning the recovery, let us take Figure 17 as an 
example. In the previous ~hapter it was mentioned that 35mg 
.·· 
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FIGURE 17: Chromatography of bovine zinc-free insulin 
with Sephadex G-50 (superfine) resin. A: 280nrn; Eluant: 
lM acetic acid; Sample: lml containing 35mg insulin; 
Flow rate: 6rnl per hour; Chart speed: lOrnm per hour; 
Fractions: 3rnl; Bed: 85cm; a: crude proinsulin; 
b: insulin. 
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FIGURE 18: Chromatography of porcine zinc-free insulin 
with Sephadex G-50 (superfine) resin. A: 230 run; Eluant: 
lM acetic acid; Sample: lml containing 35rng insulin; Flow 
rate: 4.2rnl per hour; Chart speed: lOmrn per hour; Fractions: 
3ml; Bed: 85crn; a: crude proinsulin; b: insulin. 
.. 
Q) 
(,) 
c 
IU 
.. 
.. 
·~ 
c 
llS 
~ 
10 
20 
40 
.. 60 
c 
QJ 
u 
I. Q) 
D. 
80 
113 
b 
25 30 35 40 45 50 
Tube Number 
r 
" ' 
114 
of the unpurified bovine zinc-free insulin was subjected 
to purification by column chromatography. Upon comp'J{etion 
of the chromatographic procedure and after lyophilization of 
the respective insulin and proinsulin fractions, it was found 
that the designated insulin fraction weigh~d approximately 
30mg whereas the proinsulin fraction weighed approximately 
3.2mg. This represented a recovery of 33.2 of the original 
35mg or approximately 95% by weight recovery of insulin and 
proinsulin. 
It:has been previously shown (152) that "single peak" 
insulin was heterogenous. According to the authors, the 
first band moving toward the anode was monodesamido insulin. 
The major band was insulin which may also contain a noncon-
vertable insulin dimer accounting for about 2% of the total 
insulin. It was very difficult to distinguish between the 
monodesamido insulin and the single component insulin, there-
fore it can be said that the first large band was probably a 
combination of monodesamido insulin and single component 
insulin. The next band comprised the proinsulin intermediates. 
This was followed by a very prominent band corresponding to 
about 4% of the insulin. It contained arginine insulin, i.e. 
insulin with an arginine at position B-31 and insulin ethyl 
ester produced by the acid ethanol extraction procedure. The 
following band, fifth from the anode, was proinsulin. All 
other bands remained unidentified. Polyacrylamide disc gel 
electrophoresis of a sample of bovine zinc-free insulin be-
fore and after purification was performed (Figure 19). The 
observations discussed above can be applied. It can be seen 
... 
'• 
.. 
FIGURE 19.· Polyacrylamide disc gel electrophoresis of 
bovine zinc-free insulin before (-~) and after (----) 
column chromatography in lM acetic acid. ,\: 280nm; 
A: proinsulin; B: arginine insulin and insulin ethyl ester;~ 
C: proinsulin intermediates; D: single component insulin; 
E: monodesamido insulin. 
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that after purification, portions corresponding to pro-
insulin and proinsulin intermediates were removed. 
Finally, a sample of porcine zinc-free insulin before 
and after purification was subjected to column chromatography 
in the presence of urea (Figure 20). Hypersharp leading and 
trailing boundaries were obtained. Under these conditions, 
insulin was completely dissociated into the monomeric form 
and as a result a symmetrical peak was obtained. According 
to this study, the crude proinsulin peak represented approxi-
mately 5.6% of the total amount of protein eluted from the 
column. This was determined by measuring the areas under the 
respective UV elution profiles. Utilizing the weight figures 
discussed previously, the crude proinsulin peak represented. 
approximately 9.6% of the total. These figures were in agree-
ment with a previous report suggesting that 7% of the material 
may be proinsulin-like and insulin aggregates (129). 
Nitration of Insulin 
Insulin was nitrated according to the following 
reaction (153). 
Tyrosine side 
chain of 
insulin 
+ 
TNM 
(Tetranitromethane) 
+ 
C(N02)) 
It is quite clear from the above mechanism that the reaction 
proceeded with a decrease in pH. As far as the extent of 
., 
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.. 
FIGURE 20. Sephadex G-50 (superfine) chromatography of 
procine zinc-free insulin under dissociating conditions. 
~: 280nm; Eluant: O.OSM tris-7M urea, pH 7.4; Sample: lml 
containing 9mg insulin; Flow rate: 4.2ml per hour; Chart 
spleed: lOmm per hour; Fractions: 3ml; Bed height: 85cm; 
( • • • ·): before purification; (--): after purification. 
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nitration is concerned, it has been suggested by one group 
of investigators (134) that the treatment of bovine insulin 
with TNM at pH 8 resulted in the nitration of 2.5 of the 4 
residues of tyrosine in the insulin molecule. In another 
study (125), it was reported that treatment of zinc-free 
insulin in 0.05M tris, pH 8, with TNM yielded an insulin pre-
paration with all four of the tyrosines nitrated. According 
to Gattner (154), the four tyrosines of insulin showed dif-
ferent reactivity toward TNM: TyrA14> TyrA19> TyrB16> 
TyrB26. With proceeding nitration the reactivities of TyrA14, 
TyrA19 and TyrB16 were equalized whereas TyrB26 kept a signi-
ficantly lower reactivity. 
A UV study of the time dependence of insulin nitration 
in 0.05M tris, pH 8 was performed (Figure 21). A more detailed 
explanation of the method was given in Chapter II. Absor-
bance was measured at 276 and 353nrn at selected points over 
an interval of 1127 minutes. It is important to mention again 
that nitrotyrosine residues absorb at both 276 and 353nm at 
an acidic pH whereas tyrosine residues absorb only at 276nrn 
under acidic conditions. The pH prior to the addition of TNM 
was approximately 7.8. Upon completion of the incubation 
period, the pH dropped to 7.65. A drop in pH was expected 
since 2 protons were released for each tyrosine residue 
nitrated. It was felt that the pH change did not significantly 
affect the extent of reaction since it has been reported that 
the reaction was terminated by adjusting the pH to 3 (134). 
It is evident from Figure 21 that there was only a slow increase 
in absorbance at both wavelengths beyond 200 minutes. The 
' 
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FIGURE 21~ A UV study of the time dependence of insulin 
nitratiorr in O.OSM tris, pH 8. 
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nitrated insulin which resulted at the end of 1127 minutes 
of reaction with TNM behaved peculiarly in that precipitation 
occurred upon acidification with HCl. Also, this preparation 
failed to dissolve in lM acetic acid. The crystals were 
soluble however, in either 0.05~ tris or 0.067.M phosphate 
buffer, pH 7.4. This behavior may indicate a high degree of 
polYJ!l.erization. As a result of this experiment, and keeping 
in mind that excessive nitration was accompanied by poly-
rner i za tion of insulin (134), 2 hours was designated to be a 
suff icien£ period for nitration. 
A similar UV study was performed to compare the extent 
of nitration in the presence and absence of urea. It was 
assumed that the dissociative effect of urea would result in 
a greater degree of nitration. Conditions were identical to 
those of the preceeding experiment, except that UV scans were 
performed over the range of 240 to 400nm at selected time 
intervals. A series of UV scans for nitration in the presence 
of urea are shown (Figure 22). The absorbance change due to 
nitrotyrosine (353nm) between 0 and 120 minutes is evident. 
From these scans, plots of absorbance at 276nm and absorbance 
at 353nm versus time were made (Figure 23). These plots in-
cluded corrections for absorbance changes due to interactions 
between TNM and the buffer constituents (Tables VIII, IX). 
It can be seen that nitration in the presence of urea resulted 
in a significant increase in the absorbance at 353nm. This 
seemed to indicate greater nitration of tyrosine residues 
since only nitrotyrosine absorbs at 353nm. Up to 90 minutes 
.·· 
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FIGURE 22: UV scans during insulin nitration in O.OSM 
tris-7M urea, pH 8. 
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FIGURE 23.~ A UV study of the time dependence of insulin 
nitration 'in the presence (coo) and absence (••••) of 
urea. (-): 353nm; (----): 276nm. .5 
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TABLE VIII. A UV study of the time dependence of insulin nitration in the absence 
of urea. 
Time 
(Hin) 
0 
10 
40 
80 
120 
Total 
Absorbance 
( 353nm) 
.006 
.112 
.471 
.642 
.752 
Blank * 
Absorbance 
(353nm) 
.003 
.022 
.019 
.019 
.019 
Protein 
Absorbance 
(353nm) 
.003 
.090 
.452 
.623 
.733 
*Includes absorbance due to buffer constituents. 
• A 
Total 
Absorbance 
(276nm) 
.042 
.078 
.185 
.227 
.254 
Blank 
Absorbance 
(276nm) 
.004 
.071 
.062 
.075 
.029 
Protein 
Absorbance 
(276nm) 
.038 
.007 
.123 
.152 
.225 
i-' 
[\) 
~ 
TABLE IX. A UV study of the time dependence of insulin nitration in the presence 
of urea. 
Time Total Blank * Protein 
- . 
Total Blank Protein 
P.bsorbance P...bsorbance Absorbance Absorbance Absorbance Absorbance 
(Min) (353nm) (353nrn) (353nm) (276run) (276nm) ( 2 7 6nm) 
0 .012 0 .012 .047 .003 .044 
'--
10 .252 .020 .232 .175 .038 .137 
40 .574 .022 .552 .218 .039 .179 
80 .738 .029 .709 .254 .059 .195 
120 .819 .041 .778 .271 .129 .142 
*Includes absorbance due to buffer constituents. 
t-' 
N 
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the absorbance at 276nm for the urea situation exceeded that 
for the non-urea situation. After 90 minutes, however, the 
absorbance at 276nm for the urea situation dropped off 
whereas that for the non-urea condition increased. Since 
tyrosine residues absorb at 276nm, this indicates that 
tyrosine residues were more completely nitrated under urea 
conditions resulting in a decrease in absorbance at 276nm. 
This suggestion is only speculative since nitrotyrosine also 
absorbs at 276nm and may have obscured the picture. 
To•demonstrate the changes in molecular weight dis-
tribution that occurred during nitration of insulin, the 
reaction was stopped at various time intervals by the addition 
of 1 drop of concentrated HCl to the reaction vessel. This 
resulted in a pH drop to about 2.5 which was sufficient to 
stop the reaction. The contents were then dialyzed, lyophi-
lized and chromatographed as discussed in Chapter II. The 
results of column chromatography of insulin after periods of 
nitration of 120 and 1127 minutes in the absence of urea, are 
shown (Figure 24). In general, the figure seems to indicate 
a tendency to shift to higher molecular weight species for 
the 1127 minute nitration period as compared to nitration for 
120 minutes. A similar situation occurred for nitration in 
the presence of urea (Figures 25,26). In this case, however, 
the shift to larger molecular weights was more evident since 
shorter nitration periods were studied. 
Finally, the nitration procedure was utilized on a 
preparative basis for the production of nitrated insulin. 
In this situation, insulin in th~ presence and absence of urea, 
.·· 
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FIGURE 24: Column chromatography of insulin nitrated 
in the absence of urea. .\: 280nrn; Eluant: o.os.~1 tris-
7M urea, pH 7.4; Sample: lml containing entire nitrated 
product; Flow rate: 4.2ml per hour; Chart speed: lOmrn 
per hour; Fractions: 3ml; Bed: 85crn Sephadex G-50 (super-
fine); ( • • • ·): after 120 minutes nitration; (--): after 
1127 minutes nitration. 
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FIGURE 25... Column chromatography of insulin nitrated in 
the pres1e·nce of urea. A.: 280nm; Eluant: O.OSM tris-7M 
urea, pH 7.4; Sample: lml containing entire nitrated 
prod~1ct; Flow rate: 4. 2rnl per hour; Chart speed: 1 Omm 
per hour; Fractions: 3ml; Bed: 85cm Sephadex G-50 (super-
fine) ; (--) : 15 minutes ni tr at.ion; (---) : 30 minutes 
nitration; (• • ••): 60 minutes nitration. 
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was allowed to react with TW1 for a period of 2 hours. The 
pH changes at the beginning and end of the nitration pro-
cedure for both the insulin solutions and buffers without 
insulin are shown below. 
TABLE X. Changes in pH during the nitration of insulin. 
Time T TU 
0 7.88 7.70 8.0 8.0 
• 2hr 7.65 6.95 8.05 7.93 
* I = insulin 
T = 0.05M tris, pH 8 
TU= 0.05!.1 tris--7M urea, pH 8 
It is most noteworthy that the change in pH for insulin nitrated 
in the presence of urea was much greater than that which oc-
curred in the absence of urea. This observation supports the 
view that insulin is nitrated to a greater extent in the presence 
of urea. The molecular weight distributions for both cases 
along with the elution volumes for several markers are shown 
(Figure 27). Specific details concerning the markers and pro-
cedure were discussed in Chapter II. In both cases four peaks 
were evident. Peak 4 eluted with a volume near that of insulin 
(MW 5778) and most likely represents the nitrated insulin 
monomer. Consequently, tubes 26 to 32 were pooled and utilized 
for the frontal gel studies presented later. Peak 3 eluted 
with a volume near that of ribonuclease (MW 13,600) while 
peak 2 eluted between ribonuclease and myoglobin (MW 17,800). 
Peak 1 eluted between rnyoglobin and chymotrypsinogen (~IW 25, 000). 
l 
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FIGURE 27 •. Column chromatography of insulin nitrated 
in the presence (--) and absence (----) of urea: 
Molecular weight distribution defined by markers. ~= 
280nm; Eluant: 0.0511 tris-7.M urea, pH 7.4; Sample: lml 
containing entire nitrated product; Flow rate: 4.2ml 
per hour; Chart speed: lOmm per hour; Fractions: 3ml; 
Bed: 85cm Sephadex G-50 (superfin2); Nitration period: 
120 minutes; B: blue dextran; C: chymotrypsinogen; 
M: myoglobin; R: Ribonuclease; I: insulin. 
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The implications for the latter three peaks are that they 
may represent covalent dimers, trimers and tetramers of 
insulin. Another observation that deserves mention is the 
difference in absorbance of peak 4 between insulin nitrated 
in the presence and absence of urea. The increased absorbance 
(decreased % Transmittance) at 280nm is supportive for greater 
nitration in the presence of urea since tyrosine absorbs at 
this wavelength. This observation must be interpreted with 
caution since nitrotyrosine also absorbed at 280nm. Overall, 
however, the evidence seems to favor increased nitration in 
the presence of urea. 
Solubilization of Trivalent Chromium 
Several buffers suitable for studies in the physio-
logical pH range were selected. The pH in each case was 
adjusted to 7.4. Trivalent chromium in the form of CrK(S04)2· 
12H2o was added to final concentrations of 5 x lo-
4
, 1 X 10-3 
and 2 X lo-3M. After 18 to 24 hours of agitation at room·tem-
perature (22.5°C), the solutions were observed for precipitation. 
These observations as well as pH changes upon the addition of 
chromium are shown below (Table XI). For further details con-
cerning this procedure see Chapter II. It is clear from the 
table that only the phosphate buffers (0.13M and 0.067M) al-
lowed solubilization of trivalent chromium. It was then 
decided to add various nitrogen containing compounds to the 
phosphate buffers with the idea in mind that they may act as 
weak chelators of the metal. In this case chromium was added 
to a final concentration of 4 X 10-3M. This concentration 
132 
TABLE XI. Solubility of trivalent chromium in various 
buffers in the physiological pH rarige. 
Buff er 
pH 7.42 
0.067M 
Sorensen's 
phosphate 
0. l 3I'-1 
phosphate: 
O.OSM 
tr is 
O.lM 
barbital 
O.OSH 
~ES 
0.05M 
MES 
O.OSM 
EEPES 
O.OSM 
BICil-J"E 
*pHl 
pE2 
pH 
**ppt. 
= pH 
= pH 
= pH 
= 
= 
pH 
l* 2 3 
7.35 7.31 
f 
7.40 7.38 7.33 
7.35 
7.30 
7.10 
7.21 
after addition of 5 
after addition of l 
after addition of 2 
precipitate 
not recorded 
Cr+J Co~centration 
No ppt.** ppt. 
No ppt. No ppt. 
ppt. 
ppt. 
ppt. 
ppt. 
ppt. 
ppt. 
x l0- 4M Cr +3 
x l0- 3M cr+ 3 
x l0- 3M Cr +3 
ppt. 
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was chosen since it was desirable for the planned spectral 
studies. Changes in pH and observations concerning prPcipi-
tation aftPr an 18 to 24 hour incubation period are shown 
(Table XII) . It is evident that three additions, namely 
niacinamide, pyridine and imidazole, seemed to enhance 
solubilization of trivalent chromium in 0.13M phosphate buffer 
only~ Nicotinic acid, which has been implicated as a com-
ponent of the glucose tolerance factor (58), did not seem to 
enhance the solubilization of trivalent chromiur,1 according to 
the criteria of this study. Since niacinamide is both physic-
logically and structurally related to nicotinic acid, it was 
chosen for further study in the solubilization of trivalent 
chromium. 
Chromiwn-Niacinamide Interactions 
The first part of this study was concerned with the 
ability of 0.067M phosphate buffer-0.lM niacinamide solutions 
to solubilize trivalent chromium in the form of CrK(so4 ) 2 ·12E2o. 
Chromium was added to the above solutions to a final concen-
-3 -3 -3 -3 tration of l X 10 , 2 X 10 , 3 X 10 , and 4 X 10 M. The 
pH was recorded before the addition of chromium and after 0.5 
and 16 hours incubation with chromium (Table XIII). A de-
crease in pH was expected with increasing chromium concen-
tration since 0.067M phosphate buffer is not quite strong 
enough to counteract the acidity of the added chromium aliquots. 
See Chapter II for more details concerning this matter. It 
is also important to note that less pH change occurred in the 
presence of niacinamide for each chromium concentration over 
134 }! 
TASLE XII. Solubility of trivalent chromium (4 X l0- 3M) 
in phosphate buffers containing various nitrogenous 
compounds 
0.067M PhosEhate 0.13M Phos:ehate 
Addition 
pHl pH2 pHl pH2 ( 0. lH) ppt. ** ~ 
0 7.39 7.09 4+ 7.40 7.26 4+ 
Niacinamide 7.42 7.18 4+ 7.41 7.26 3+ 
. 
Nicotinic . 7.48 7.20 4+ 7.42 4+ 
Acid 
Pyridine 7.46 7.30 2+ 
Urea 7.41 7.26 4+ 
Imidazole 7.44 7.36 l+ 
Formamide 7.46 7.24 4+ 
Ethylene- 7.42 7.25 4+ 
di amine 
Glycine 7.42 4+ 
*pHl = pH before addition of 4 x l0- 3M cr+3 
pP.2 = pH after 18 to 24 hrs. incubation with 
4 x l0- 3M cr+3 
= not recorded 
**ppt = precipitate 
4+ = heavy 
3+ = medium 
2+ = light 
l+ = fine 
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TABLE XIII. Changes in pH during solubilization of 
trivalent chromium in phosphate buff er - niacinamide 
solutions. 
+3 0.067.M 0.067.M Phosphate Cr Phosphate Buff er Buffer-0.lM Niacinarnide 
(M) O* 0.5 hr 16 hr 0 0.5 hr 16 hr 
10- 3 
< 
l x 7.42 7.36 7.32 7.42 7.39 7.37 
2 x 10- 3 7.42 7.31 7.28 7.42 7.33 7.31 
3 x 10- 3 7.42 7.25 7.20 7.42 7.26 7.26 
4 x 10- 3 7.42 7.18 7.16 7.42 7.20 7.17 
* = No chromium 
136 . 
the 16 hour period that readings were taken. Upon comple-
tion of the 18 hour incubation period, aliquots were removed 
and the absorbance values recorded at 400nm (Figure 28). It 
is quite clear that the presence of niacinamide enhanced the 
solubilization of trivalent chromium in 0.067M phosphate 
buffer, pH 7.42. This is con~rary to the visual observations 
of the previous section. The spectrophotometric measurements, 
however, are much more reliable. 
To further investigate a possible interaction between 
chromium a~d niacinamide, a study was initiated concerning 
the effect of trivalent chromium on the UV absorption spectrum 
of niacinamide. The UV absorption spectrum of 2 X 10-5M 
niacinamide in 0 .13!,1 phosphate buffer, pH 7. 42 is shown 
(Figure 29). A characteristic spectrum was obtained with an 
absorption maximum at 262nm and shoulders at 255 and 263nm. 
Before completion of this study, however, it was necessary to 
investigate the absorbance due to chromium over the same range. 
Solutions of chromium (2 X lo-4 and 2 x 10-5M) in 0.13M phos-
phate buffer, pH 7.42, were scanned over the range of 240 to 
340nrn (Figure 30). It can be seen that trivalent chromium, 
because of its electronic configuration, has a characteristic 
UV spectrum. Contributions of this metal to the total 
absorbance, therefore, cannot be neglected. Trivalent chromium 
was added to solutions of 2 X lo-5M niacinamide in 0.13M phos-
phate buffer, pH 7.42, resulting in chromium concentrations 
of 2 x lo-4 and 2 X lo-5;1 and chromium-to-niacinarnide ratios 
of 10:1 and 1:1, respectively. Further details concerning the 
... 
.. 
.. 
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FIGURE 28~ A spectral study of the solubility of tri-
valent chromium in 0.067M phosphate buffer, pH 7.42, 
in the presence (--) and absence (----) of O.lM 
niacinamio.e. 
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FIGURE 29: UV absorption spectrJm of 2 X io-Sr1 niacinamide 
in 0.13M phosphate buffer, pH 7.42. 
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FIGURE 30: UV absorption spectrum of chromium (III) in 
0.13M phos~hate buffer, pH 7.42. A: 2 X 10-(M Cr+3; 
B: 2 x lo- ~I er+ 3. 
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composition of the various solutions of this UV study are 
located in Chapter II. After a 19.5 hour incubation period, 
the absorption spectra of the respective solutions were taken 
over the range of 250 to 350nm. The resulting spectra, cor-
rected for absorbance due to chromium and buffer, are shown 
(Figure 31). The addition of chromium to a 1:1 ratio with 
respect to niacinamide had no effect on the absorption spectrum 
of niacinamide. The addition of chromium to a 10:1 ratio with 
respect to niacinamide resulted in an increase in absorbance 
at 262nm and the appearance of a peak at 325nm. The pH re-
mained constant after the addition of chromium and upon 
completion of the incubation period. To make an analogy, the 
reduction of NAD+ (nicotinamide adenine dinucleotide) to NADH 
is associated with an increase in absorbance at 340nm and a 
decrease in absorbance at 260nrn (155). Since the primary 
component of NAD+ is the nicotinami~e moiety, identical to 
niacinamide, a partial explanation may be related to reduction. 
However, in this case an increase in absorbance at 262nm was 
observed along with the appearance of a peak at 325nm. Con-
sidering the stability of the trivalent state of chromium, 
it seems unlikely that a change in its oxidation state to a 
higher value could occur. As a result, the peak at 325nm may 
be related in some manner to complex formation (156). 
It was previously shown (Table XII) that the presence 
of O.lM niacinarnide enhanced the solubilization of trivalent 
chromium after 18 to 24 hours in 0.13M phosphate buffer, 
pH 7.4. A pilot study was performed to determine how long 
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FIGG RE 31.: Effect of chromiam (I II) on the UV absorption 
spectrum of niacinarnide in 0.13M phosphate buffer, pH 
7.42. (---): 2 x io-SM niacinan-:ide - 2 x io-4M cr+3; 
(-): 2 X io-SM niacinamide; ( • • ·): 2 x io-SH niacinamide1 
- 2 x io-5~1 cr+3 " 
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chromium (III) in phosphate buffer and phosphate buffer-
niacinamide would remain solubilized. The reader should 
recall that chromium (III) undergoes elation and eventually 
precipitates out of solution. This process is slowed con-
siderably in the presence of stabilizing ligands such as 
niacinamide. Chromium (III) was added to solutions of 0.13M 
phosphate buffer and 0.13M phosphate buffer- 2 X l0-5M 
niaci~amide to a final concentration of 1 X lo-3M. The pH 
was recorded and the presence of precipitation observed over 
. 
a period.of 96 hours (Table XIV). Results indicated that the 
presence of niacinamide enhanced the solubilization of tri-
valent chromium. This pilot procedure was followed by a long 
term spectrophotometric study on the solubilization of chromium 
(III) by 0.13M phosphate buffer-2 X l0- 5M niacinarnide solutions, 
pH 7.43, at various chromium-to-niacinamide ratios (Figure 32). 
The progressive increase in absorbance at T=O for the various 
ratios was the result of chromiQm. In all cases solutions 
were clear at T=O. It should be mentioned also that absorbance 
readings were taken in a lOcm cell in this study. Chromium 
at a 1:1 and 10:1 ratio with respect to niacinamide remained 
in solution for 118 hours. At a 100:1 ratio, chromium gradually 
precipitated following dissolution and was not studied beyond 
10 hours. At ratios of 25:1, 40:1 and 50:1, precipitation 
occurred after 100, 50 and 40 hours, respectively. Changes 
in pH were recorded at 1 and 185 hours for the various ratios 
studied. 
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TABLE XIV. Solubility of trivalent chromium (1 X 10-~M) 
in phosphate buffer in the presence and absence of 
niacinamide. 
0.13M Phosphate Buff er 0.13M Phosphate 
Time· pH 7.43 Niacinamide* pH 
Buff er-
7.43 
(hrs) pH ppt. ** 
_EB_ ppt. 
24 
48 
72 
96 
-5 
*2 X 10 M 
7.38 0 
7.38 + 
7.38 + 
7.38 + 
**visual observance of precipitation 
0 = absent 
+ = present 
7.30 0 
7.38 0 
7.38 + 
7.38 + 
... 
.. 
.. 
FIGURE 32. Solubilization of trivalent chromium at various chromium~to-niacinamide ratios. Niacinamide: 2 X lo-SM; · 
:Suffer: 0.13M: phosphate, pH 7.43; A: l to l; B: 10 to l; 
C: 25 to l; D: 40 to l; E: SO to l; F: 100 to 1. 
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TABLE XV. Changes in pH during the solubilization of 
trivalent chromium at various chromium-to-niacinamide 
ratios in 0.13~ phosphate buffer. 
Time pH at Various Chromium-to-(2 X l0- 5M) Niacinami<le Ratios 
(hrs) 0 1:1 10:1 25:1 40:1 50:1 
1 7.43 7.43 7.41 7.40 7.39 7.37 
·185 7.44 7.43 7.41 7.39 7.39 7.37 
An expected drop occurred with increasing chromium (III) 
concentration as discussed previously. Within each ratio, 
however, the pH remained rather constant over the entire 
period. 
Upon completion of this study, the individual tubes 
were checked for bacterial growth. Colonies were evenly 
distributed over all plates and as a result bacterial growt~ 
was not considered a factor in the observed absorbance changes. 
Further details as to the procedure are outlined in Chapter II. 
Four types of bacteria were identified; namely, Enterobacter 
agglomerans, Pseudomonas maltophilia, Alcaligenes denitrificans 
a11d ~·1oraxella nonliquefaciens. l\n interesting growth pattern 
that deserves comment was obtained (Table XVI). It seemed 
that Enterobacter agglomerans and Moraxella nonliguef aciens 
grew at all chromium concentrations whereas Alcaligenes 
denitrificans and particularly Pseudomonas maltophilia seemed 
to be limited in growth. The pattern seems to suggest an 
optimal requirement for chromium (III) above which the element 
becomes inhibitory. Further clarification is necessary, 
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TABLE XVI. Bacterial growth in 0.13M phosphate buffer, pE 7.37 to 7.44, at various chromium-to-niacinamide ratios. 
Growth at Various Chromium-to-(2 x lo-5M) 
Niacinamide Ratios 
Bacteria 
0 1:1 10:1 25:1 40:1 50:1 100:1 
E.a. * + + + + + + + 
P.m. + 
A.d. + + 
M.n. + + + + + + + 
*E.a. = Enterobacter a9srlomerans + = present 
P.m. = Pseudomonas malto12hilia = absent 
A.d. = Alcaligenes denitrificans 
M.n. = Moraxella nonlig:uef aciens 
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however, before any definite conclusions can be drawn. 
Hydrogen-Deuterium Exchange of Insulin 
Infrared analysis of hydrogen-deuterium exchange is a 
useful tool for the measurement of changes in protein con-
formation at the level of the peptide bond. The technique 
is limited to measurement of conformational changes involving 
disruption of the a-helix or changes in secondary structure 
involving hydrogen bonding. This technique is not useful 
for measu~ing subtle changes in protein conformation that 
occur, for example, as a result of aggregation. In this case 
circular dichroism spectroscopy would be more appropriate. 
One drawback of the infrared technique is that large concen-
trations of insulin (lOmg/ml) had to be utilized to achieve 
a proper spectral response. For comparative purposes, a study 
of insulin by circular dichroism spectroscopy would require 
approximately O.lmg/ml for a reasonable response in the near 
UV region (250 to 320nm) and 0.004mg/ml for the far UV region 
(190 to 250nm). In this study, bovine crystalline zinc in-
sulin (10 mg/ml in n2o) was examined by infrared spectroscopy 
in the presence and absence of 10- 6 to 10-BM chromium (III) 
potassium sulfate.. Insulin at this concentration and es-
pecially in the presence of zinc, is very difficult to 
solubilize. As a result, the solution had to be acidified 
with deuterium chloride (DCl) to pD 2.5 (pH 2.1). Such changes 
in molecular environment undoubtedly contributed significantly 
to alterations in macromolecular structure and as a result 
data from this type of experiment must be interpreted with 
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caution~ Dissolution of bovine zinc insulin in o2o (pD 2.5) 
resulted in a decrease in the amide II response and an increase 
in the deuterated amide II response with time (Figure 33). 
In this case it is evident that a greater change occurred in 
the deuterated amide II region. As a result it was decided 
to monitor the change in transmittijnce a~ 1~50cm-l with time 
in the presence and absence of chromium, even though in most 
cases the decrease in the amide II.region is measured. See 
Chapter II for detail~. In the absence of chromium a signi-
f icant exchange was obtained following a .period of absorbance 
loss (Figure 34). This loss was attr~buted to stabilization 
of the insulin in equilibration to 37.5°C since sGlutions were 
prepared at room temperature (22 to 24°C). In the presence 
of trivalent chromium the initial loss of absorbance as well 
as the exchange, measured by the change in transmittance at 
1450cm-1 , were absent. Also, the pD remained constant for 
the period studied. These results support the view that 
trivalent chromium has a stabilizing effect on the conformation 
of insulin (157). 
Thermal Analysis of Insulin-Chromiwn III Solutions 
A 1 X l0- 4M t0.578mg/ml) solution of porcine zinc-free 
insulin was prepared in 0.13M phosphate buffer, pH 7.43. 
Utilizing an extinction coefficient of 1. 04 ODU/cm (mg/ml) 
at 276nm, the insulin concentration was determined to be 
0.927 X l0- 4M (0.536mg/ml). If the same solution of insulin 
is placed in each of two matched cells (sample and reference) 
and the rJv absorption spectrum taken over the range of 220 to 
... 
.. 
.. 
FIGURE 33: Infrared spectra of bovine zinc insulin in 
deuterium'oxide. Sample: O.Olg in lml D20
1 
pD 2.5; 
Cell: CaF2 (0.065mm pathlength); Temperature: 37.5°C; 
A : l hr ; B : 5 l1r s ; C : 8 hrs . 
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FIGURE 34~ Transmittance at 1450cm-l versus time for 
bovine zinc insulin in deuterium oxide. Sample: O.Olg 
in lml D20, pD 2.5; Cell: CaF2 (0.065rnm pathlength); 
TemQerature: 37.5°C; (-): no addition; (· •• ·): lo-6M 
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320nm, a straight line would be expected. If the solution in 
the sample cell is subjected to some kind of treatment, a 
difference spectrum is produced which is essentially the 
difference in absorbance between the sample before and after 
the treatment. In this study insulin ( 1 o- 4t1) in 0 .13M phos-
phate buffer in the presence and absence of lo-4M trivalent 
chromium was incubated for 1 hour at room temperature. It 
was then placed in both sample and reference cells and the 
UV absorption spectrum taken at 28°C over the range of 220 to 
-< 
320nm. The sample compartment was then subjected to a gradual 
change in temperature to 98°C by means of a Tm analyzer. See 
Chapter II for details as to this procedure. After attainment 
of 98°C, the UV absorption spectrum was again taken (Figure 35). 
It can be seen that at 98°C absorption maxima occurred at 238, 
281 and 29lnm and absorption minima occurred at 276 and 284nm. 
There appeared to be very little difference at 284 and 29lnm 
between insulin in the presence and absence of trivalent 
chromium. The greatest difference occurred at 238nm with less 
of a difference at 276 and 28lnm. Similarly, the UV absorption 
spectrum of trivalent chromium (lo-4M) in 0.13M phosphate 
buffer, pH 7.43 was taken at 28°C. The sample cell was then 
subjected to an increase in temperature to 98°C, after which 
the UV spectrum between 220 and 320nm was taken (Figure 36). 
The chromium solution exhibited a gradual increase in absor-
bance at shorter wavelengths at 98°C. Since chromium undergoes 
elation with an increase in temperature, it may be that the 
olated product absorbed at lower wavelengths. All solutions 
.·· 
.. 
FIGURE 35·. Temperature dependent difference spectra 
porcine zinc-free insulin in 0 .13l:''l phosphate buff er, 
pH 7.43, in the presence (----) and absence (--) of 
chromium (III). Insulin: 1 x lo-4M; cr+3: 1 x lo-4M. 
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FIGURE 36: Temperature dependent difference spectra for 
chromium '(III) in 0.13M phosphate buffer, pH 7.43. cr+3: 
1 X 10-4~L 
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were clear at room temperature and at 98°C, however, when 
allowed to cool to room temperature, a precipitate formed. 
This seemed to indicate that a soluble elation product with 
a characteristic UV absorption spectrum was formed at ele-
vated temperatures. 
To determine whether the behavior of trivalent chroumium 
at elevated te~peratures is unique, solutions of 0.13M phos-
phate buffer, pH 7.43, 10-4M chromium (III) in .13M phosphate 
buffer, pH 7.43 and 0.5 X 10-4M zn+2 in 0.13M phosphate buffer, 
pH 7.43 w~re subjected to thermal analysis after a 1 hour 
incubation period. In this case absorbance at 276nm was moni-
tored continuously over a temperature span of 20 to 100°C 
(Figure 37). It is evident that phosphate buffer underwent 
little change while zinc in phosphate buffer exhibited a slight 
decrease in absorbance above 60°C. Chromi1m on the other hand, 
exhibited a gradual increase in absorbance above 50°C. In all 
cases the pH remained at 7.43 after the addition of cr+3 and 
zn+2 and upon completion of the study when the solutions cooled 
to room temperature. The pH was not recorded at elevated tem-
peratures. It was decided to repeat the same procedure at 276 
and 238nm for phosphate buffer, chromium in phosphate buffer, 
insulin in phosphate buffer and i~sulin-chromium in phosphate 
buffer. The reader will recall that these wavelengths were 
selected previously because they exhibited the greatest dif-
ference in absorbance between insulin and insulin-chromium at 
98°C. Absorbance at 238nm was recorded over the range of 25 
to 98°C (Figure 38). The absorbance due to chromium increased 
! . 
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FIGURE 37. Absorbance at 276nrn vers·:.is temperature 
Cr+"-3 and zn+2 in 0.13M phosphate buffer, pH 7.43: 
plications for elation of cr+3. (····): 1 x io-4M 
(----): 0.5 X l0-4M zn+2; (-): phosphate buffer. 
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.FIGURE 38.. Absorbance at 233nm versus temperature for 
solutions of porcine zinc-free insulin (I), chromium 
(III) (Cr) and insulin-chromium III (ICr) in 0.13M phos-
phate buffer, pH 7.43. Insulin: 1 X l0-4M; cr+3: 1 X 
lo-4M; (----): represents subtraction curves ICr-I and ICr-Cr. 
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with change in temperature from 25 to 95°C. Insulin-chromium 
also exhibited an increase in absorbance, although considerably 
greater. If no change had occurred on interaction of chromium 
(III) with insulin, it was reasoned that the subtraction curve 
ICr-Cr would be identical to that for insulin (I). It is 
obvious from the figure that insulin in the presence of chromium 
exhibits hypochromicity with increasing temperature. Similar 
reasoning can be applied to the ICr-I subtraction curve. If, 
as was discussed previously, the change in absorbance with 
_, 
increasing temperature for chromium (III) was due to olation, 
it would be reasonable to assume from the nature of the curve 
that less chromium underwent olation in the presence of 
insulin. One possible interpretation could be that chromium 
(III) not bound to insulin undergoes olation to about 70°C. 
After 88°C we may be looking at olation of bound chromium. 
This seems unlikely, however, since the Cr/I molar ratio is 
1:1. A more likely explanation would attribute the absorbance 
change solely to bound chromium. 
Absorbance at 276nm was recorded over the temperature 
range of 25 to 100°C (Figure 39). Chromium exhibited an ex-
pected increase in absorbance. Insulin-chromium exhibited 
hypochromicity as before; the curve falling considerably below 
t~at for chromium. Viewing the subtraction curve as before, 
it can be seen that ICr-Cr is not identical to I. Therefore, 
it can be said that insulin in the presence of chromium ex-
hibits hypochromicity at 276nm with elevated temperatures. 
If the changes in absorbance are related to the olation of 
i·,; 
.. 
.. 
.. 
FIGURE 39~ Absorbance at 27Gnm versus temperature for 
solutions' of porcine zinc-free insulin (I), chromium 
III (Cr) and insulin-chromium III (ICr) in 0.13M phos-
phate buffer, pH 7.43. Insulin: 1 X 10-4M; cr+3; 1 X 
lo-4M; (----) : represents subtraction curves ICr-I and 
ICr-Cr. 
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chromium, it can be said that less chromium elates in the 
presence of insulin. Also, elation began at a somewhat 
higher temperature {70°C) in the presence of insulin than 
in its absence {50°C). In both experiments the pH remained 
at 7.43 after the addition of chromium and upon completion of 
the study when the solutions cooled to room temperature. 
Thes~ observations seemed to suggest that chromium binds to 
insulin and the product behaves characteristically at elevated 
temperatures (158). 
circular Dichroism Spectroscopy of Insulin-{Effect of Chromium 
III) 
This section introduces the topic of insulin conformation 
and utilizes circular dichroism (CD) spectroscopy for studying 
insulin-chromium (III) interactions. Bovine zinc insulin 
(1.71 X l0- 5M) was prepared in 0.067M phosphate buffer, pH 7.42. 
Trivalent chromium was added to a final concentration of 1.71 X 
l0- 4M. The solutions were then incubated at room temperature 
(22 to 24°C) for 1 hour after which the CD spectra were re-
corded over the range of 250 to 310nrn (Figure 40). The CD 
spectrum of bovine zinc insulin exhibited a negative extremum 
2 
at 276nm with a mean residue ellipticity of -192 deg cm per 
decimole. Also evident are shoulder regions at 262, 269 and 
284nm. The addition of trivalent chromium resulted in a shift 
of the negative extremum to 273nrn and a diminution of the nega-
tive circular dichroic band to -158 deg cm2 per decimole. The 
trough was broadened and seemed to coincide with the shoulder 
at 262nm. Crossover occurred at 262 and 297nrn. The pH 
" 
.. 
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FIGTJRE 40. The effect of trivalent· chromium on the 
near-UV circular dichroism spectrum of bovine zinc 
insulin. Sample: insulin (1. 71 X lo-SM) in 0. 067M 
phosphate buffer, pH 7.42; (--):no ad.dition; 
(----): 1.71 x 10-~M cr+3. 
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remained at 7.42 after the addition of chromium and upon com-
pletion of the spectra. To determine whether the same effect 
would occur at higher ionic strength, the same experiment was 
repeated in 0.067M phosphate buffer-0.15M NaCl, pH 7.42 
(Figure 41). In the absence of chromium a broad negative 
extremum was observed at 274nm with an ellipticity of -185 
deg cm2 per decimole of residues. Shoulders were evident at 
264 and 284nm. In the presence of chromium a negative extremum 
was observed at 275nm with an ellipticity of -157 deg cm2 per 
decimole ;nd shoulders at 265 and 284nm. Crossover occurred 
at 256nm. As before, the pH remained constant. 
Another study was designed to compare the effect of 
adding higher concentrations of trivalent chromium. Trivalent 
chromium was added to a final chromium-to-insulin ratio of 25 
to 1 as compared to the previous experiment which was 10 to 1. 
See Chapter II for more details. The solutions were incubated 
for 1 hour after which the CD spectra were recorded over the 
range of 250 to 310nm (Figure 42) . In the absence of chromium 
a negative extremum was observed at 276nm with an ellipticity 
of -205 deg crn2 per decimole. Shoulders were evident at 263, 
269 and 284nm. In the presence of chromium, a diminution of 
the negative circular dichroic band occurreJ. A negative 
extrernum was observed at 273nm with an ellipticity of -157 
deg cm2 per decimole and shoulders at 263 and 284nm. Crossover 
occ'.Irred at 254nrn only. The pH remained constant throughout 
the study. Utilizing a chromium-to-insulin ratio of 0.58 to 1 
and incubation periods of 24 and 48 hours, compared to 1 hour 
.. 
.. 
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FIGURE 41'.. The effect of trivalent chromium on the 
near-UV circular dichroisrn spectrum of bovine zinc 
insglin: Addition of NaCl. Sanple: insulin (1.71 X 
10- I1) in 0.067M phosphate buffer -0.lSM NaCl, pH 
7. 42; (-): no addition; (----): 1. 71 x 10-4M cr+3. 
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FIGURE 42 •• The effect of trivalent chromium on the 
near-UV circular dichroism spectrum of bovine zinc 
insulin: Higher chromium (III) concentration. Sample: 
insulin (l.71 X lo-5.M) in 0.067M phosphate buffer, 
pH 7.42; (-): no addition; (----): 4.28 x lo-4M cr+3. 
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above, resulted in no effect of chromium on the CD spectrum 
of bovine zinc insulin. The spectrum was identical to 
Figure 42 with no effect of chromium occurring. As before, 
the pH remained at 7.42 for the entire study. 
A study was undertaken whereby the CD spectrum of 
bovine zinc insulin was repeatedly taken over a 33 minute 
peri~d after the addition of trivalent chromium to a chromium-
to-insulin ratio of 10 to 1. See Chapter II for details. 
The CD spectrum of bovine zinc insulin was performed at T=3, 
13 and 23 ~inutes after the addition of trivalent chromium 
(Figure 43). In the absence of chromium a negative extremum 
was observed at 276nm with an ellipticity of -193 deg cm2 
per decimole. Shoulders were located at 263, 269 and 284nm. 
Upon the addition of trivalent chromium a progressive dimi-
nution of the negative circular dichroic band to an ellipticity 
of -157 deg cm2 per decimole with a slight shift of the extremum 
to approximately 274nm was observed. Shoulders were present 
as above and crossover occurred in the 254 to 258nm region. 
Bovine zinc insulin (6.66 X lo-7M) was prepared in 
0.067M phosphate buffer, pH 7.42. Trivalent chromium was added 
to a final concentration of 1 X lo-4M. The solutions were 
then incubated at room temperature for a period of 24 hours 
after which the far-UV circular dichroism spectra were recorded. 
In the absence of chromium (III) a negative band was observed 
(Figure 44). The addition of trivalent chromiun resulted in 
no change in this region of the CD spectrum. 
A solution of porcine zinc-free insulin (1.71 X lo-5M) 
was prepared in 0.067M phosphate buffer, pH 7.42. cr+3 and 
.·· 
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FIGURE 43w Time dependence of the effect of trivalent 
chromium on the near-UV circular dichroism spectrum o:'.: 
bovine zinc insulin. Sample: insulin (l.71 ~ 10-SM) in 
0. 067M phosphate buffer z.. pH 7. 42; (-) : no addition; 
(---): l. 71 X lo-4M cr+-1; A: 3 minutes; B: 13 minutes; 
C: 23 minutes. 
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FIGURE 44 .. The far-UV circular dichroism spectrum of 
bovine zinc insulin. Sample: insulin (6.66 X lo-7M) in 
0.067M phosphate buffer, pH 7.42; Identical spectra were 
obtained in the presence and absence of 1 X lo-4M cr+3 
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zn+2 were added to final concentrations of 1.71 X lo-4M and 
0.85 X lo-5M, respectively. The solutions were then incubated 
at room temperature for 1.5 hours after which the CD spectra 
were recorded over the range of 250 to 310nm (Figure 45) . 
For porcine zinc-free insulin, a broad negative extremum was 
observed at 274nm with an ellipticity of -143 deg cm 2 per 
decimole and shoulders at 263, 268 and 285nm. Addition of 
zn+ 2 to the zinc-free insulin resulted in an increase of the 
negative band to an ellipticity of -165 deg cm 2 per decirnole 
. 
and a shift of the extremur.i to 276nm. Shoulders were visible 
at 262, 268 and 284nm. Addition of chromium to the zinc-free 
insulin resulted in a diminution of the negative band at 274nm 
to an ellipticity of -134 deg cm 2 per decimole at the extrernum. 
Shoulders were visible as before. Similarly, trivalent chro-
miurn was added to a solution of porcine zinc insulin and the 
CD spectrum taken over the range of 250 to 310nm (Figure 46). 
See Chapter II for further details. For porcine zinc insulin 
a negative extremum was observed at 276nm with an ellipticity 
of -165 deg cm 2 per decimole and shoulders at 262, 268 and 
284nm. 1\ddi tion of trivalent chromium resulted in a signif i-
cant diminution of the negative band to -144 deg cm 2 per 
decimole; the same ellipticity observed for porcine zinc-free 
insulin. A shift of the extrernum to 274nrn and shoulders at 
262, 268 and 280nm were also observed. In both experiments 
the pH remained at 7.42 throughout the study. 
Insulin Aggregation as Evidenced by CD Spectroscopy 
A stock lmg/rnl solution of porcine zinc-free insulin was 
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FIGURE 4~. The near-UV circular dichroism spectrum 
porcine zinc-free insulin: Effect of cr+3and zn+2. 
Sample: insulin (l.71 x io-SM) in 0.067!1 phosphate 
buffer, pH 7.42; (-): no addition; (• • • ·): 0.85 X 
io-sM zn=i-2; (----): l. 71 x lo-4M cr+3. 
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FIGURE 46. The effect of trivalent chromium on the 
near-UV circular dichroism spectrum of porcine zinc 
insulin. Sample: insulin (l.71 X io-5M) in 0.067M 
phosphate buffer, pH 7.42; (-): 0.85 x io-5M zn+2; 
(----): 0.85 x io-5M zn+2 and 1.71 x io-4M cr+3. 
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prepared in 0.067M phosphate buffer, pH 7.47. The UV spectrum 
between 240 and 320nm was recorded (Figure 47). Insulin ex-
hibited a characteristic absorption spectrum with an absorp-
tion maximum at 276nm and shoulders at 258, 269 and 283nm. 
Insulin ~olutions A, B and C were then prepared from the stock 
solution and aliquots of cr+3, zn+2 and dilute HCl were added 
in pqirs as discussed in Chapter II. The respective solutions 
were incubated for a total of 3 hours, after which solution A 
(0.5mg/ml), solution B (0.2mg/ml) and solution C (O.lmg/ml) 
were placed in 2, 5 and lOcm cells, respectively. CD spectra 
were then recorded over the range of 250 to 310nm. The CD 
spectra of solutions A, B and C for the addition pair "10 
microliters dilute HCl-50 microliters dilute HCl" are.shown 
(Figure 48). For solution A the negative extremum was observed 
at 274nm with an ellipticity of -197 deg cm2 per decimole. 
For solution B the extremum was observed at 273nm with an el-
lipticity of -191 deg cm2 per decimole and for solution C it 
was observed at 272nm with an ellipticity of -179 deg cm2 
per decimole. Note the shift in wavelength of the extremum 
with progression from a more concentrated solution (A) to a 
more dilute solution (C). The CD spectra of solutions A, B 
and C for the addition pair "10 microliters EDTA-50 microliters 
dilute HCl" are shown (Figure 49). For solution A the negative 
extremum was observed at 274nm with an ellipticity of -198 deg 
cm per decimole. For solution B the extremum was observed at 
275nm with an ellipticity of -186 deg cm 2 per decimole and 
for solution C it was observed at 273nm with an ellipticity 
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FIGURE 47: Near UV spectrum of porcine zinc-free insulin. 
Sample: insulin (lmg/ml) in 0.067M phosphate buffer, 
pH 7.47. 
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FIGURE 48.· Aggregation of porcine zinc-free insulin 
as evidencied by circular dichroism spectroscopy. 
Buffer: 0.067i·1 phosphate, pH 7.47; Addition pair: 10 
microliters dilute HCl-50 microliters dilute HCl; 
(--): solution A in 2cm cell; (---): solution B in 
Scm cell; (••••): solution C in lOcm cell. 
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FIGURE 491 Aggregation of porcine zinc-free insulin 
as evidenced by circular dichroism spectroscopy: 
Effect of EDTA. Buffer: 0.067M phosphate, pH 7.47; 
Addition pair: 10 microliters EDTA (l0- 1 M)-50 rnicro-
liters dilute HCl; (~-): solution A in 2cm cell; 
(----): solution Bin Scro cell; (····): solution C in 
lOcm cell. 
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of -171 deg cw per decirnolP. This experiment was identical 
to that above except for the addition of 0.1~ EDTA. It was 
+? presumed that the EDTA would chelate any traces of Zn -
that could cause insulin aggregation. As a result, it was 
assumed that the CD changes were due solely to the aggregation 
of zinc-free insulin. The CD changes, on the other hand, must 
be i~terpreted with caution since the Zn+ 2-EDTA complex may 
still cause aggregation. This seems unlikely, however, since 
one method for the preparation of zinc-free insulin involved 
the use of EDTA (159). The CD spectra of solutions A, Band 
C for the addition pair "10 microliters dilute HCl-50 micro-
liters Cr+ 3 " are shown (Figure 50). For solution A the 
negative extremum was observed at 273nm with an ellipticity 
of -188 deg cm 2 per decimole. For solution B, the extremum 
was observed at 275nm with an ellipticity of -196 deg crn 2 per 
decimole and for solution C it was observed at 273nm with an 
ellipticity of -182 deg crn 2 per decimole. Similar spectra 
b . d f h dd . . . '' 5 0 . 1 . + 3 10 were o taine or t e a ition pair micro iters Cr -
microliters dilute HCl" and as a result it was not included 
in this evaluation. The CD spectra of solutions A, B and C 
for the addition pair "10 microliters Zn+ 2-50 microliters 
dilute HCl" are shown (Figure 51). For solution A the nega-
tive extremum was observed at 276nm with an ellipticity of 
-256 deg cm2 per decimole. For solution B the extremum was 
observed at 277nm with an ellipticity of -222 deg cm2 per 
decimole and for solution C it was observed at 273nm with an 
ellipticity of -186 deg cm2 per decimole. Similar spectra 
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FIGURE 50~ Aggregation of porcine zinc-free insulin as 
evidenced'by circular dichroism spectroscopy: Effect of 
trivalent chromium. Buffer: 0.067M phosphate, pH 7.47; 
Addition pair: 10 microliters dilute HCl-50 microliters 
cr+3; (~-): solution A in 2cm cell; (----): solution B 
in Scm cell; ( • • • ·) : solution C in 1 Ocm eel 1. 
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FIGURE 51: Aggregation of porcine zinc-free insulin as 
evidenced' by circular dichroism spectroscopy: Effect of 
zn+2. Buffer: 0.067M phosphate, pH 7.47; Addition pair: 
10 microliters zn+2-so microliters dilute HCl; (--): 
solution A in 2cm cell; (----): solution B in Scm cell; 
(••••): solution C in lOcm cell. 
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were obtained for the addition pair ''50 microliters dilute 
IICl-10 microliters Zn+ 211 . The CD spectra of solutions A, B 
and C for the addition pair ''50 microliters Cr+ 3-10 micro-
liters zn+ 2 ,, are shown (Figure 52). For solution A the nega-
tive extremum was observed at 275nm with an ellipticity of 
-191 deg crn2 per decimole. For solution B the extremum was 
observed at 274nm with an ellipticity of -189 deg crn2 per 
decirnole and for solution C it was observed at 273nm with an 
ellipticity of -172 deg cm 2 per decimole. Similar spectra 
\·Jere obtained for the addition pair "10 rnicroli ters Zn +2-
50 microliters Cr+ 311 . Up to this point the CD changes for 
the 8 addition pairs have been briefly reviewed. The entire 
picture is clarified by a sumrnary of the CD changes at 2 7 4nm 
for the various addition pairs (Table XVII). It is evident 
that the addition of EDTA to porcine zinc-free insulin re-
sulted in little change in the CD band at 274nm for solutions 
A, B and C although a slight diminution occurred for solu-
tions B and C. The addition of trivalent chromium on the 
other hand, resulted in a dimunition of the CD band for solu-
tion A and a slight increase in the CD response for solutions 
B and C when compared to zinc-free insulin. The addition of 
zinc resulted in a significant increase in the response at 
+2 +3 . 274nm. When both Zn and Cr were present, however, zinc 
did not induce an increase in the CD band at 274nm. In this 
case the response for the individual solutions seemed to be 
less than that of zinc-free insulin without any additions. 
Implications will be presented in Chapter IV. Upon completion 
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FIGURE 52. Aggregation of porcine zinc-free insulin as 
evidenced· b~ circular dichroism spectroscopy: Effect of 
cr+3 and Zn 2. Buffer: 0.067M phosphate, pH 7.47; Ad-
dition pair: 50 microliters cr+3_10 microliters zn+2; 
(--): solution A in 2cm cell; (----): solution B in 
5cm cell; ( • • · ·): solution C in lOcm cell. 
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TABLE XVII. Ellipticity at 274nm for various addition 
pairs. 
Solution 
A 
B 
c 
I 
Ellipticity (deg cm 2dmole- 1 ) at 274nm 
* HCl-HCl EDTA-HCl HC1-Cr+ 3 
-197 -198 -187 
-191 -186 -194 
-176 -171 -180 
zn+ 2-Hcl 
-246 
-219 
-186 
C +3 z +2 r - n 
-190 
-189 
-172 
*Refers to zinc-free insulin with aliquots of dilute HCl 
added to compensate for the other additions. For the 
composition of solutions A, B and C and the concentrations 
of zn+2 and cr+3, see Chapter II. 
180 
of the CD spectra, UV scans over the range of 250 to 320nm 
were recorded for all solutions. Since 8 addition pairs were 
studied, the stock solution was prepared and dilutions made 
at least 8 times. Absorbance at 276nm for the stock solu-
tions and resulting dilutions along with their respective 
concentrations are shown (Table XVIII). The concentration 
rang~ for the stock solutions was .860 to .904mg/ml. The 
concentration range for solution A was .443 to .465mg/ml 
while that for solutions B and C were .168 to .178 and .085 
to . 089, .respectively. The fluctuations between the approxi-
mate concentrations (by weight) and the actual concentrations 
[utilizing an extinction coefficient of 1.04 ODU/cm (mg/ml)] 
are evident. ·Among the probable causes was the accumulation 
of moisture with continued thawing and freezing of the freeze-
dried insulin sample despite the precautions mentioned in 
Chapter II. Another cause involved the preparation of the 
stock insulin solutions. They were prepared by diluting 25mg 
of insulin to 25ml. Working with such small amounts can in-
troduce error among repetitive weighings. Differences in 
insulin concentration among the various experiments, however, 
did not effect the CD data since e was expressed as the mean 
residue ellipticity. See Chapter II for further details. 
Upon completion of the UV spectra, the pH of each solution 
was recorded (Table XIX) . In most cases the values were within 
the range 7.42 to 7.48. 
Finally, it was decided to study the time dependency of 
the CD change at 274nm. Solutions containing insulin at con-
-~~ .42 t ~ 
TABLE XVIII. Absorbance at 276nm and resulting concentrations for insulin 
aggregation study by circular dichroism spectroscopy. 
Absorbance at 276nrn and Concentration 
Addition 
Pair 
Stock Solution A Solution B Solution C 
Approx. A Actual Approx. Actual Approx. A Actual Approx. A Actual 
Cone. 27 6 Cone. Cone. A276 Cone. Cone. 276 Cone. Cone. 27 6 Cone. 
(mg/ml) 
--
(mg/ml) (rng/ml) 
--
(mg/ml) (rng/ml) 
--
(mg/ml) (mg/ml) 
--
(rrg/ml) 
* HCl-OCl 1 .903 .868 0.5 .443 .426 0.2 .178 .171 0.1 .089 .086 
HC1-Zn+2 1 .940 .904 0.5 .458 .440 0.2 .185 .178 0.1 .091 .088 
zn+2-oc1 1 .921 .886 0.5 .459 .441 0.2 .181 .174 0.1 .092 .088 
Cr+3-HC1 1 .931 .895 0.5 .464 .446 0.2 .183 .176 0.1 .092 .088 
HCl~r+3 1 .894 .860 0.5 .454 .437 0.2 .175 .168 0.1 .088 .085 
'7 +2~ +3 LJn r 1 .913 .878 0.5 .449 .432 0,2 .183 .176 0.1 .091 .088 
er+3-zn+2 1 .908 .873 0.5 .465 .447 0.2 .180 .173 0.1 .091 .088 
EIJI'A-HCl 1 .926 .890 0.5 .455 .438 0.2 .182 .175 0.1 .093 .089 
*Refers to dilute HCl (pH 3. 5). 
f-' 
·co 
t-' 
r 
' 
' 
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TABLE XIX. Final pH for selected addition pairs in 
insulin aggregation study by circular dichroism 
spectroscopy. 
pH 
Solution 
* +3 +2 I-ICl-HCl EDTA-I-!Cl HCl-Cr Zn -HCl Cr 
Base A ** 7.47 7.48 7.44 7.47 
A 7.44 7.45 7.41 7.44 
Base E 7.45 7.47 7.45 7.46 
B 7.45 7.46 7.44 7.45 
Base c 7.46 7.46 7.45 7.47 
c 7.45 7.46 7.45 7.46 
+3 
-Zn 
7.42 
7.39 
7.43 
7.42 
7.44 
7.44 
**Refers to the pH of the baseline solution detailed in 
Chapter II. The solution contains no protein. 
*Refers to dilute HCl {pH 3.5). 
+2 
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centrations equivalent to that of solutions A and B above 
were prepared. Zinc was added as before and the solutions 
were incubated for 1.5 hours after which trivalent chromium 
was added and the CD intensity monitored at 274nm with time 
(Figure 53). See Chapter II for details. It can be seen 
that the dimunition of the negative circular dichroic band 
was complete in about 30 minutes with most of the change 
occurring in the first 15 minutes. In each case the total 
CD change was determined. Variations of percent of the total 
CD change with time are shown (Table XX). An attempt was also 
made to monitor the effect of adding zinc to zinc-free in-
sulin and recording the increase in CD intensity at 274nm. 
CD increases were observed but the time dependency could not 
be recorded because of the rapidity of the reaction. In both 
cases above, the pH remained constant throughout the study. 
Frontal Gel Analysis of Insulin 
For the frontal gel studies, a column was prepared, and 
calibrated with specific markers as described in Chapter II. 
The elution volumes (Ve) for the various markers were deter-
mined and the weight average sieve coefficients (ow) calculated 
(Table XXI). Note the reproducibility of the elution volumes 
for the two determinations shown. A standard curve was then 
prepared by plotting the sieve coefficients versus the natural 
log (ln) of the molecular weights (Figure 54). Various solu-
tions of porcine zinc-free insulin were then prepared in 
0.067M phosphate buffer, pH 7.42, according to Table V. UV 
scans over the range of 212 to 320nm were performed on each 
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FIGURE 53~ The effect of trivalent chromium on the CD 
spectrum of porcine zinc insulin: Time dependency at 
274nrn. Buffer: 0.067M phosphate, oH 7.47. Addition 
at T=O: 50µ1 of stock (1 X 10-lM) ~r+3 solution; 
A: solution A; B: solution B. 
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TABLE xx. The effect of trivalent chromiu~ on the CD 
spectrum of porcine zinc-insulin: Variation of percent 
of the total CD change with time. 
Ellipticity in deg cm2dmole-l 
T Solution A Solution B 
(Min) 81 82 82-81 % Total e1 82 82-81 % Total 
5 . 48 49 
-90 . -51 39 -90 -58 32 
10 -90 -28 62 76 -90 -41 49 75 
15 -90 -17' 73 89 -90 -33 57 88 
20 -90 -12 78 95 -90 -28 62 95 
25 -90 - 9 81 99 -90 -26 64 98 
30 -90 - 8 82 100 -90 -25 65 100 
TABLE XXI. Column calibration for the self-association 
of porcine zinc-free insulin as studied by frontal gel 
chromatography. 
~1arker MW Vel (ml) 
Blue ·oextran ** 2,000,000 4.68 
Ovalb 1..imin 45,000 4.85 
Chymotrypsinogen 25,000 5.48 
Myoglobin 17,700 6.00 
F.ibonuclease 12,600 6.43 
ACTG 4,500 7.81 
K2Cr0 4 
*** 194 11.09 
*Result of 2 determinations. 
**Void volume (V
0
). 
***Total volume (Vt). 
Ve 2 (ml) a + w 
4.58 
4.81 .031 + 
5.47 .131 + 
5.93 .207 + 
6.38 .275 + 
7.73 .486 + 
11. 08 
* SD 
.004 
.006 
.001 
.002 
.002 
r 
f: 
~ ' I 
.. 
.. 
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FIGURE 54~ Standard curve for the self-association of 
porcine zinc-free insulin as studied by frontal gel 
chromatography. Buffer: 0.067!·1 phosphate, pH 7.42; 
Bed: Sephadex G-50 (superfine); Bedheight: 8.5cm; Flow 
rate: 6ml per hour; 0: ovalburnin; C: chymotrypsinogen; 
M: myoglobin; R: ribonuclease; A: ACTH. 
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insulin solution to determine the actual concentrations and 
to select the most appropriate wavelength at which to moni-
tor the insulin solutions during frontal chromatography. UV 
scans for a 1.0 and O.lmg/ml solution of insulin in phos-
phate buff er are shown (Figure 55) . A wavelength of 280nm 
was selected at which to monitor the lmg/ml solution. It 
is obvious that the O.lmg/ml solution could not be monitored 
at the same wavelength because of the poor absorbance response. 
As a result, 230nm was selected for monitoring this solution. 
Each insulin solution was then applied to the column and the 
absorbance monitored at the selected wavelength. Elution 
profiles were obtained, two examples of which are shown 
(Figure 56). Hypersharp unimodal leading boundaries, a plateau 
and diffuse unimodal trailing boundaries are evident. It 
was somewhat difficult to determine the elution volumes from 
these profiles. An estimate for the 4mg/ml solution would 
be between 6 and 6.Sml and for the 0.05mg/ml solution between 
7.5 and 8.5ml. To obtain an accurate value for the elution 
voluMes, the leading boundaries of the elution profiles were 
differentiated (Figure 57). Elution volumes of 6.2 and 8.0ml 
for the 4 and 0.05mg/ml insulin solutions were recorded. Sieve 
coefficients were then calculated from the elution volumes as 
discussed in Chapter II. With the aid of the sieve coeffi-
cients, the weight average molecular weights (~1w) were 
determined from the previously prepared standard curve. All 
insulin concentrations studied were treated similarly. Actual 
concentrations (as determined by extinction coefficient), 
... 
.. 
FIGURE 55. UV scans of porcine zinc-free insulin: 
Selection of wavelengths for monitoring during frontal 
gel chromatography. Sample: lmg/ml insulin (~-) and 
O.lmg/ml insulin (---) in 0.067M phosphate buffer, 
pH 7.42. 
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FIGURE 56 .: Elution profiles for frontal gel chromatography 
of porcine zinc-free insulin. Buffer: 0.067M phosphate, 
pH 7.42; Bed: Sephadex G-50 (superfine); Bedheight: 8.5crn; 
Flow rate: 6rnl per hour; Sample: 4mg/ml insulin (--) and 
0.05mg/ml insulin (---). 
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FIGURE 57: Differentiation of the elution profiles to 
determine· elution volumes. (--) : 4mg/ml insulin; 
(----): O.OSmg/ml insulin. 
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monitoring wavelengths, elution volumes, sieve coefficients 
and molecular weights were recorded (Table XXII). The pH 
remained at 7.42 throughout the study. 
In the remaining frontal gel studies, a nitrated insulin 
was utilized for column calibration. It was felt that a non-
associating marker with a molecular weight in the range of the 
insulin monomer was most desirable since this is the limiting 
molecular weight approached on continued dilution of the in-
sulin solutions. Because of the scarcity of a commercially 
available marker in this molecular weight range, a nitrated 
insulin was synthesized as discussed previously. Before using 
this compound as a marker, it was subjected to frontal gel 
chromatography at pH 7.42 to study its associative properties. 
As before, wavelengths had to be selected at which to monitor 
the elution profiles. Two solutions of the nitrated insulin 
were prepared, namely 0.5 and 0.05mg/ml. UV scans were per-
formed over the range of 210 to 370nm (Figure 58). Wavelengths 
of 305 and 220nm were selected at which to monitor the 0.5 and 
0.05mg/ml solutions, respectively. The nitrated insulin pre-
parations were then subjected to frontal gel chromatography 
after which the elution profiles were differentiated and the 
elution volumes determined (Figure 59). Elution volumes of 
8.71 and 8.75ml were obtained for the 0.5 and 0.05mg/ml 
solutions, respectively. In the previous study (Table XXII) 
non-nitrated insulins had elution volumes of 7.23 and 8.00ml 
for the same concentration range. These results seemed to 
indicate that the nitrated insulin did not aggregate at pH 7.42 
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Tl\BLE XXI I. Summary of results for the self-association 
of porcine zinc-free insulin as studied by frontal gel 
chromatography. 
Approx. Actual Monitoring v a ~ 
Cone. Cone. Wavelength e w w 
(mg/ml) (mg/ml) (HM) (ml) 
4 3.928 291 6.20 .1348 26,077 
2 1. 957 288 6.43 .1704 21,829 
1 .981 280 6.88 .2401 15,411 
. 9 .882 280 7.05 .2665 13,507 
. 7 .687 280 7.05 .2665 13,507 
. 5 .491 240 7.23 .2943 11,756 
. 3 .294 238 7.40 .3207 10,304 
.1 . 09 8 230 7.85 .3904 7,274 
. 05 .049 220 8.00 .4136 6,478 
* 
. 01 .0098 224 8.40 .4756 4,753 
* 
.005 .0049 212 8.47 .4864 4,503 
*Scale expansion utilized. 
... 
.. 
.. 
FIGURE 58~ UV scans of nitrated porcine insulins: Selection 
of wavelengths for monitoring during frontal gel chromato-
graphy. Buffer: 0.067M phosphate, pH 7.42; (-): 0.5mg/ml; 
(----).: O. 05mg/ml. 
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FIGURE 59 .. Frontal gel chromatography of nitrated porcine 
insulins.: Integral and differential elution profiles. 
Buffer: 0.067M phosphate, pH 7.42; Bed: Sephadex G-50 
(superfine); Bedheight: 9.0cm; Flow rate: 6rnl per hour; 
Sample: 0.5rng/rnl nitrated insulin (--) and 0.05rng/ml 
nitrated insulin (----); (••••):differentiation of the 
elution profil~s. 
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over the concentration range studied. The column was 
calibrated utilizing the markers discussed in Table VII. 
Elution .volumes were determined and sieve coefficients cal-
culated (Table XXIII). With the aid of the sieve coefficients, 
a standard curve was drawn as before (Figure 60). The slope 
was determined to be approximately -2.33 while that for 
Figuxe 54 was -2.00. Finally, solutions A, B and C were 
subjected to frontal gel chromatography in 0.067M phosphate 
buffer, pH 7.42. Details concerning the preparation and 
composition of these solutions are located in Chapter II under 
the CD aggregation study. UV scans of the stock solutions 
and dilutions (solutions A, B and C) were taken prior to the 
addition of cr+3 and zn+ 2 (Figure 61). Wavelengths of 239, 
234 and 229nm were chosen at which to monitor solutions A, B 
and C, respectively. The absorbance at 276nm and resulting 
insulin concentrations were determined for each solution 
(Table XXIV). Aliquots of cr+3 and zn+2 were added as addition 
pairs and the solutions incubated at room temperature for a 
total of 3 hours (Table XXV). Upon completion of the in-
cubation period, the solutions were subjected to frontal gel 
chromatography as discussed in Chapter II. Elution profiles 
representing solutions A, B and C for the "10µ1 dilute HCl-
50µ1 dilute HCl" addition pair are shown (Figure 62). To 
simplify matters, only that portion of the elution profile 
corresponding to the leading boundary is presented. Through 
differentiation of the elution profiles, elution volumes of 
7.50, 7.91 and 8.22rnl were obtained for solutions A, Band C, 
TABLE XXIII. Column calibration for the effect of Cr + 3 
and zn+ 2 on the self-association of porcine zinc-free 
insulin as studied by frontal gel chromatography. 
:1arker MW Vel (ml) V8 2 (ml) Ve3 (ml) 
** Blue·Dextran 2,000,000 4.58 4.67 4.54 
Carbonic 
Anhydrase 31,000 6.17 6.04 5.98 
Chymotrypsinogen 25,000 6.19 6.26 6.14 
Myoglobin 17,000 6.87 6.84 6.79 
Ribonuclease 12,600 7.44 7.42 7.30 
Nitrated Insulin 5,891 3.98 8.84 
*** K2Cr04 194 12.19 12.19 12.04 
*Result of 3 determinations except nitrated insulin 
(2 determinations). 
**Void volume (V0 ). 
***Total volume (Vt). 
ow 
.194 
.212 
.297 
.370 
.573 
* + SD 
+ .011 
+ .ooo 
+ .006 
+ .004 
+ .001 
-
... 
.. 
FIGURE 60~ Standard curve for the effect of cr+ 3 and 
zn+2 on the self-association of porcine zinc-free 
insulin as studied by frontal gel chromatography. 
Buffer: 0.067M phosphate, pH 7.42; Bed: Sephadex G-50 
(superfine); Bedheight: 9.0crn; Flow rate: 6ml per hour; 
CA: carbonic anhydrase; C: chyrnotrypsinogen; M: rnyoglobin; 
R: rihonuclease; In: nitra~ed insulin. 
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FIGURE 61~ UV scans of solutions A, B and C: Selection 
of wavelengths for monitoring during frontal gel chroma-
tography of porcine zinc-free insulin. Buffer: 0.067M 
phosphate, pII 7.42; A: stock (lmg/ml) insulin solution; 
B: solution A (O.Smg/ml); c. solutions B (0.25mg/ml); 
D: solution C (O.lmg/ml). 
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TAB~E XXIV. Absorbance at 276nm and resultin2 insulin 
·concentrations for the effect of cr+3 and zn+ on the 
self-association of procine zinc-free insulin as studied 
by frontal gel chromatography. 
Addition 
Pair' 
Stock Solution A Solution B Solution C 
* Cone. Cone. Cone. Cone. 
A276 (mg/ml) A276 (mg/ml) A276 (mg/ml) A276 (mg/ml) 
HCl-HCl** .957 .920 .478 .460 .182 .175 .096 .092 
Zn+ 2-EC1 .980 .942 .488 .469 .198 .190 .097 .093 
HC1-Cr+ 3 .972 .935 .485 .466 .185 .178 .098 .094 
Z + 2 " + 3 984 n -..._r . .946 .488 .469 .187 .180 .097 .093 
*Utilizing an extinction coefficient of 1.04 ODU/cm (mg/ml). 
**10µ1 dilute HCl-50µ1 dilute HCl, synonymous with the term 
"no addition". 
r 
261 
TABLE XXV. Incubation periods and additions for the effect 
of cr+J and zn+2 on the frontal gel chromatography of por-
cine zinc-free insulin. 
Addition 
Pair 0 to l. 5hrs l. 5 to 3hrs 
ECl-HCl 10µ1 dilute HCl 50µ1 dilute HCl 
Zn+ 2 -HC1 10µ1 Zn +2 50µ1 dilute HCl 
HC1-Cr+ 3 10µ1 dilute HCl 50µ1 Cr+ 3 
Zn +2 c +3 - r 10µ1 zn+ 2 50µ1 Cr+ 3 
r 
... 
.. 
.. 
FIGURE 62~ Elution profiles for the frontal gel chroma-
tography of porcine zinc-free insulin: No addition. 
Buffer: 0.067M phosphate, pH 7.42; Bed: Sephadex G-50 
(superfine); Bedheight: 9.0cm; Flow rate: 6.0ml per hour; 
Addition pair: 10µ1 dilute I-ICl-50µ1 dilute HCl; (--): 
solution A; (----): solution B; ( · · · ·): sol:1tion C. 
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respectively. Similarly, elution profiles representing 
solutions A, B and C for the "10µ1 dilute HCl-50µ1 cr+3,, 
addition pair are shown (Figure 63). In this case elution 
volumes of 7.51, 7.95 and 8.24ml were obtained for solutions 
A, B and C, respectively. It is quite clear that very little 
difference exists between this and the previous addition pair. 
The third addition pair studied was "10µ1 Zn+ 2-50µl dilute 
HCl". The elution profiles representing solutions A, Band 
C for this addition pair along with elution profiles for 
solutions:A, B and C in the absence of zn+ 2 are shown (Figure 64). 
For the Zn+ 2 addition pair, elution volumes of 6.93, 7.74 and 
8.26ml were obtained for solutions A, B and C, respectively. 
+2 +3 . Finally, the addition pair "10µ1 Zn -50µ·1 Cr " was studied 
(Figure 65). Elution volumes of 7.41, 7.89 and 8.23ml were 
obtained for solutions A, B and C, respectively. It is ob-
vious that zn+ 2 does not have the same effect on elution volume 
in the presence of cr+ 3 as in its absence. To clarify the 
matter, elution profiles for solutions A, B and C in the pre-
+2 +2 +3 sence of Zn and in the presence of Zn and Cr are shown 
(Figure 66). Sieve coefficients were then calculated and 
molecular weights determined from the previously prepared 
standard curve. A summary including these values for all addi-
tion pairs to solutions A, B and C is presented (Table XXVI). 
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FIGURE 63. Elution profiles for the frontal gel chroma-
tography of porcine zinc-free insulin: Effect of cr+3. 
Buffer: 0.067M phosphate, pH 7.42; Bed: Sephadex G-50 
(superfine); Bedheight: 9.0cm; Flow rate: 6.0ml per hour; 
Addition pair: 10µ1 dilute HCl-50µ1 cr+3; (~-): solution 
A;(----): solutionB; (••••): solutionC. 
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FIGURE 64.· Elution profiles for the frontal gel chro-
matography of porcine zinc-free insulin: Effect of zn+2 
compared to no addition. Buffer: 0.067M phosphate, 
pH 7.42; Bed: Sephadex G-50 (superfine); Bedheight: 
9.0cm; Flow rate: 6ml per hour; Addition pairs: 10µ1 
zn+2_50µ1 dilute llCl (-) and 10µ1 dilute HCl-50µ1 
dilute HCl (-·-·-·); A: solution A; B: solution B; 
C: solution C. 
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FIGURE 65.' Elution profiles for the frontal gel chro-
matography of porcine zinc-free ins·-ilin: Effect of zn+2 
and cr+3. Buffer: 0.067M phosphate, pH 7.42; Bed: 
Sephadex G-50 (superfine); Bedheight: 9.0cm; Flow rate: 
6ml per hour; Addition pair: 10µ1 zn+2_50µ1 cr+3; 
(--): solution A; (----): solution B; ( • • • ·): solution 
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FIGURE 66: Elution profiles for the frontal gel chro-
matography of porcine zinc-free insulin: Effect of zn+2 
and cr+3 compared to effect of zn+2. Buffer: 0.067M 
phosphate, pH 7.42; Bed: Sephadex G-50 (superfine); 
Bedheight: 9.0crn; Flow rate: 6ml per hour; Addition pairs: 
10µ1 zn+2-soµl cr+3 (---) and 10µ1 zn+2_50µ1 dilute HCl 
(~-);A: solution A; B: solution B; C: solution C. 
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TABLE XXVI. Elution volumes, sieve coefficients and molecular weights of 
solutions A, B and c for the effect of zn+2 and cr+3 on the frontal gel 
chromatography of porcine zinc-free insulin. 
Solution 
Ve 
(ml) 
* HCl-BCl 
aw M w 
zn+ 2-Hcl 
Ve aw M w 
(ml) ~~- -~~-
HC1-Cr+3 
Ve aw MW 
(ml) ____ _ 
v 
e 
(ml) 
Z +2 c +3 n - r 
aw MW 
A 7.50 .3846 12,502 6.93 .3090 16,866 7.51 .3859 12,438 7.41 .3727 13,105 
B 7.91 .4390 10,079 7.74 .4164 11,022 7.95 .4443 9,870 7.89 .4363 10,187 
c 8.22 .4801 8,565 8.26 .4854 8,387 8.24 .4828 8,474 8.23 .4814 8,521 
*Refers to addition pair (10µ1 dilute HCl-50µ1 dilute HCl). 
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CHAPTER IV 
DISCUSSION AND CONCLUSION 
It is the purpose of this dissertation to provide 
evidence for an interaction between insulin and trivalent 
chromium with particular emphasis on the associative-
dissociative process of insulin. Although the techniques of 
infrared analysis of hydrogen-deuterium exchange and thermal 
denaturation of insulin-chromium (III) solutions provided 
valuable evidence for an interaction between insulin and chro-
mium they did not focus on the aggregation process. Possible 
conclusions concerning these two techniques were included in 
Chapter III and will not be discussed further. The remainder 
of this discussion will be concerned with the techniques of 
circular dichroism spectroscopy and frontal gel chromatography 
which were specifically selected to provide evidence for the 
effect of trivalent chromium on insulin aggregation. Before 
continuing, however, let us briefly discuss the topic of 
chromium and insulin concentrations utilized in this disserta-
tion and how they related to physiological levels. Feldman 
(18) reported an average plasma chromium concentration of 29ppb. 
It has also been suggested (19) that plasma concentrations of 
chromium may only represent 1/100 of the chromium concentrations 
in most organs. With these figures in mind and equating lppb 
with lng/ml we can arrive at an approximation of plasma and 
209 
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tissue chromium levels. 
TABLE XXVII. Approximate physiological levels of insulin, 
chromium and zinc. 
Plasma chromium 
Tissue chromium 
Plasma Insulin (116) 
Plasma Zinc (116) 
Concentration 
(M) 
10-7 
10-5 
10- 9 
10- 5 
With regard to the chromium levels, the reader must be cau-
tioned that a great deal of uncertainty exists in these values. 
Low chromium levels do not necessarily indicate chromium de-
f iciency since the metal is rapidly sequestered by certain 
tissues. Plasma levels are more appropriately a measure of 
the most recent dietary intake. It should also be pointed out 
that plasma chromium concentrations increased considerably after 
oral administration of glucose in both healthy subjects and 
certain cases of impaired glucose tolerance (50). No inform-
ation could be obtained regarding a similar behavior for zinc. 
As a result plasma chromium concentrations may vary considerably 
and it doesn't seem unreasonable to say that plasma chromium 
levels may attain a level equal or greater than plasma zinc. 
It can be seen from the data of Table XXVII that the chromium 
to insulin ratio may be in the vicinity of 100 to 1. Whether 
the same ratio exists at the tissue receptor level is unknown 
since insulin and chromium concentrations at these sites cannot 
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be determined at present. Information such as this would be 
extremely valuable since it may implicate the concentration 
dependent insulin aggregation process in the regulation of 
insulin action. 
With regard to the circular dichroism and frontal gel 
chromatography studies of this dissertation, the following 
concentrations were utilized. 
TABLE XXVIII. Experimental values for insulin, chromium and 
zinc concentrations. 
Chromium 
Insulin 
Zinc 
Approximate Concentration 
(M) 
Circular Frontal 
Dichroism Gel 
10-4 10-4 
10-5 10-5 
10-5 10-5 
Insulin concentrations as low as l0- 6M (.005mg/ml) were studied 
by means of frontal gel chromatography (Table XXII). In this 
case an expanded scale had to be utilized on the UV monitor 
in order to obtain an adequate response. This resulted in error 
in the elution profile due to noise amplification. The lower 
limit of insulin concentration for frontal gel chromatography 
without scale expansion was of the order of l0- 5M (0.05mg/ml). 
Also, the same concentration (l0- 5M) was the lower limit for 
an adequate response in the near-UV circular dichroism spectre-
scopy studies (Figure 40). Clearly, in both cases above, the 
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most dilute working solutions resulting in reliable data were 
selected. 
As discussed in Chapter II, circular dichroism spectro-
scopy represented an excellent technique for studying the 
association-dissociation process of insulin. That trivalent 
chromium (the primary component of the glucose tolerance factor) 
caused a significant change in the near-UV circular dichroism 
spectrum of bovine zinc insulin was shown in Figure 40. It 
is evident that the addition of chromium resulted in a signi-
ficant diminution of the circular dichroism spectrum of insulin. 
Several interpretations are available for this behavior. The 
most obvious is that the process represents dissociation of 
a higher aggregated insulin species since dissociation is re-
lated to a decrease in the circular dichroism spectrum and 
association is related to an increase in the spectrum (122). 
Changes in the near-UV circular dichroism region (250 to 320nm) 
result mainly from changes in the orientation of the tyrosyl 
residues of insulin as a consequence of the state of aggregation 
(124). Clearly, as insulin associates or dissociates, these 
essential residues will either become exposed or buried. See 
Chapter I for details concerning orientation of specific residues 
of the insulin monomer on association. To draw an analogy, 
Frank et al. (160), reported a molecular weight of 17,500 for 
porcine zinc insulin at a concentration of O.lmg/ml and a 
zinc-to-insulin ratio of 1/3 in 0.03M phosphate buffer, pH 7.02. 
The conditions of Figure 40 were identical except for the use 
of 0.067M phosphate buffer, pH 7.42 which probably makes a 
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negligible contribution to the molecular weight in comparison. 
Considering a MW of 5778 for the insulin monomer, it is clear 
that the observed CD change could be the result of a dissocia-
tive process. Just exactly how cr+ 3 accomplished this process 
is not quite clear. One explanation may be a direct inter-
action with zinc at the level of the BlO histidines which are 
involved in the conversion of dimer to hexamer (Figure 12). 
The rationale behind this statement stems from an equilibrium 
dialysis binding study in 0.02M phosphate buffer, pH 7.4, 
concerning the binding of trivalent chromium to various bio-
logical substances (161}. Of all the amino acids studied, 
histidine had the most outstanding coordinating ability with 
respect to trivalent chromium. Also, changes in the near-UV 
circular dichroism spectrum of insulin in the presence of zinc 
have been attributed to hexamer formation (Figure 14). If the 
observed CD changes are due to dimer-monomer conversion, then 
+3 Cr would have to affect dissociation at the level of the re-
sidues responsible for dimer formation, particularly the nonpolar 
sidechains of the B21 to B30 residues (Figure 10). This is a 
rather interesting point since the hydrophobic residues such 
as B24 Phe, B25 Phe, B26 Tyr, Bl2 Val and Bl6 Tyr may be in-
valved in receptor binding (121). Another interpretation for 
the observed CD changes resulting from chromium interaction may 
involve reaction of the metal with a non-specific surface residue 
leading to a conformational change which indirectly results in 
the release of zinc and consequent dissociation of the hexamer. 
At the dimer level, the conformational change would have to 
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disturb the beta-pleated sheet structure formed between re-
sidues in the B21 to B30 region (Figure 11). 
That cr+3 would induce the same effect on insulin 
conformation in the presence of high ionic strength can be 
seen by comparing Figures 40 and 41. Although slight dif-
ferences in the CD spectrum are evident, the same basic change 
(diminution of the CD response) occurred in the presence of 
trivalent chromium. It must be remembered that in these two 
cases the insulin concentration was approximately O.lmg/ml and 
the chromium-to-insulin ratio was 10/1. A similar study uti-
lizing a ratio of 0.58/1 resulted in no change in the CD 
spectrum of zinc insulin. Ratios between 0.58/l and 10/1 were 
not studied in this segment. Thus far, the only conclusion 
that could be drawn is that trivalent chromium at a chromium-
to-insulin ratio between 0.58/1 and 10/1 induces a significant 
change in the near-UV circular dichroism spectrum of insulin 
at physiological pH. Higher chromium concentrations produce 
basically the same change (Figure 42), however solubilization 
problems are encountered as discussed in Chapter II. 
The time dependency for trivalent chromium to produce 
the change in the CD spectrum of bovine zinc insulin was of 
the order of 23 minutes (Figure 43). If one compares curve 
"C" of Figure 43 with the respective curve of Figure 40, it is 
obvious that no further change occurred between 23 minutes and 
1 hour. Such a long period for trivalent chromium to achieve 
its effect does not seem unreasonable since it is well docu-
mented (25) that this metal, in this state, has a strong 
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tendency to form complexes whose ligand rates of exchange are 
low (half-times of several hours). 
Up to now we have been dealing with the effect of 
trivalent chromium on the CD spectrum of bovine zinc insulin. 
In Figures 45 and 46 the insulin was of porcine origin. The 
same effect of trivalent chromium was observed (162), however, 
there were obvious differences in the absolute ellipticities 
attained. Porcine insulin differs from that of bovine origin 
in that it contains threonine and isoleucine at positions 8 
and 10 in the "A" chain while bovine insulin contains alanine 
and valine at these positions. One point that deserves men-
tion with regard to Figure 45 is that consistent decreases in 
the CD spectrum were observed when trivalent chromium was 
added to porcine "zinc-free" insulin. The reader will recall 
that up to this point the major topic of discussion concerned 
"zinc insulin". Since the insulin preparation was termed "zinc-
free" it was tempting to assume that displacement of zinc by 
chromium could be eliminated as one of the mechanisms of action 
of chromium. This cannot be done, however, since a minimum 
amount of zinc was supposedly present (less than 0.035 g-atom 
of zinc per mole of insulin). In comparison, the zinc insulin 
contained 0.44 g-atom per mole of insulin. The term "zinc-free" 
is used commonly and usually represents a maximal effort to 
remove most of the zinc. 
The associative process can be viewed in another manner 
as described in Chapter II. The basic principle revolves about 
the fact that differences exist between non-aggregating and 
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aggregating protein systems with respect to their circular 
dichroisrn spectra; pairing protein concentration and cell 
size such that the product equals one. For example: (lmg/ml 
and lcm), (0.Smg/ml and 2cm) and (O.lmg/ml and lOcrn). For 
an interacting protein system sucllias insulin which undergoes 
a concentration dependent association, CD spectra representing 
each pair will differ. The behavior of porcine zinc-free in-
sulin in this system was shown in Figure 48. The different 
degrees of association are evident. In an attempt to elimi-
nate the effects due to the presence of trace amounts of zinc, 
the same experiment was performed in the presence of EDTA 
(Figure 49). Basically, the same spectra were obtained. Two 
interpretations can be made: (1) The amount of zinc present 
was insufficient to induce association resulting in no CD 
change in the presence of EDTA. The degree of association 
observed would be solely due to side chain interactions bet-
ween monomers. (2) Both zinc and the zinc-EDTA complex have the 
same affinity for the essential histidines involved in the zinc 
induced aggregation. The situation would also lead to no 
change in the CD spectrum in the presence of EDTA. This seems 
unlikely since EDTA has been used as a precaution against the 
effects of metal ion contamination during a sedimentation 
equilibrium study involving the self-association of porcine 
insulin at pH 7.00 (126). The available evidence seems to 
favor the first interpretation. In a similar manner, trivalent 
chromium was added to porcine zinc-free insulin (Figure 50) . 
At a first glance the CD changes seem to be somewhat decreased 
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when compared to Figure 48 which can be referred to as a 
"baseline" CD change to which all others are compared. Taking 
a closer look (Table XVII), it is obvious that the value re-
presenting solution A for the HC1-Cr+ 3 addition pair is some-
what decreased at 274nm in comparison to the values repre-
senting solutions B and C which seem to be much closer to the 
respective values for the HCl-HCl addition pair. The data 
seemed to indicate that trivalent chromium resulted in a dis-· 
sociative effect for solution A whereas solutions B and C 
were unaffected (163). Once again zinc was added to zinc-free 
insulin (Figure 51). An expected aggregation related increase 
in the CD spectra was observed for all solutions with a more 
pronounced effect for solution A and less of an effect for 
solutions B and C when compared to "no addition" (Figure 48, 
Table XVII). The addition of both Cr+ 3 and Zn+ 2 (Figure 52, 
Table XVII) resulted in very little to no change in comparison 
to "no addition" (Figure 48, Table XVII). It is obvious that 
zinc did not cause an associative effect in the presence of 
trivalent chromium. Since the same results were obtained ir-
respective of the sequence of addition, the above statement can 
be turned around to say that trivalent chromium resulted in a 
dissociation of the zinc-induced aggregated species. Also, in 
the other cases, the reversal of the addition sequence pro-
duced the same CD change resulting in only one sequence being 
discussed. 
So far the data seem to indicate that trivalent chromium 
has a dissociative effect on the zinc induced insulin aggregate. 
/ 
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It was estimated (Figure 43) that the reaction was completed 
in about 23 minutes. To take a closer look, the ability of 
trivalent chromium to produce a decrease in the CD spectrum 
of zinc insulin was followed with time at 276nm (Figure 53). 
If it is assumed that no further change occurred after 30 
minutes, the total CD change can be calculated (Table XX). 
It is obvious that the greatest effect was produced within 
the first 10 minutes. 
The remainder of this discussion will be centered about 
defining molecular weight variations that occur upon the addi-
tion of trivalent chromium to zinc insulin. The technique of 
frontal gel chromatography was utilized in an attempt to aid 
in the clarification of the previously discussed circular 
dichroism changes. The technique was adapted to study insulin 
aggregation on a small scale utilizing a 1.2 x 9cm. column such 
that a total of 65mg of insulin was all that was required for 
the complete study. That an aggregating protein system such 
as insulin can be studied by frontal gel chromatography was 
clearly established (164, Table XXII). Insulin concentrations 
over the range of 0.005 to 4mg/ml were studied and molecular 
weights from 4,503 to 26,077, respectively, were determined. 
This is in excellent agreement with ultracentrifugational data 
concerning insulin association at neutral pH (115) . Let us 
now turn to the topic of "standard curves" which play a 
critical role in the determination of molecular weight dis-
tribution by frontal gel chromatography. It is obvious from 
Table XXII that the molecular weight of the insulin monomer 
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will be less than 4,503 when it is actually 5,778. Such 
variance is not unreasonable since there is a small amount 
of deviation in the sieve coefficient for a single protein 
as determined by repetitive chromatography. For example, 
for chymotrypsinogen (MW 25,000) the sieve coefficient was 
reported as .131 ~ .006 for two successive experiments. On 
the other hand, the sieve coefficient for myoglobin (MW 17,700) 
was .207 + .001. The larger proteins (MW greater than 25,000) 
seemed to deviate somewhat more on repetitive chromatography 
(Table XXI). A closer look should be taken at the standard 
curve for this frontal gel experiment (Figure 54). It is ob-
vious that a curve with a greater slope would have resulted in 
a larger molecular weight for the insulin monomer. It was 
reasoned that such a curve may have resulted if the two limiting 
proteins, namely ovalbumin (MW 45,000) and ACTH (MW 4,500) were 
eliminated. The reader will recall from Table XXI that the 
sieve coefficient for ACTH was determined to be in the range of 
.484 to .488. Insulin monomer, which has a molecular weight 
greater than that of ACTH should have exhibited a sieve co-
efficient somewhat less than that of ACTH. Keeping in mind 
that the sieve coefficient for the insulin monomer is approached 
upon dilution, it is obvious that its final value will be in the 
range of that for ACTH (Table XXII). The reader should also 
be aware that the difference in molecular weight for insulin and 
ACTH is only small and it is reasonable to assume that they 
may not be separable under the conditions of this technique. 
In any event it was decided to replace this protein by a 
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nitrated insulin (MW 5891). For ovalburnin, it was felt that 
it eluted with a volume too near that of blue dextran which 
was used in the determination of void volume and was com-
pletely excluded from the resin. For the remaining experiments 
ovalbumin was replaced by carbonic anhydrase (MW 31,000). 
Before continuing, the use of nitrated insulin for a 
marker protein should be discussed. The procedure and results 
concerning the synthesis of this insulin derivative were in-
cluded in Chapters II and III. Basically, any protein utilized 
for column calibration should not possess aggregating pro-
perties. That this derivative did not aggregate over the 
concentration range of 0.05 to 0.5mg/ml was clearly shown 
(Figure 59). In comparison, insulin (non nitrated) exhibited 
molecular weights of 6,478 and 11,756 at 0.05 and 0.5mg/ml, 
respectively (Table XXII). Finally the column was calibrated 
with the new series of markers (Table XXIII) and a standard 
curve drawn (Figure 60). The slope of this curve was -2.33 
in comparison to the previous curve which was -2.00. In 
any event, this curve was selected for the experimentation 
involving the effect of trivalent chromium on insulin mole-
cular weight distribution. 
Solutions A, B and c, identical to those used in the 
CD aggregation study, were prepared as described in Chapter 
II. A description of the various additions and insulin con-
centrations for solutions A, B and C in this study were located 
in Table XXIV. When the series representing "no addition" to 
insulin (Table XXIV) was subjected to frontal gel chromatography, 
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a clear separation of the leading boundaries representing each 
solution was achieved (Figure 62). Utilizing the standard 
curve, the molecular weights were determined to be 12,502, 
10,079 and 8,565 for solutions A, B and C, respectively 
(Table XXVI). This provides excellent supportive evidence 
that the changes observed for zinc-free insulin in the previous 
CD study (Figure 48) most likely represented an aggregation 
process. When trivalent chromium was added to zinc free 
insulin, very little change resulted in the molecular weight 
distribution (Figure 63, Table XXVI) when compared to "no 
addition". The reader will recall, that in the CD aggregation 
study (Figure 50, Table XVII), the addition of trivalent chro-
mium resulted in a decreased CD spectrum for solution A whereas 
solutions B and C were basically unaffected. Now, it may be 
that the aggregation process was affected, but it was too sub-
tle to be picked up by frontal gel chromatography. In any 
event, the available CD evidence seems to indicate that tri-
valent chromium has a definite effect on zinc-free insulin 
conformation at a concentration of 0.5mg/ml and it most likely 
represents a direct interaction at the level of the residues 
responsible for dimer formation. +2 +2 When Zn as the "Zn -
dilute HCl" addition pair was added to zinc-free insulin, an 
aggregation related increase in weight-average molecular 
weight (Mw) and consequent decrease in elution volume (Ve) was 
obtained (Figure 64). Weight average molecular weights of 
16,866, 11,022 and 8,387 were obtained for solutions A, B and 
C, respectively (Table XXVI). The increase in Mw was probably 
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due to a shift of the equilibrium toward hexamer formation 
(Figure 12). Finally, when zn+ 2 and cr+3 were present 
together, irregardless of the sequence of addition, the zinc-
induced aggregation of insulin did not occur and the weight-
average molecular weights remained very similar to the values 
corresponding to "no addition", namely "dilute HCl-dilute HCl". 
The only exception was that the ~ for solution A in the pre-
sence of zn+ 2 was somewhat higher than that for "no addition" 
(Table XXVI), indicating that the species did not dissociate 
to the same extent in the presence of cr+3. To place this 
situation into perspective, the elution profiles representing 
"no addition" and "zn+2_cr+3" were shown together (Figure 66). 
These data are in excellent agreement with the circular dich-
roism spectroscopy data discussed above. Clearly, insulin 
did not associate to the same extent in the presence of zn+ 2 
when cr+3 was present. 
Previous investigators have labeled trivalent chromium 
as a co-factor of insulin (161) and yet a direct relationship 
on a molecular level between trivalent chromium and insulin has 
never been established. The results of this dissertation have 
provided evidence for such a relationship and as a result have 
contributed toward the understanding of the mechanism of action 
of this trace metal. As far as the site of such a reaction 
is concerned, one can only speculate. It may be that trivalent 
chromium acts at the level of the pancreatic beta cell, facili-
tating the release of insulin through its dissociative effect. 
On the other hand, the dissociative effect of trivalent chromium 
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on insulin may be involved at the level of the insulin 
receptor. Whether the aggregation phenomenon of insulin 
plays a role in insulin action remains a mystery. Since the 
discovery some time ago that chromium was a major component 
of the glucose tolerance factor, a wide variety of data has 
been published linking this element with impaired glucose 
tolerance and indirectly with insulin action. In view of the 
fact that the identity of the glucose tolerance factor is as 
yet unknown, and that crude extracts of glucose tolerance 
factor and synthetic complexes resembling this factor have 
significantly greater effects on glucose oxidation in the 
presence of insulin than insulin alone, it seems reasonable 
to predict that trivalent chromium, when part of the glucose 
tolerance factor, is at an optimal sterochemical orientation 
to permit maximum interaction with insulin. 
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